Back to Journals » Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment


Journal Articles:

- 3,000 records -

Characteristics of Patients with Meningeal Carcinomatosis Combined with Myelopathy

Jiao L, Wei M, Fu Y

Neuropsychiatric Disease and Treatment 2022, 18:1069-1075

Published Date: 19 May 2022

Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes

Khandker R, Shepherd J, Chekani F, Qureshi Z, Bailey H, Berry M, Wright J, Massey L

Neuropsychiatric Disease and Treatment 2022, 18:1057-1067

Published Date: 18 May 2022

Epilepsy Stigma Among University Students in Makkah: A Cross-Sectional Study

Alkhotani AM, Alkhotani AM

Neuropsychiatric Disease and Treatment 2022, 18:1047-1056

Published Date: 17 May 2022

Association of Pain with Plasma C5a in Patients with Neuromyelitis Optica Spectrum Disorders During Remission

Tong Y, Liu J, Yang T, Wang J, Zhao T, Kang Y, Fan Y

Neuropsychiatric Disease and Treatment 2022, 18:1039-1046

Published Date: 17 May 2022

Tenecteplase in Ischemic Stroke: Challenge and Opportunity

Li G, Wang C, Wang S, Xiong Y, Zhao X

Neuropsychiatric Disease and Treatment 2022, 18:1013-1026

Published Date: 11 May 2022

Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia

Culpepper L, Vieta E, Kelly DL, Patel MD, Szatmári B, Hankinson A, Earley WR

Neuropsychiatric Disease and Treatment 2022, 18:995-1011

Published Date: 12 May 2022

Association Between the Neutrophil-to-Lymphocyte Ratio and Adverse Clinical Prognosis in Patients with Spontaneous Intracerebral Hemorrhage

Du Y, Wang A, Zhang J, Zhang X, Li N, Liu X, Wang W, Zhao X, Bian L

Neuropsychiatric Disease and Treatment 2022, 18:985-993

Published Date: 10 May 2022

Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection

Moga S, Teodorescu A, Ifteni P, Petric PS, Miron AA

Neuropsychiatric Disease and Treatment 2022, 18:977-983

Published Date: 4 May 2022

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Basurte-Villamor I, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N

Neuropsychiatric Disease and Treatment 2022, 18:965-976

Published Date: 4 May 2022

Efficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study

Meng X, Zeng Z, Wang Y, Guo S, Wang C, Wang B, Guo S

Neuropsychiatric Disease and Treatment 2022, 18:953-964

Published Date: 3 May 2022

Elevated Serum Complement C1q Levels After Traumatic Brain Injury [Letter]

Paiva WS, Ortiz J, Amorim RL

Neuropsychiatric Disease and Treatment 2022, 18:951-952

Published Date: 4 May 2022

Serum Calcium Levels and in-Hospital Infection Risk in Patients with Acute Ischemic Stroke

Chen X, Liang X, Zhang J, Chen L, Sun J, Cai X

Neuropsychiatric Disease and Treatment 2022, 18:943-950

Published Date: 3 May 2022

Venous Flow Profiles on Perfusion CT are Associated with Futile Recanalization After Thrombectomy

Su M, Chen Z, Chen X, Huang J, Li Z, Zhou Y, Xu G

Neuropsychiatric Disease and Treatment 2022, 18:933-942

Published Date: 29 April 2022

Effects of Atorvastatin Therapy on Postoperative Delirium After Malignant Tumor Surgeries in Older Adults

Wan R, Cai S, Pan D, Yang W, Zhou R

Neuropsychiatric Disease and Treatment 2022, 18:915-923

Published Date: 19 April 2022

Influence of Pre-Existing Cerebral Small Vessel Disease on the Outcome of Acute Cardioembolic Stroke: A Retrospective Study

Su Y, Guo Y, Chen Z, Zhang M, Liu J, Wang Q, Yao T

Neuropsychiatric Disease and Treatment 2022, 18:899-905

Published Date: 15 April 2022

Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study

Sugawara N, Yasui-Furukori N, Yamada S, Aoki M, Takeuchi Y, Miyazaki K, Shimoda K

Neuropsychiatric Disease and Treatment 2022, 18:891-897

Published Date: 15 April 2022

Risk Factors for Depression in Tuberculosis Patients: A Meta-Analysis

Shen R, Zong K, Liu J, Zhang L

Neuropsychiatric Disease and Treatment 2022, 18:847-866

Published Date: 11 April 2022

Effectiveness and Quality of Life with Paliperidone Palmitate 3-Monthly in Comparison with Other Long-Acting Drugs

Di Lorenzo R, Iorio A, Pinelli M, Magarini F, Marchi M, Sacchetti A, Calogero C, Galeazzi GM, Ferri P, Rovesti S, Minarini A

Neuropsychiatric Disease and Treatment 2022, 18:829-846

Published Date: 12 April 2022

Study on the Correlation Between Iris Characteristics and Schizophrenia

Tian C, Duan L, Fu C, He J, Dai J, Zhu G

Neuropsychiatric Disease and Treatment 2022, 18:811-820

Published Date: 8 April 2022

Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study

Ikenouchi A, Konno Y, Fujino Y, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R

Neuropsychiatric Disease and Treatment 2022, 18:801-809

Published Date: 8 April 2022

Hallucinations and Other Psychotic Symptoms in Patients with Borderline Personality Disorder

Belohradova Minarikova K, Prasko J, Holubova M, Vanek J, Kantor K, Slepecky M, Latalova K, Ociskova M

Neuropsychiatric Disease and Treatment 2022, 18:787-799

Published Date: 8 April 2022

Psychometric Evaluation of the Polish Version of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD)

Nowak P, Narayanan U, Szmurło M, Krzyżańska A, Głowacki M, Misterska E, Jóźwiak M

Neuropsychiatric Disease and Treatment 2022, 18:773-785

Published Date: 7 April 2022

Swimming Exercise Modulates Gut Microbiota in CUMS-Induced Depressed Mice

Xie Y, Wu Z, Zhou L, Sun L, Xiao L, Wang G

Neuropsychiatric Disease and Treatment 2022, 18:749-760

Published Date: 5 April 2022

CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations

Li YH, Huang W, Xiao MY, Huang SQ, Chen H, Li ZF, Li XS, Cheng Y

Neuropsychiatric Disease and Treatment 2022, 18:731-736

Published Date: 2 April 2022

Abnormalities of Gray Matter Volume and Its Correlation with Clinical Symptoms in Adolescents with High-Functioning Autism Spectrum Disorder

Zhao X, Zhu S, Cao Y, Cheng P, Lin Y, Sun Z, Jiang W, Du Y

Neuropsychiatric Disease and Treatment 2022, 18:717-730

Published Date: 1 April 2022

Kinesiophobia in Elderly Polish Patients After Ischemic Stroke, Including Frailty Syndrome

Bąk E, Młynarska A, Marcisz C, Kadłubowska M, Marcisz-Dyla E, Sternal D, Młynarski R, Krzemińska S

Neuropsychiatric Disease and Treatment 2022, 18:707-715

Published Date: 31 March 2022

Effect of Early Swimming on the Behavior and Striatal Transcriptome of the Shank3 Knockout Rat Model of Autism

Meng Y, Xu D, Zhang W, Meng W, Lan XY, Wang X, Li M, Zhang X, Zhao Y, Yang H, Zhang R, Zhen Z

Neuropsychiatric Disease and Treatment 2022, 18:681-694

Published Date: 31 March 2022

Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial

Chen S, Xu Z, Li Y, Wang T, Yue Y, Hou Z, You L, Lu N, Yin Y, Liu X, Tan L, Ji H, Shi Y, Xin X, Jiang W, Yuan Y

Neuropsychiatric Disease and Treatment 2022, 18:669-679

Published Date: 29 March 2022

XGBoost Machine Learning Algorithm for Prediction of Outcome in Aneurysmal Subarachnoid Hemorrhage

Wang R, Zhang J, Shan B, He M, Xu J

Neuropsychiatric Disease and Treatment 2022, 18:659-667

Published Date: 29 March 2022

Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene Expression

Chen CC, Nakano T, Hsu LW, Chu CY, Huang KT

Neuropsychiatric Disease and Treatment 2022, 18:645-657

Published Date: 23 March 2022

Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey

Hermanowicz N, Ospina MC, Torres-Yaghi Y, Gould S, Papesh K, Rivera JA, Miller S, Jones S, Musick K, May D

Neuropsychiatric Disease and Treatment 2022, 18:633-643

Published Date: 23 March 2022

Between Personality Traits and Postpartum Depression: The Mediated Role of Maternal Self-Efficacy

Han L, Zhang J, Yang J, Yang X, Bai H

Neuropsychiatric Disease and Treatment 2022, 18:597-609

Published Date: 19 March 2022

Fasting Blood-Glucose Level and Clinical Outcome in Anterior Circulation Ischemic Stroke of Different Age Groups After Endovascular Treatment

Yuan L, Sun Y, Huang X, Xu X, Xu J, Xu Y, Yang Q, Zhu Y, Zhou Z

Neuropsychiatric Disease and Treatment 2022, 18:575-583

Published Date: 18 March 2022

Prevalence and Consequences of Cerebral Small Vessel Diseases: A Cross-Sectional Study Based on Community People Plotted Against 5-Year Age Strata

Mu R, Qin X, Guo Z, Meng Z, Liu F, Zhuang Z, Zheng W, Li X, Yang P, Feng Y, Jiang Y, Zhu X

Neuropsychiatric Disease and Treatment 2022, 18:499-512

Published Date: 3 March 2022

Role of Calcium Homeostasis in Alzheimer’s Disease

Ge M, Zhang J, Chen S, Huang Y, Chen W, He L, Zhang Y

Neuropsychiatric Disease and Treatment 2022, 18:487-498

Published Date: 3 March 2022

The Index of Esophageal Cancer Related Ischemic Stroke: A Retrospective Patient Control Study

Liu Y, Lu L, Cheng X, Qin Q, Wei Y, Wang D, Li H, Li G, Liang H, Li S, Liang Z

Neuropsychiatric Disease and Treatment 2022, 18:477-485

Published Date: 2 March 2022

Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan

Yen K, Liu CC, Lin YT, Chien YL, Hsieh MH, Liu CM, Hwang TJ, Liao WH, Hwu HG

Neuropsychiatric Disease and Treatment 2022, 18:465-475

Published Date: 1 March 2022

Research Progress in the Study of Startle Reflex to Disease States

Zhang J, Wang M, Wei B, Shi J, Yu T

Neuropsychiatric Disease and Treatment 2022, 18:427-435

Published Date: 24 February 2022

Interleukin-6 as Predictor of One-Year Cognitive Function After Ischemic Stroke or TIA

Wang Y, Li J, Pan Y, Wang M, Lin J, Meng X, Liao X, Wang Y

Neuropsychiatric Disease and Treatment 2022, 18:391-399

Published Date: 22 February 2022

Depression in Osteoarthritis: Current Understanding

Wang ST, Ni GX

Neuropsychiatric Disease and Treatment 2022, 18:375-389

Published Date: 22 February 2022

Therapeutic Potential of Vortioxetine for Anhedonia-Like Symptoms in Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

Watanabe K, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Inoue T

Neuropsychiatric Disease and Treatment 2022, 18:363-373

Published Date: 19 February 2022

Use of DWI-FLAIR Mismatch to Estimate the Onset Time in Wake-Up Strokes

Zhang J, Ta N, Fu M, Tian FH, Wang J, Zhang T, Wang B

Neuropsychiatric Disease and Treatment 2022, 18:355-361

Published Date: 21 February 2022

Validation of the Chinese Version of the Autism Diagnostic Interview-Revised in Autism Spectrum Disorder

Huang CF, Lin YS, Chiu YN, Gau SSF, Chen VCH, Lin CF, Hsieh YH, Liu WS, Chan HL, Wu YY

Neuropsychiatric Disease and Treatment 2022, 18:327-339

Published Date: 18 February 2022

Stress and Coping in Nurses Taking Care of People Living with HIV in Hunan, China: A Descriptive Qualitative Study

Pan C, Wang H, Chen M, Cai Y, Li P, Xiao C, Tang Q, Koniak-Griffin D

Neuropsychiatric Disease and Treatment 2022, 18:303-315

Published Date: 17 February 2022

Victimization in Childhood Influences Presenteeism in Adulthood via Mediation by Neuroticism and Perceived Job Stressors

Hashimoto S, Ichiki M, Ishii Y, Morishita C, Shimura A, Kusumi I, Inoue T, Masuya J

Neuropsychiatric Disease and Treatment 2022, 18:265-274

Published Date: 15 February 2022

Childhood Victimization and Neuroticism Mediate the Effects of Childhood Abuse on Adulthood Depressive Symptoms in Volunteers

Masuya J, Ichiki M, Morishita C, Higashiyama M, Ono M, Honyashiki M, Iwata Y, Tanabe H, Inoue T

Neuropsychiatric Disease and Treatment 2022, 18:253-263

Published Date: 15 February 2022

Relationship Between Sleep Duration and Stroke History in Middle-Aged and Elderly in Guiyang: A Cross-Sectional Survey

Liu L, Yang J, Wang J, Nie M, Wang Z, Guan H, Hu J, Hong F

Neuropsychiatric Disease and Treatment 2022, 18:243-252

Published Date: 11 February 2022

Reduced Peripheral Nerve Conduction Velocity is Associated with Alzheimer’s Disease: A Cross-Sectional Study from China

Qian X, Yue L, Mellor D, Robbins NM, Li W, Xiao S

Neuropsychiatric Disease and Treatment 2022, 18:231-242

Published Date: 11 February 2022

Treatment Approaches for First Episode and Early-Phase Schizophrenia in Adolescents and Young Adults: A Delphi Consensus Report from Europe

Correll CU, Fusar-Poli P, Leucht S, Karow A, Maric N, Moreno C, Nordentoft M, Raballo A

Neuropsychiatric Disease and Treatment 2022, 18:201-219

Published Date: 9 February 2022

The Changes of Brain Function After Spinal Manipulation Therapy in Patients with Chronic Low Back Pain: A Rest BOLD fMRI Study

Yang YC, Zeng K, Wang W, Gong ZG, Chen YL, Cheng JM, Zhang M, Huang YW, Men XB, Wang JW, Zhan S, Tan WL

Neuropsychiatric Disease and Treatment 2022, 18:187-199

Published Date: 5 February 2022

Lack of Association of FLT3 rs2504235 and Absence of SLITRK1 var321 in Patients with Tic Disorders from Guangdong Province, China

Gao M, Lin H, Li B, Wen J, Wang Y, Zhang Z, Chen W

Neuropsychiatric Disease and Treatment 2022, 18:155-161

Published Date: 2 February 2022

Post COVID-19 Vaccination-Associated Neurological Complications

Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A

Neuropsychiatric Disease and Treatment 2022, 18:137-154

Published Date: 2 February 2022

Willis Covered Stent for Treating Intracranial Pseudoaneurysms of the Internal Carotid Artery: A Multi-Institutional Study

Lu D, Ma T, Zhu G, Zhang T, Wang N, Lei H, Sui J, Wang Z, He S, Chen L, Deng J

Neuropsychiatric Disease and Treatment 2022, 18:125-135

Published Date: 29 January 2022

Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians

Citrome L, Belcher E, Stacy S, Suett M, Mychaskiw M, Salinas GD

Neuropsychiatric Disease and Treatment 2022, 18:111-123

Published Date: 26 January 2022

Translation and Cross-Cultural Adaptation of Post-Stroke Checklist into Mandarin: A Cognitive Interview Study

Jia M, Lu H, Olutoye F, Li J, Huang S, Zhou H

Neuropsychiatric Disease and Treatment 2022, 18:87-95

Published Date: 15 January 2022

Correlation Between Lacunae and the Wearing-off Phenomenon in Parkinson’s Disease

Zhang M, Chen H, Liu G, Wang X, Wang Z, Feng T, Zhang Y

Neuropsychiatric Disease and Treatment 2022, 18:67-74

Published Date: 11 January 2022

Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial

Fan F, Hao L, Zhang S, Zhang Y, Bian Z, Zhang X, Wang Q, Han F

Neuropsychiatric Disease and Treatment 2022, 18:57-66

Published Date: 11 January 2022

Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis

Yan XJ, Li YB, Liu W, Wu HY, Yu GF

Neuropsychiatric Disease and Treatment 2022, 18:47-55

Published Date: 8 January 2022

Schema Therapy for Patients with Bipolar Disorder: Theoretical Framework and Application

Ociskova M, Prasko J, Kantor K, Hodny F, Kasyanik P, Holubova M, Vanek J, Slepecky M, Nesnidal V, Minarikova Belohradova K

Neuropsychiatric Disease and Treatment 2022, 18:29-46

Published Date: 6 January 2022

A Preliminary Study of Different Treatment Strategies for Anxious Depression

Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y

Neuropsychiatric Disease and Treatment 2022, 18:11-18

Published Date: 4 January 2022

Functional Connectivity Density in the Sensorimotor Area is Associated with Sleep Latency in Patients with Primary Insomnia

Ji B, Dai M, Guo Z, Li J, Cao Y, Zhang Z, Zhang Y, Liu X

Neuropsychiatric Disease and Treatment 2022, 18:1-10

Published Date: 4 January 2022

Adverse Drug Reaction and Its Predictors Among Psychiatric Patients Taking Psychotropic Medications at the Mizan-Tepi University Teaching Hospital

Ejeta F, Aferu T, Feyisa D, Kebede O, Siraj J, Hammeso WW, Tadesse E, Tinishku A

Neuropsychiatric Disease and Treatment 2021, 17:3827-3835

Published Date: 29 December 2021

QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson’s Disease Psychosis: A Narrative Review

Torres-Yaghi Y, Carwin A, Carolan J, Nakano S, Amjad F, Pagan F

Neuropsychiatric Disease and Treatment 2021, 17:3791-3818

Published Date: 24 December 2021

Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K

Neuropsychiatric Disease and Treatment 2021, 17:3781-3790

Published Date: 21 December 2021

EMT-Related Markers in Serum Exosomes are Potential Diagnostic Biomarkers for Invasive Pituitary Adenomas

Chen K, Li G, Kang X, Liu P, Qian L, Shi Y, Osman RA, Yang Z, Zhang G

Neuropsychiatric Disease and Treatment 2021, 17:3769-3780

Published Date: 21 December 2021

Resting-State Functional Magnetic Resonance Imaging Reveals Overactivation of the Habitual Control Brain System in Tobacco Dependence

Tan Q, Li S, Niu J, Liu S, Li Y, Lu Y, Wang Z, Xu W, Wei Y, Guo Z

Neuropsychiatric Disease and Treatment 2021, 17:3753-3768

Published Date: 19 December 2021

Early Improvement with Vortioxetine Predicts Response and Remission: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan

Inoue T, Fujimoto S, Marumoto T, Kitagawa T, Ishida K, Nakajima T, Moriguchi Y, Fujikawa K, Watanabe K

Neuropsychiatric Disease and Treatment 2021, 17:3735-3741

Published Date: 18 December 2021

Effect of Deep Brain Stimulation on Female Parkinsonian Patients with Lower Urinary Tract Symptoms

Liang F, Tang Y, Bi K, Liu X, Li C, Chen S, Zhang C, Yan L, Xu Z, Yang N

Neuropsychiatric Disease and Treatment 2021, 17:3727-3733

Published Date: 18 December 2021

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms

Ruetsch C, Davis T, Liberman JN, Velligan DI, Robinson D, Jaeger C, Carpenter W, Forma F

Neuropsychiatric Disease and Treatment 2021, 17:3715-3726

Published Date: 16 December 2021

Selective Impairment of Processing Task-Irrelevant Emotional Faces in Cerebral Small Vessel Disease Patients

Fan Z, Guo Y, Hou X, Lv R, Nie S, Xu S, Chen J, Hong Y, Zhao S, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:3693-3703

Published Date: 16 December 2021

Paliperidone Compared with Haloperidol on the Theory of Mind Tasks in Schizophrenia: A Pilot Trial

Zhong J, Zhu H, Yin D, Ning Y, Zheng S, Zhang Y, Jia H

Neuropsychiatric Disease and Treatment 2021, 17:3683-3691

Published Date: 14 December 2021

From Personalized Medicine to Precision Psychiatry?

Češková E, Šilhán P

Neuropsychiatric Disease and Treatment 2021, 17:3663-3668

Published Date: 14 December 2021

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study

Matsuzaki H, Hatano M, Iwata M, Yamada S

Neuropsychiatric Disease and Treatment 2021, 17:3655-3661

Published Date: 14 December 2021

LncRNA FTX Regulates Angiogenesis Through miR-342-3p/SPI1 Axis in Stroke

Gao Q, Wang Y

Neuropsychiatric Disease and Treatment 2021, 17:3617-3625

Published Date: 11 December 2021

Relationship Among Homocysteine, Inflammation and Cognitive Impairment in Patients with Acute Ischemic Stroke and Transient Ischemic Attack

Cui L, Lu P, Li S, Pan Y, Wang M, Li Z, Liao X, Wang Y

Neuropsychiatric Disease and Treatment 2021, 17:3607-3616

Published Date: 11 December 2021

Cariprazine in Three Special Different Areas: A Real-World Experience

Gesi C, Paletta S, Palazzo M C, Dell'Osso B, Mencacci C, Cerveri G

Neuropsychiatric Disease and Treatment 2021, 17:3581-3588

Published Date: 7 December 2021

MRI Evaluation of the Relationship Between Abnormalities in Vision-Related Brain Networks and Quality of Life in Patients with Migraine without Aura

Cui W, Zhang J, Xu F, Zhi H, Li H, Li B, Zhang S, Peng W, Wu H

Neuropsychiatric Disease and Treatment 2021, 17:3569-3579

Published Date: 8 December 2021

The Role of PAX2 in Neurodevelopment and Disease

Lv N, Wang Y, Zhao M, Dong L, Wei H

Neuropsychiatric Disease and Treatment 2021, 17:3559-3567

Published Date: 7 December 2021

Association of Versican Gene Polymorphisms with Intracranial Aneurysm Susceptibility in the Eastern Chinese Population

Zhu L, Yu C, Zhou S, Xue M, Chen J, Wu M, Dong S, Huang G, Chang Y, Zhang M

Neuropsychiatric Disease and Treatment 2021, 17:3531-3537

Published Date: 7 December 2021

Challenges Surrounding the Diagnosis of Autism in Children

Hus Y, Segal O

Neuropsychiatric Disease and Treatment 2021, 17:3509-3529

Published Date: 3 December 2021

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease

Zhong M, Jiang X, Zhu S, Gu R, Bai Y, He H, Pan Y, Xu P, Yan J, Zhang L

Neuropsychiatric Disease and Treatment 2021, 17:3499-3508

Published Date: 3 December 2021

The Relationship Between Antipsychotic-Induced Akathisia and Suicidal Behaviour: A Systematic Review

Kalniunas A, Chakrabarti I, Mandalia R, Munjiza J, Pappa S

Neuropsychiatric Disease and Treatment 2021, 17:3489-3497

Published Date: 3 December 2021

Reduced Plasma Estradiol Levels are Associated with Sleep Apnea in Depressed Peri- and Post-Menopausal Women

Cai L, Huang L, Wei L, Yao J, Xu L, Chen W

Neuropsychiatric Disease and Treatment 2021, 17:3483-3488

Published Date: 2 December 2021

Predictors of Neurological Presentations of COVID-19 Infected Patients in South Egypt, Aswan Governorate: A Single Center Study

Tony AA, Ahmed SBA, Tony EAE, Maklad S, Elnakeeb I, Amin MM

Neuropsychiatric Disease and Treatment 2021, 17:3471-3482

Published Date: 1 December 2021

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials

Borentain S, Williamson D, Turkoz I, Popova V, McCall WV, Mathews M, Wiegand F

Neuropsychiatric Disease and Treatment 2021, 17:3459-3470

Published Date: 30 November 2021

Critical Appraisal of Cenobamate as Adjunctive Treatment of Focal Seizures in Adults

Zaccara G, Lattanzi S, Leo A, Russo E

Neuropsychiatric Disease and Treatment 2021, 17:3447-3457

Published Date: 30 November 2021

Rumination Mediates the Effects of Childhood Maltreatment and Trait Anxiety on Depression in Non-Clinical Adult Volunteers

Deguchi A, Masuya J, Naruse M, Morishita C, Higashiyama M, Tanabe H, Inoue T, Ichiki M

Neuropsychiatric Disease and Treatment 2021, 17:3439-3445

Published Date: 23 November 2021

Analysis of Risk Factors for Poor Short-Term Outcomes in Acute Cardioembolic Stroke Patients without Reperfusion Therapy

Guo Y, Zhang M, Su Y, Liu J, Fu H, Wang Q, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:3431-3437

Published Date: 23 November 2021

Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points

Hashijiri K, Watanabe Y, Fukui N, Motegi T, Ogawa M, Egawa J, Enomoto T, Someya T

Neuropsychiatric Disease and Treatment 2021, 17:3407-3413

Published Date: 20 November 2021

Content Validation of an Algorithm for the Assessment, Management and Monitoring of Drug-Induced QTc Prolongation in the Psychiatric Population

Zolezzi M, Elhakim A, Elamin WM, Homs S, Mahmoud DE, Qubaiah IA

Neuropsychiatric Disease and Treatment 2021, 17:3395-3405

Published Date: 19 November 2021

Preliminary Findings on Visual Event-Related Potential P3 in Asymptomatic Patients with Cerebral Small Vessel Disease

Nie S, Shen C, Guo Y, Hou X, Hong Y, Xu S, Lv R, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:3379-3394

Published Date: 18 November 2021

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review

Woranush W, Moskopp ML, Sedghi A, Stuckart I, Noll T, Barlinn K, Siepmann T

Neuropsychiatric Disease and Treatment 2021, 17:3359-3377

Published Date: 19 November 2021

Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging

Iliopoulou SM, Tsartsalis S, Kaiser S, Millet P, Tournier BB

Neuropsychiatric Disease and Treatment 2021, 17:3345-3357

Published Date: 18 November 2021

Association of Two Variable Number of Tandem Repeats in the Monoamine Oxidase A Gene Promoter with Schizophrenia

Tanifuji T, Okazaki S, Otsuka I, Horai T, Shinko Y, Kim S, Sora I, Hishimoto A

Neuropsychiatric Disease and Treatment 2021, 17:3315-3323

Published Date: 11 November 2021

Not All Cases of Visual Snows are Benign: Mimics of Visual Snow Syndrome

Hang C, Leishangthem L, Yan Y

Neuropsychiatric Disease and Treatment 2021, 17:3293-3300

Published Date: 10 November 2021

Retinal Imaging Techniques Based on Machine Learning Models in Recognition and Prediction of Mild Cognitive Impairment

Zhang Q, Li J, Bian M, He Q, Shen Y, Lan Y, Huang D

Neuropsychiatric Disease and Treatment 2021, 17:3267-3281

Published Date: 6 November 2021

High Serum S100A12 Levels Predict Poor Outcome After Acute Primary Intracerebral Hemorrhage

Qiu SZ, Zheng GR, Ma CY, Chen B, Huang JJ, Huang G, Hua H

Neuropsychiatric Disease and Treatment 2021, 17:3245-3253

Published Date: 2 November 2021

Factors That Affect Patient Attrition in Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Real-World Study Using Electronic Health Records

Ker S, Hsu J, Balani A, Mukherjee SS, Rush AJ, Khan M, Elchehabi S, Huffhines S, DeMoss D, Rentería ME, Sarkar J

Neuropsychiatric Disease and Treatment 2021, 17:3229-3244

Published Date: 28 October 2021

Treatment Strategies for Cryptogenic Stroke Patients with Patent Foramen Ovale: What Do We Choose?

Shen Y, Nie Q, Zhang Y, Cao Q, Hou Z, Xu L

Neuropsychiatric Disease and Treatment 2021, 17:3205-3214

Published Date: 22 October 2021

Herbal Medicine for Patients with Cognitive Impairment: An Observational Study

Choi Y, Kim AR, Lee JY, Kim HS, Yang C, Kim JK, Go Y, Jung IC

Neuropsychiatric Disease and Treatment 2021, 17:3183-3194

Published Date: 21 October 2021

Victimization in Childhood Mediates the Association Between Parenting Quality, Stressful Life Events, and Depression in Adulthood

Ishii Y, Masuya J, Morishita C, Higashiyama M, Inoue T, Ichiki M

Neuropsychiatric Disease and Treatment 2021, 17:3171-3182

Published Date: 19 October 2021

Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate Among Veterans with Schizophrenia

El Khoury AC, Patel C, Mavros P, Huang A, Wang L, Bashyal R

Neuropsychiatric Disease and Treatment 2021, 17:3159-3170

Published Date: 19 October 2021

Inhibition of miR-448-3p Attenuates Cerebral Ischemic Injury by Upregulating Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2)

Xu M, Xiang D, Wang W, Chen L, Lu W, Cheng F

Neuropsychiatric Disease and Treatment 2021, 17:3147-3158

Published Date: 19 October 2021

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]

Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D

Neuropsychiatric Disease and Treatment 2021, 17:3135-3136

Published Date: 15 October 2021

Tardive Dyskinesia in Older Persons Taking Antipsychotics

Citrome L, Isaacson SH, Larson D, Kremens D

Neuropsychiatric Disease and Treatment 2021, 17:3127-3134

Published Date: 14 October 2021

Effectiveness and Safety of Pressure Dressings on Reducing Subdural Effusion After Decompressive Craniectomy

Huang W, Zhou B, Li Y, Shao Y, Peng B, Jiang X, Xiang T

Neuropsychiatric Disease and Treatment 2021, 17:3119-3125

Published Date: 14 October 2021

Association Between the A118G Polymorphism of the OPRM1 Gene and Suicidal Depression in a Large Cohort of Outpatients with Depression

Nobile B, Olie E, Ramoz N, Dubois J, Guillaume S, Gorwood P, Courtet P

Neuropsychiatric Disease and Treatment 2021, 17:3109-3118

Published Date: 14 October 2021

Change in Antidepressant Use After Initiation of ADHD Medication in Japanese Adults with Comorbid Depression: A Real-World Database Analysis

Sakai C, Tsuji T, Nakai T, Namba Y, Mishima H, Fujiwara M, Matsunaga H

Neuropsychiatric Disease and Treatment 2021, 17:3097-3108

Published Date: 11 October 2021

Can Goal-Based Health Management Improve the Health Knowledge, Health Belief and Health Behavior in People at High Risk of Stroke? A Non-Randomized Controlled Trial

He Y, Guo L, Liu Y, Wei M, Guo Y, Dong X, Yang C, Zhou Q, Lei X, Zhang G, Zhang M

Neuropsychiatric Disease and Treatment 2021, 17:3085-3095

Published Date: 8 October 2021

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment

Moga S, Teodorescu A, Ifteni P, Gavris C, Petric PS

Neuropsychiatric Disease and Treatment 2021, 17:3053-3060

Published Date: 2 October 2021

Parents of Children Diagnosed with Autism Spectrum Disorder: What Do They Expect and Experience from Preschools?

Westman Andersson G, Gillberg N, Miniscalco C

Neuropsychiatric Disease and Treatment 2021, 17:3025-3037

Published Date: 28 September 2021

Reduced Brain Activation in Response to Social Cognition Tasks in Autism Spectrum Disorder with and without Depression

Ohtani T, Matsuo K, Sutoh C, Oshima F, Hirano Y, Wakabayashi A, Shimizu E

Neuropsychiatric Disease and Treatment 2021, 17:3015-3024

Published Date: 28 September 2021

Impact of the COVID-19 Pandemic on Family Wellbeing in the Context of Neurodevelopmental Disorders

Rizzo R, Karlov L, Maugeri N, di silvestre S, Eapen V

Neuropsychiatric Disease and Treatment 2021, 17:3007-3014

Published Date: 24 September 2021

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study

Baune BT, Florea I, Ebert B, Touya M, Ettrup A, Hadi M, Ren H

Neuropsychiatric Disease and Treatment 2021, 17:2995-3006

Published Date: 23 September 2021

The Association Between Hypoxia Improvement and Electroconvulsive Therapy for Major Depressive Disorder

Bian Z, Li H, Liu Y, Cao Y, Kang Y, Yu Y, Zhang F, Li C, Kang Y, Wang F

Neuropsychiatric Disease and Treatment 2021, 17:2987-2994

Published Date: 22 September 2021

Current Perspectives on the Assessment and Management of Gait Disorders in Parkinson’s Disease

Smith MD, Brazier DE, Henderson EJ

Neuropsychiatric Disease and Treatment 2021, 17:2965-2985

Published Date: 21 September 2021

Severity of Depressive Symptoms is Associated with Venous Thromboembolism in Hospitalized Patients with a Major Depressive Episode

Yoshizawa K, Takeshima M, Ishino S, Ogasawara M, Fujiwara D, Itoh Y, Imanishi A, Ohta H, Mishima K

Neuropsychiatric Disease and Treatment 2021, 17:2955-2963

Published Date: 21 September 2021

Patient and Physician Perspectives of Depressive Symptoms and Expectations for Treatment Outcome: Results from a Web-Based Survey

Ishigooka J, Hoshino T, Imai T, Yoshida H, Ono M, Ota M, Moriguchi Y, Fujikawa K, Shintani A, Fernandez JL

Neuropsychiatric Disease and Treatment 2021, 17:2915-2924

Published Date: 10 September 2021

Risk Factors and Neurologic Outcomes in Patients with Traumatic Brain Injury and Coagulopathy Within 72 h After Surgery

Chang T, Yan X, Zhao C, Zhang Y, Wang B, Gao L

Neuropsychiatric Disease and Treatment 2021, 17:2905-2913

Published Date: 10 September 2021

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D

Neuropsychiatric Disease and Treatment 2021, 17:2885-2904

Published Date: 9 September 2021

Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project

Konno Y, Fujino Y, Ikenouchi A, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Kato M, Tsuboi T, Yasui-Furukori N, Nakagawa A, Kikuchi T, Watanabe K, Yoshimura R

Neuropsychiatric Disease and Treatment 2021, 17:2867-2876

Published Date: 7 September 2021

Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder

Pan C, Zhao Y, Xie H, Zhou Y, Duan R, Li Y, Jia Y, Peng T

Neuropsychiatric Disease and Treatment 2021, 17:2859-2866

Published Date: 7 September 2021

Prevalence of Symptoms of Anxiety Among Residents of Kabul During Pandemic of COVID-19: A Report from Capital of Afghanistan

Rasib AR, Nemat A, Azimi M, Zaki N, Sediqi MF, Raufi N, Asady A

Neuropsychiatric Disease and Treatment 2021, 17:2841-2846

Published Date: 29 August 2021

Mental Health Outcomes among Frontline Health-Care Workers at Eka Kotebe National COVID-19 Treatment Center, Addis Ababa, Ethiopia, 2020: A Cross-Sectional Study

Habtamu Y, Admasu K, Tullu M, Damene W, Birhanu A, Beyero T, Birhanu Tereda A

Neuropsychiatric Disease and Treatment 2021, 17:2831-2840

Published Date: 28 August 2021

High Uric Acid Level Predicts Early Neurological Deterioration in Intracerebral Hemorrhage

Gong X, Lu Z, Feng X, Yuan K, Zhang M, Cheng X, Xue M, Yu L, Lu J, Yu C

Neuropsychiatric Disease and Treatment 2021, 17:2803-2809

Published Date: 24 August 2021

Clinical Characteristics and Risk Factors of Cerebral Hemorrhage in Patients with Occult Malignant Tumors

Zhao Y, Xie H, Pan C, Yao Y, Gong Z, Li Y, Jia Y

Neuropsychiatric Disease and Treatment 2021, 17:2729-2738

Published Date: 19 August 2021

Myxedema Psychosis: Systematic Review and Pooled Analysis

Mohamed MFH, Danjuma M, Mohammed M, Mohamed S, Siepmann M, Barlinn K, Suwileh S, Abdalla L, Al-Mohanadi D, Silva Godínez JC, Elzouki AN, Siepmann T

Neuropsychiatric Disease and Treatment 2021, 17:2713-2728

Published Date: 18 August 2021

Regional Neural Activity Changes in Parkinson’s Disease-Associated Mild Cognitive Impairment and Cognitively Normal Patients

Xing Y, Fu S, Li M, Ma X, Liu M, Liu X, Huang Y, Xu G, Jiao Y, Wu H, Jiang G, Tian J

Neuropsychiatric Disease and Treatment 2021, 17:2697-2706

Published Date: 17 August 2021

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

Iyo M, Ishigooka J, Nakamura M, Sakaguchi R, Okamoto K, Mao Y, Tsai J, Fitzgerald A, Takai K, Higuchi T

Neuropsychiatric Disease and Treatment 2021, 17:2683-2695

Published Date: 16 August 2021

Correlations Between Working Memory Impairment and Neurometabolites of the Prefrontal Cortex in Drug-Naive Obsessive-Compulsive Disorder

Yue J, Zhong S, Luo A, Lai S, He T, Luo Y, Wang Y, Zhang Y, Shen S, Huang H, Wen S, Jia Y

Neuropsychiatric Disease and Treatment 2021, 17:2647-2657

Published Date: 14 August 2021

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study

Wilkowska A, Włodarczyk A, Gałuszko-Węgielnik M, Wiglusz MS, Cubała WJ

Neuropsychiatric Disease and Treatment 2021, 17:2637-2646

Published Date: 14 August 2021

Association of Childbirth Pain with Postnatal Depressive and Anxiety Disorders in Nulliparous Parturients: A Prospective Study

Tan CW, Tan HS, Sultana R, Chui A, Chua TE, Chen H, Sng BL

Neuropsychiatric Disease and Treatment 2021, 17:2625-2636

Published Date: 13 August 2021

Association Between NR4A2 Gene Polymorphism and Depressive Symptoms and Antidepressant Effect

Song X, Sun N, Zhang A, Lei L, Li X, Liu Z, Wang Y, Yang C, Zhang K

Neuropsychiatric Disease and Treatment 2021, 17:2613-2623

Published Date: 10 August 2021

Methylation of the RIN3 Promoter is Associated with Transient Ischemic Stroke/Mild Ischemic Stroke with Early Cognitive Impairment

Miao M, Yuan F, Ma X, Yang H, Gao X, Zhu Z, Bi J

Neuropsychiatric Disease and Treatment 2021, 17:2587-2598

Published Date: 10 August 2021

Disability Status and Its Influencing Factors Among Stroke Patients in Northeast China: A 3-Year Follow-Up Study

Lv Y, Sun Q, Li J, Zhang W, He Y, Zhou Y

Neuropsychiatric Disease and Treatment 2021, 17:2567-2573

Published Date: 7 August 2021

Interaction of Insomnia and Somatization with Post-Traumatic Stress Disorder in Pregnant Women During the COVID-19 Pandemic

Zhang S, Zhou Y, Ge LK, Zeng L, Liu Z, Qian W, Yang J, Zhou X, Wei GX, Zhang X

Neuropsychiatric Disease and Treatment 2021, 17:2539-2547

Published Date: 6 August 2021

Maternal and Paternal Depression During Pregnancy in China: Prevalence, Correlates, and Network Analysis [Corrigendum]

Zhang Y, Sun H, Li W, Luo X, Liu T, Fang F, Xiao J, Garg S, Yang Y, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:2527-2528

Published Date: 3 August 2021

Electroacupuncture Improves Cerebral Ischemic Injury by Enhancing the EPO-JAK2-STAT5 Pathway in Rats

Liu F, Lu Z, Li Z, Wang S, Zhuang L, Hong M, Huang K

Neuropsychiatric Disease and Treatment 2021, 17:2489-2498

Published Date: 30 July 2021

High Serum Levels of iNOS and MIP-1α are Associated with Post-Stroke Depression

Wang X, Fang C, Liu X, Wei W, Zhang M, Chen S, Shi F

Neuropsychiatric Disease and Treatment 2021, 17:2481-2487

Published Date: 28 July 2021

Predictive Values of the SeLECT Score and IL-1β for Post-Stroke Epilepsy

Shen L, Yang J, Tang Y

Neuropsychiatric Disease and Treatment 2021, 17:2465-2472

Published Date: 27 July 2021

Social-Emotional Development and Associated Risk Factors in Chinese Toddlers with Cerebral Palsy

Wu Y, Tang J, Chen Y, Huang Y

Neuropsychiatric Disease and Treatment 2021, 17:2451-2463

Published Date: 24 July 2021

A Preliminary Randomized Controlled Trial of Different Treatment Regimens for Melancholic Depression

Wang Y, Liu X, Peng D, Wu Y, Su Y, Xu J, Ma X, Li Y, Shi J, Cheng X, Rong H, Fang Y

Neuropsychiatric Disease and Treatment 2021, 17:2441-2449

Published Date: 23 July 2021

Role of MT1A Polymorphism and Environmental Mercury Exposure on the Montreal Cognitive Assessment (MoCA)

Sirivarasai J, Chaisungnern K, Panpunuan P, Chanprasertyothin S, Chansirikanjana S, Sritara P

Neuropsychiatric Disease and Treatment 2021, 17:2429-2439

Published Date: 22 July 2021

Psychometric Properties of the Chinese Version of the Clinically Useful Depression Outcome Scale for Patients with Major Depressive Disorder

Ma HY, Wang XM, Huang XJ, Yang CJ, Sheng DF, Yang JJ, Xu MZ

Neuropsychiatric Disease and Treatment 2021, 17:2387-2395

Published Date: 21 July 2021

A Case–Control Study on Behavioral Addictions and Neurocognition: Description of the BANCO and BANCO2 Protocols

Hurel E, Grall-Bronnec M, Thiabaud E, Saillard A, Hardouin JB, Challet-Bouju G

Neuropsychiatric Disease and Treatment 2021, 17:2369-2386

Published Date: 20 July 2021

Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice

Wu X, Liu Y, Zhu L, Wang Y, Ren Y, Cheng B, Ren L, Ge K, Li H

Neuropsychiatric Disease and Treatment 2021, 17:2359-2368

Published Date: 17 July 2021

Clinically Significant Changes in the 17- and 6-Item Hamilton Rating Scales for Depression: A STAR*D Report

Rush AJ, South C, Jain S, Agha R, Zhang M, Shrestha S, Khan Z, Hassan M, Trivedi MH

Neuropsychiatric Disease and Treatment 2021, 17:2333-2345

Published Date: 14 July 2021

Acupuncture Treatment Reduced the Risk of Coronary Heart Disease in Patients with Depression: A Propensity-Score Matched Cohort Study

Huang CY, Huang MC, Sun MF, Lin CL, Wu MY, Lin WC, Yen HR

Neuropsychiatric Disease and Treatment 2021, 17:2315-2325

Published Date: 12 July 2021

Epilepsy in Older People in Sub-Saharan Africa: A Systematic Review

Bongomin F, Katabira E, Sajatovic M, Kaddumukasa M

Neuropsychiatric Disease and Treatment 2021, 17:2309-2314

Published Date: 12 July 2021

Aβ Influx into the Blood Evoked by Different Blood Aβ Removal Systems: A Potential Therapy for Alzheimer’s Disease

Kitaguchi N, Kawaguchi K, Sakata M, Aoki H, Yamazaki K, Kaneko M, Kinomura J, Kato M, Hasegawa M, Suzuki N, Mizuno M, Yuzawa Y

Neuropsychiatric Disease and Treatment 2021, 17:2291-2308

Published Date: 13 July 2021

Maternal and Paternal Depression During Pregnancy in China: Prevalence, Correlates, and Network Analysis

Zhang Y, Sun H, Li W, Luo X, Liu T, Fang F, Xiao J, Garg S, Yang Y, Chen Y

Neuropsychiatric Disease and Treatment 2021, 17:2269-2280

Published Date: 12 July 2021

A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients

Guo H, Xu W, Zhang X, Zhang S, Dai Z, Li S, Xie Y, Li Y, Xue J, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:2183-2190

Published Date: 6 July 2021

One in Five Street Traditional Coffee Vendors Suffered from Depression During the COVID-19 Pandemic in Harar Town, Ethiopia

Sisay M, Gashaw T, Degefu N, Hagos B, Alemu A, Teshome Z, Admas M, Kibret H, Dessie Y

Neuropsychiatric Disease and Treatment 2021, 17:2173-2182

Published Date: 6 July 2021

Differential Diagnosis in Children with Autistic Symptoms and Subthreshold ADOS Total Score: An Observational Study

De Giacomo A, Craig F, Palermo G, Coppola A, Margari M, Campanozzi S, Margari L, Turi M

Neuropsychiatric Disease and Treatment 2021, 17:2163-2172

Published Date: 5 July 2021

Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

de Filippis R, Gaetano R, Schoretsanitis G, Verde G, Oliveti CA, Kane JM, Segura-Garcia C, De Fazio P

Neuropsychiatric Disease and Treatment 2021, 17:2141-2150

Published Date: 1 July 2021

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model

Chen Q, Yin Y, Li L, Zhang Y, He W, Shi Y

Neuropsychiatric Disease and Treatment 2021, 17:2129-2139

Published Date: 30 June 2021

Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats

Wesołowska A, Rychtyk J, Gdula-Argasińska J, Górecka K, Wilczyńska-Zawal N, Jastrzębska-Więsek M, Partyka A

Neuropsychiatric Disease and Treatment 2021, 17:2105-2127

Published Date: 25 June 2021

MicroRNA-126a-5p Exerts Neuroprotective Effects on Ischemic Stroke via Targeting NADPH Oxidase 2

Tan Y, Zhou F, Yang D, Zhang X, Zeng M, Wan L

Neuropsychiatric Disease and Treatment 2021, 17:2089-2103

Published Date: 25 June 2021

Physical and Mental Fatigue in Subjects Recovered from COVID-19 Infection: A Case–Control Study

Elanwar R, Hussein M, Magdy R, Eid RA, Yassien A, Abdelsattar AS, Alsharaway LA, Fathy W, Hassan A, Kamal YS

Neuropsychiatric Disease and Treatment 2021, 17:2063-2071

Published Date: 22 June 2021

Clinical Characteristics, Iron Metabolism and Neuroinflammation: New Insight into Excessive Daytime Sleepiness in Parkinson’s Disease

Hu Y, Guo P, Lian TH, Zuo LJ, Yu SY, Liu L, Jin Z, Yu QJ, Wang RD, Li LX, Piao YS, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:2041-2051

Published Date: 21 June 2021

Algorithms to Predict Anxiety and Depression Among University Students in China After Analyzing Lifestyles and Sport Habits

Zhang L, Zhao S, Lin Q, Song M, Wu S, Zheng H

Neuropsychiatric Disease and Treatment 2021, 17:2011-2025

Published Date: 21 June 2021

Association of Reduced Tract Integrity with Social Communication Deficits in Preschool Autism Children: A Tract-Based Spatial Statistics Study

Yin Y, Xu S, Li C, Li M, Liu M, Yan J, Lan Z, Zhan W, Jiang G, Tian J

Neuropsychiatric Disease and Treatment 2021, 17:2003-2010

Published Date: 18 June 2021

Do Teachers Confirm Parent’s Ratings of ADHD DSM-IV Criteria? A Study of a Mexican Population

Chamorro Y, Bolaños L, Trejo S, Barrios O, Ramírez-Dueñas ML, Alvarez-Tostado P, Cervantes A, Matute E

Neuropsychiatric Disease and Treatment 2021, 17:1965-1975

Published Date: 16 June 2021

Visualizing Patterns of Medication Switching Among Major Depressive Patients with Various Stability and Difficulty to Treatments

Hung YC, Chen HC, Kuo PH, Lu ML, Huang MC, Chen CH, Wang S, Mao WC, Wu CS, Wu TH

Neuropsychiatric Disease and Treatment 2021, 17:1953-1963

Published Date: 16 June 2021

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment

Kawamata Y, Sugawara N, Ishioka M, Kubo K, Suzuki K, Fujii A, Furukori H, Nakagami T, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2021, 17:1927-1936

Published Date: 15 June 2021

Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect Profile

Zolezzi M, Abouelhassan R, Eltorki Y, Haddad PM, Noorizadeh M

Neuropsychiatric Disease and Treatment 2021, 17:1917-1926

Published Date: 14 June 2021

Differences in the Association of Anxiety, Insomnia and Somatic Symptoms between Medical Staff and the General Population During the Outbreak of COVID-19

Huang Y, Zhou Y, Wei Y, Zeng L, Yang J, Li Y, Song X, Li H, He H, Li T, Wu K, Yang M, Wu F, Ning Y, Zhang X

Neuropsychiatric Disease and Treatment 2021, 17:1907-1915

Published Date: 14 June 2021

Cortical Pathways or Mechanism in the Face Inversion Effect in Patients with First-Episode Schizophrenia

Liu Y, Bi T, Kuang Q, Zhang B, Wu H, Li H, Zhang B, Zhao J, Ning Y, She S, Zheng Y

Neuropsychiatric Disease and Treatment 2021, 17:1893-1906

Published Date: 10 June 2021

Eye Avoidance of Threatening Facial Expressions in Parents of Children with ASD

Yang T, Li D, Zhang Y, Zhang L, Li H, Ji GJ, Yang Z, Zhang L, Zhu C, Wang K

Neuropsychiatric Disease and Treatment 2021, 17:1869-1879

Published Date: 9 June 2021

Met and Unmet Needs in an Inpatient Psychiatry Setting in Spain

Gomez-Sanchez-Lafuente C, Guzman-Parra J, Lopez-Zambrano MA, Moreno-Kustner B, Mayoral-Cleries F

Neuropsychiatric Disease and Treatment 2021, 17:1859-1868

Published Date: 8 June 2021

Periventricular White Matter Hyperintensity in Males is Associated with Post-Stroke Depression Onset at 3 Months

Tu XQ, Lai ZH, Zhang Y, Ding KQ, Ma FY, Yang GY, He JR, Zeng LL

Neuropsychiatric Disease and Treatment 2021, 17:1839-1857

Published Date: 8 June 2021

Updated Review on the Diagnosis and Primary Management of Psychogenic Nonepileptic Seizure Disorders

Lanzillotti AI, Sarudiansky M, Lombardi NR, Korman GP, D´Alessio L

Neuropsychiatric Disease and Treatment 2021, 17:1825-1838

Published Date: 4 June 2021

Neuroprotective Effects and Related Mechanisms of Echinacoside in MPTP-Induced PD Mice

Zhang ZN, Hui Z, Chen C, Liang Y, Tang LL, Wang SL, Xu CC, Yang H, Zhang JS, Zhao Y

Neuropsychiatric Disease and Treatment 2021, 17:1779-1792

Published Date: 3 June 2021

Psychiatric Emergencies During the Covid-19 Pandemic: A 6-Month Observational Study

Di Lorenzo R, Frattini N, Dragone D, Farina R, Luisi F, Ferrari S, Bandiera G, Rovesti S, Ferri P

Neuropsychiatric Disease and Treatment 2021, 17:1763-1778

Published Date: 3 June 2021

Combined Effects of Mother’s, Father’s and Teacher’s Psychological Distress on Schoolchildren’s Mental Health Symptoms

Li S, Na J, Mu H, Li Y, Liu L, Zhang R, Sun J, Li Y, Sun W, Pan G, Yan L

Neuropsychiatric Disease and Treatment 2021, 17:1735-1743

Published Date: 3 June 2021

High Mobility Group Box 1/Toll-like Receptor 4 Signaling Increases GABRB3 Expression in Alcohol Exposure

Sun G, Qi X, Wang W, Li X, Luo C, Bai S, Xu S, Zhong X, Huang C, Zhu X, Huang Z

Neuropsychiatric Disease and Treatment 2021, 17:1725-1732

Published Date: 1 June 2021

Clinical Analysis of Bilateral Thalamic Infarction Caused by Percheron Artery Occlusion

Chen P, Hao MM, Chen Y, Zhang H, Wang Z, Zhao B, Xue Y, Chai Y, Huang YF, Zhu J

Neuropsychiatric Disease and Treatment 2021, 17:1707-1712

Published Date: 28 May 2021

Value of Combining of the NLR and the Fibrinogen Level for Predicting Stroke-Associated Pneumonia

Cheng W, Chen L, Yu H, Lu D, Yu R, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:1697-1705

Published Date: 28 May 2021

Social Inferences as Mediators of Wellbeing in Depression

Giurgi-Oncu C, Bredicean C, Frandeș M, Enătescu V, Papavă I, Riviș I, Ursoniu S

Neuropsychiatric Disease and Treatment 2021, 17:1679-1687

Published Date: 27 May 2021

Eating Disorders and the Use of Cognitive Enhancers and Psychostimulants Among University Students: A Cross-Sectional Study

Damiri B, Safarini OA, Nazzal Z, Abuhassan A, Farhoud A, Ghanim N, Al Ali R, Suhail M, Qino M, Zamareh M, Thabaleh A, Zahran J

Neuropsychiatric Disease and Treatment 2021, 17:1633-1645

Published Date: 25 May 2021

Transient Global Amnesia: Risk Factors, Imaging Features, and Prognosis

He S, Ye Z, Yang Q, Lin J, Chen X, Chen Z, Chen L

Neuropsychiatric Disease and Treatment 2021, 17:1611-1619

Published Date: 25 May 2021

Psychiatric Disorders of Neurocysticercosis: Narrative Review

El-Kady AM, Allemailem KS, Almatroudi A, Abler B, Elsayed M

Neuropsychiatric Disease and Treatment 2021, 17:1599-1610

Published Date: 25 May 2021

Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations

Jackson R, Brams MN, Citrome L, Hoberg AR, Isaacson SH, Kane JM, Kumar R

Neuropsychiatric Disease and Treatment 2021, 17:1589-1597

Published Date: 24 May 2021

Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study

Jiang S, Zheng K, Wang W, Pei Y, Qiu E, Zhu G

Neuropsychiatric Disease and Treatment 2021, 17:1579-1587

Published Date: 21 May 2021

Ventilation Adjustment in ECT During COVID-19: Voluntary Hyperventilation is an Effective Strategy

de Arriba-Arnau A, Dalmau Llitjos A, Soria V, Labad J, Menchón JM, Urretavizcaya M

Neuropsychiatric Disease and Treatment 2021, 17:1563-1569

Published Date: 20 May 2021

Temporal Dynamics in Degree Centrality of Brain Functional Connectome in First-Episode Schizophrenia with Different Short-Term Treatment Responses: A Longitudinal Study

Wang Y, Jiang Y, Su W, Xu L, Wei Y, Tang Y, Zhang T, Tang X, Hu Y, Cui H, Wang J, Yao D, Luo C, Wang J

Neuropsychiatric Disease and Treatment 2021, 17:1505-1516

Published Date: 18 May 2021

Cognitive Impairment and Associated Factors Among Chronic Kidney Disease Patients: A Comparative Cross-Sectional Study

Gela YY, Getu AA, Adane A, Ayal BM, Akalu Y, Ambelu A, Diress M, Yeshaw Y

Neuropsychiatric Disease and Treatment 2021, 17:1483-1492

Published Date: 17 May 2021

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]

Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G

Neuropsychiatric Disease and Treatment 2021, 17:1481-1482

Published Date: 17 May 2021

Late-Onset Leukodystrophy Mimicking Hereditary Spastic Paraplegia without Diffuse Leukodystrophy on Neuroimaging

Zhang T, Yan C, Liu Y, Cao L, Ji K, Li D, Chi L, Zhao Y

Neuropsychiatric Disease and Treatment 2021, 17:1451-1458

Published Date: 12 May 2021

Association of CDKN2A/CDKN2B Gene Polymorphisms with Increased Susceptibility to Intracranial Aneurysm in a Chinese Han Population

Cui X, Xin WQ, Wang B, Zhao Y, Hou C, Cai S, Peng C, Wang Z, Li J, Huan L, Chen L, Yang X

Neuropsychiatric Disease and Treatment 2021, 17:1443-1449

Published Date: 12 May 2021

Psychological Impact of COVID-19, Isolation, and Quarantine: A Cross-Sectional Study

Jassim G, Jameel M, Brennan E, Yusuf M, Hasan N, Alwatani Y

Neuropsychiatric Disease and Treatment 2021, 17:1413-1421

Published Date: 11 May 2021

Mechanism of Autophagy Regulation in MPTP-Induced PD Mice via the mTOR Signaling Pathway by Echinacoside

Zhang ZN, Hui Z, Chen C, Liang Y, Tang LL, Wang SL, Xu CC, Yang H, Zhao Y, Zhang JS

Neuropsychiatric Disease and Treatment 2021, 17:1397-1411

Published Date: 10 May 2021

Self-Reported Symptoms of Depression, Anxiety, and Stress Among Healthcare Workers in Ethiopia During the COVID-19 Pandemic: A Cross-Sectional Study

Jemal K, Deriba BS, Geleta TA, Tesema M, Awol M, Mengistu E, Annous Y

Neuropsychiatric Disease and Treatment 2021, 17:1363-1373

Published Date: 6 May 2021

Depression and Related Factors in Patients with Parkinson’s Disease at High Altitude

Cao Y, Li G, Xue J, Zhang G, Gao S, Huang Y, Zhu A

Neuropsychiatric Disease and Treatment 2021, 17:1353-1362

Published Date: 6 May 2021

Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer’s Disease

Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM

Neuropsychiatric Disease and Treatment 2021, 17:1311-1339

Published Date: 4 May 2021

The Role of Cognitive Complaints in the Relationship Between Trait Anxiety, Depressive Symptoms, and Subjective Well-Being and Ill-Being in Adult Community Volunteers

Toyoshima K, Ichiki M, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I

Neuropsychiatric Disease and Treatment 2021, 17:1299-1309

Published Date: 30 April 2021

Association Between ApoA1 Gene Polymorphisms and Antipsychotic Drug-Induced Dyslipidemia in Schizophrenia

Fan L, You Y, Fan Y, Shen C, Xue Y

Neuropsychiatric Disease and Treatment 2021, 17:1289-1297

Published Date: 30 April 2021

Comparative Effects of Repetitive Odor Identification and Odor Memory Tasks on Olfactory Engagement in Older Populations – A Pilot fMRI Study

Rai N, Hipolito MM, VanMeter JW, Seth R, Adenuga A, Shelby M, Misiak-Christian M, Nwaokobia C, Manaye KF, Obisesan TO, Nwulia E

Neuropsychiatric Disease and Treatment 2021, 17:1279-1288

Published Date: 30 April 2021

Handgrip Strength and Depression Among Older Chinese Inpatients: A Cross-Sectional Study

Zhang XM, Jiao J, Cao J, Guo N, Zhu C, Li Z, Wu X, Xu T

Neuropsychiatric Disease and Treatment 2021, 17:1267-1277

Published Date: 30 April 2021

Depressive-, Cognitive- or Stroke-Related Risk Factors of Post-Stroke Depression: Which One Could Better Help Clinicians and Patients?

Perrain R, Calvet D, Guiraud V, Mekaoui L, Mas JL, Gorwood P

Neuropsychiatric Disease and Treatment 2021, 17:1243-1251

Published Date: 29 April 2021

Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients with Essential Thrombocythemia

Jiao L, Huang X, Fan C, Zhao H, Li Z, Shen H, Chen J, Duan J

Neuropsychiatric Disease and Treatment 2021, 17:1195-1206

Published Date: 22 April 2021

Exploring the Hereditary Nature of Migraine

Bron C, Sutherland HG, Griffiths LR

Neuropsychiatric Disease and Treatment 2021, 17:1183-1194

Published Date: 22 April 2021

Biliverdin Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating the miR-27a-3p/Rgs1 Axis

Li J, Peng L, Bai W, Peng P, Chen W, Yang W, Shao J

Neuropsychiatric Disease and Treatment 2021, 17:1165-1181

Published Date: 22 April 2021

Venlafaxine Inhibits the Apoptosis of SHSY-5Y Cells Through Active Wnt/β-Catenin Signaling Pathway

Geng R, Li H, Wang H, Ye C, Mao Y, Huang X

Neuropsychiatric Disease and Treatment 2021, 17:1145-1151

Published Date: 21 April 2021

Association Analysis of Polymorphisms in BIN1, MC1R, STARD6 and PVRL2 with Mild Cognitive Impairment in Elderly Carrying APOE ϵ4 Allele

Wu Y, Yin J, Yang B, Tang L, Feng W, Liu X, Zhao X, Cheng Z

Neuropsychiatric Disease and Treatment 2021, 17:1125-1133

Published Date: 21 April 2021

Characteristics of TCM Constitution and Related Biomarkers for Mild Cognitive Impairment

Deng X, Teng J, Nong X, Yu B, Tang L, Liang J, Zou Z, Liu Q, Zhou L, Li Q, Zhao L

Neuropsychiatric Disease and Treatment 2021, 17:1115-1124

Published Date: 20 April 2021

Identifying Subjective Symptoms Associated with Psychomotor Disturbance in Melancholia: A Multiple Regression Analysis Study

Tamada Y, Inoue T, Sekine A, Toda H, Takeshima M, Sasaki M, Shindome K, Morita W, Kuyama N, Ohmae S

Neuropsychiatric Disease and Treatment 2021, 17:1105-1114

Published Date: 19 April 2021

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis

Hýža M, Šilhán P, Češková E, Skřont T, Kacířová I, Uřinovská R, Grundmann M

Neuropsychiatric Disease and Treatment 2021, 17:1069-1075

Published Date: 14 April 2021

Electroacupuncture Ameliorates Depressive-Like Behaviors in Poststroke Rats via Activating the tPA/BDNF/TrkB Pathway

Dong H, Qin YQ, Sun YC, Yao HJ, Cheng XK, Yu Y, Lu SS

Neuropsychiatric Disease and Treatment 2021, 17:1057-1067

Published Date: 13 April 2021

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder

Ichinose M, Miura I, Horikoshi S, Yamamoto S, Kanno-Nozaki K, Watanabe K, Yabe H

Neuropsychiatric Disease and Treatment 2021, 17:1047-1053

Published Date: 13 April 2021

Construct Validity and Differential Item Functioning of the PHQ-9 Among Health Care Workers: Rasch Analysis Approach

Jiraniramai S, Wongpakaran T, Angkurawaranon C, Jiraporncharoen W, Wongpakaran N

Neuropsychiatric Disease and Treatment 2021, 17:1035-1045

Published Date: 8 April 2021

Benzodiazepine and Z-Drug Use in Switzerland: Prevalence, Prescription Patterns and Association with Adverse Healthcare Outcomes

Landolt S, Rosemann T, Blozik E, Brüngger B, Huber CA

Neuropsychiatric Disease and Treatment 2021, 17:1021-1034

Published Date: 12 April 2021

Traditional Chinese Formula Xiaoyaosan Alleviates Depressive-Like Behavior in CUMS Mice by Regulating PEBP1-GPX4-Mediated Ferroptosis in the Hippocampus

Jiao H, Yang H, Yan Z, Chen J, Xu M, Jiang Y, Liu Y, Xue Z, Ma Q, Li X, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:1001-1019

Published Date: 6 April 2021

A Systematic Review and Meta-Analysis of Transcranial Direct Current Stimulation to Remediate Age-Related Cognitive Decline in Healthy Older Adults

Indahlastari A, Hardcastle C, Albizu A, Alvarez-Alvarado S, Boutzoukas EM, Evangelista ND, Hausman HK, Kraft J, Langer K, Woods AJ

Neuropsychiatric Disease and Treatment 2021, 17:971-990

Published Date: 29 March 2021

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G

Neuropsychiatric Disease and Treatment 2021, 17:957-970

Published Date: 7 April 2021

Urinary Metabolite Signatures for Predicting Elderly Stroke Survivors with Depression

Chen J, Lv Y, Li X, Xiong J, Liang H, Xie L, Wan C, Chen Y, Wang H, Liu P, Zheng H

Neuropsychiatric Disease and Treatment 2021, 17:925-933

Published Date: 25 March 2021

The Association of Insomnia with Depression and Anxiety Symptoms in Patients Undergoing Noncardiac Surgery

Huang X, Wu D, Wu AS, Wei CW, Gao JD

Neuropsychiatric Disease and Treatment 2021, 17:915-924

Published Date: 25 March 2021

Vagal Nerve Stimulation Protects Against Cerebral Ischemia–Reperfusion Injury in Rats by Inhibiting Autophagy and Apoptosis

Zhang LN, Zhang XW, Li CQ, Guo J, Chen YP, Chen SL

Neuropsychiatric Disease and Treatment 2021, 17:905-913

Published Date: 25 March 2021

Psychometric Properties of the General Anxiety Disorders-7 Scale Using Categorical Data Methods: A Study in a Sample of University Attending Ethiopian Young Adults

Manzar MD, Alghadir AH, Anwer S, Alqahtani M, Salahuddin M, Addo HA, Jifar WW, Alasmee NA

Neuropsychiatric Disease and Treatment 2021, 17:893-903

Published Date: 22 March 2021

Patterns of Migraine in Postmenopausal Women: A Systematic Review

Ornello R, Caponnetto V, Frattale I, Sacco S

Neuropsychiatric Disease and Treatment 2021, 17:859-871

Published Date: 19 March 2021

Monocyte-to-Lymphocyte Ratio is Associated with Depression 3 Months After Stroke

Ding K, Lai Z, Zhang Y, Yang G, He J, Zeng L

Neuropsychiatric Disease and Treatment 2021, 17:835-845

Published Date: 19 March 2021

The Relationship Between Type D Personality and the Complexity of Coronary Artery Disease

Enatescu VR, Cozma D, Tint D, Enatescu I, Simu M, Giurgi-Oncu C, Lazar MA, Mornos C

Neuropsychiatric Disease and Treatment 2021, 17:809-820

Published Date: 18 March 2021

A National Survey of Self-Prescription of Beta-Blockers and Their Relation to Undiscovered Anxiety Among Medical and Pharmacological Students in Saudi Arabia

Alsini A, Alkhodaidi I, Alsini Y, Alsseeni S, Alkhodaidi S, Alsini E, Alsini A, Sindi H, Alswat K

Neuropsychiatric Disease and Treatment 2021, 17:797-807

Published Date: 17 March 2021

Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder

Chen JX, Yin L, Xu HT, Zhang SY, Huang WQ, Li HJ, Li BB, Yang KB, Li Q, Berk M, Su YA

Neuropsychiatric Disease and Treatment 2021, 17:787-795

Published Date: 12 March 2021

Recruitment Challenges for Studies of Deep Brain Stimulation for Treatment-Resistant Depression

Ramasubbu R, Golding S, Williams K, Mackie A, MacQueen G, Kiss ZHT

Neuropsychiatric Disease and Treatment 2021, 17:765-775

Published Date: 10 March 2021

Taiwanese Depression Questionnaire and AD8 Questionnaire for Screening Late-Life Depression in Communities

Wei YC, Huang LY, Lin C, Shyu YC, Chen CK

Neuropsychiatric Disease and Treatment 2021, 17:747-755

Published Date: 9 March 2021

Parkinson’s Disease-Associated Melanin Steal [Retraction]

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2021, 17:733-734

Published Date: 3 March 2021

5-HTP Efficacy and Contraindications [Retraction]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2021, 17:731-732

Published Date: 3 March 2021

Construction and Standardization of Dementia Arabic Scale

Farghaly WM, El Tallawy HN, Mohamed H, El Tallawy SH, Abdelhamed MA

Neuropsychiatric Disease and Treatment 2021, 17:721-729

Published Date: 3 March 2021

Short- and Long-Term Effects of Vitamin D Treatment on Bacillus Calmette-Guerin-Induced Depressive-Like Behavior in Mice

Saleh LA, Almutairi FM, Alorabi WK, Alkuhayli BA, Alzaidi SS, Alzahrani SB, Aljumayi FA, Abduljabbar MH, Alharthi AS, Alsufyani MA, Alhazmi MH, Althobaiti AA, Almutairi FN, Alshehri FS, Altowairqi E, Althobaiti YS

Neuropsychiatric Disease and Treatment 2021, 17:711-720

Published Date: 2 March 2021

Early Post-Stroke Electroacupuncture Promotes Motor Function Recovery in Post-Ischemic Rats by Increasing the Blood and Brain Irisin

Liu L, Zhang Q, Li M, Wang N, Li C, Song D, Shen X, Luo L, Fan Y, Xie H, Wu Y

Neuropsychiatric Disease and Treatment 2021, 17:695-702

Published Date: 1 March 2021

P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12

Zhu G, Yang S, Wang R, Lei J, Ji P, Wang J, Tao K, Yang C, Ge S, Wang L

Neuropsychiatric Disease and Treatment 2021, 17:681-693

Published Date: 26 February 2021

Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users

Yuferov V, Butelman ER, Randesi M, van den Brink W, Blanken P, van Ree JM, Kreek MJ

Neuropsychiatric Disease and Treatment 2021, 17:659-670

Published Date: 25 February 2021

Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus

Elsharkawy RE, Abdel Azim GS, Osman MA, Maghraby HM, Mohamed RA, Abdelsalam EM, Ebrahem EE, Seliem NMA

Neuropsychiatric Disease and Treatment 2021, 17:627-635

Published Date: 24 February 2021

Changes in the Practice of Electroconvulsive Therapy in Poland: A Nationwide Survey Comparing Data Between 2005 and 2020

Antosik-Wójcińska AZ, Dominiak M, Mierzejewski P, Jażdżyk P, Gazdag G, Takacs R, Wichniak A

Neuropsychiatric Disease and Treatment 2021, 17:605-612

Published Date: 22 February 2021

Risk of Psychiatric Disorders in Multiple Sclerosis: A Nationwide Cohort Study in an Asian Population

Huang YC, Chien WC, Chung CH, Chang HA, Kao YC, Wan FJ, Huang SH, Chung RJ, Wang RS, Wang BL, Tzeng NS, Sun CA

Neuropsychiatric Disease and Treatment 2021, 17:587-604

Published Date: 22 February 2021

Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression

Ni P, Liu M, Wang D, Tian Y, Zhao L, Wei J, Yu X, Qi X, Li X, Yu H, Ni R, Ma X, Deng W, Guo W, Wang Q, Li T

Neuropsychiatric Disease and Treatment 2021, 17:567-574

Published Date: 22 February 2021

Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls

Chan G, Rosic T, Pasyk S, Dehghan M, Samaan Z

Neuropsychiatric Disease and Treatment 2021, 17:545-554

Published Date: 17 February 2021

Therapeutic Effect of Idebenone on Rats with Vascular Dementia via the MicroRNA-216a/RSK2/NF-κB Axis

Qian X, Xu Q, Li G, Bu Y, Sun F, Zhang J

Neuropsychiatric Disease and Treatment 2021, 17:533-543

Published Date: 17 February 2021

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]

Zhang M, Han W, Xu Y, Li D, Xue Q

Neuropsychiatric Disease and Treatment 2021, 17:513-514

Published Date: 16 February 2021

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia

Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J

Neuropsychiatric Disease and Treatment 2021, 17:503-512

Published Date: 16 February 2021

Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis

Fowler JC, Cope N, Knights J, Fang H, Skubiak T, Shergill SS, Phiri P, Rathod S, Peters-Strickland T

Neuropsychiatric Disease and Treatment 2021, 17:483-492

Published Date: 12 February 2021

Valproate Reverses Mania-Like Behavior of Clockdelta19 Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus

Liu S, Wei J, Ni R, Gao T, Ni P, Zhao L, Duan X, Ma X, Sham PC, Li T

Neuropsychiatric Disease and Treatment 2021, 17:471-480

Published Date: 11 February 2021

A Bidirectional View of Migraine and Diet Relationship

Gazerani P

Neuropsychiatric Disease and Treatment 2021, 17:435-451

Published Date: 11 February 2021

The Psychological Experience and Intervention in Post-Acute COVID-19 Inpatients

Rossi Ferrario S, Panzeri A, Cerutti P, Sacco D

Neuropsychiatric Disease and Treatment 2021, 17:413-422

Published Date: 11 February 2021

Serum Albumin Levels and Clinical Outcomes Among Ischemic Stroke Patients Treated with Endovascular Thrombectomy

Gao J, Zhao Y, Du M, Guo H, Wan T, Wu M, Liu L, Wang H, Yin Q, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:401-411

Published Date: 10 February 2021

Hippocampal miRNA-144 Modulates Depressive-Like Behaviors in Rats by Targeting PTP1B

Li Y, Wang N, Pan J, Wang X, Zhao Y, Guo Z

Neuropsychiatric Disease and Treatment 2021, 17:389-399

Published Date: 10 February 2021

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage

Zhang C, Zhong J, Chen WX, Zhang XY, Li YH, Zhou TY, Zou YJ, Lan C, Li L, Lai ZP, Feng H, Hu R

Neuropsychiatric Disease and Treatment 2021, 17:355-363

Published Date: 9 February 2021

Bushen Huoxue Acupuncture Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in SAMP8 Mouse Model of Alzheimer’s Disease

Zhang T, Guan B, Tan S, Zhu H, Ren D, Li R, Xiao L

Neuropsychiatric Disease and Treatment 2021, 17:339-346

Published Date: 5 February 2021

Psychosomatic Stress Responses and Sleep Disturbance Mediate the Effects of Irregular Mealtimes on Presenteeism

Hayashida T, Shimura A, Higashiyama M, Fujimura Y, Ono K, Inoue T

Neuropsychiatric Disease and Treatment 2021, 17:315-321

Published Date: 4 February 2021

Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke

Li N, Li J, Gao T, Wang D, Du Y, Zhao X

Neuropsychiatric Disease and Treatment 2021, 17:305-314

Published Date: 3 February 2021

(2R,6R)-Hydroxynorketamine Alleviates Electroconvulsive Shock-Induced Learning Impairment by Inhibiting Autophagy

Zhong X, Ouyang C, Liang W, Dai C, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:297-304

Published Date: 3 February 2021

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

Montes JM, Montes P, Hernández-Huerta D

Neuropsychiatric Disease and Treatment 2021, 17:291-296

Published Date: 3 February 2021

Prevalence and Predictors of Postictal Confusion After Electroconvulsive Therapy

Ittasakul P, Jarernrat P, Tor PC

Neuropsychiatric Disease and Treatment 2021, 17:283-289

Published Date: 2 February 2021

Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk Schizophrenia

Chen X, Chen C, Ji F, Xu Y, Wang W, Lin X, Jiang D, Song X, Gao X, Tian H, Zhuo C, Zhang J

Neuropsychiatric Disease and Treatment 2021, 17:277-282

Published Date: 29 January 2021

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease

Zhang M, Han W, Xu Y, Li D, Xue Q

Neuropsychiatric Disease and Treatment 2021, 17:269-275

Published Date: 29 January 2021

Schisandrin Inhibits NLRP1 Inflammasome-Mediated Neuronal Pyroptosis in Mouse Models of Alzheimer’s Disease

Li Q, Wang Q, Guan H, Zhou Y, Liu L

Neuropsychiatric Disease and Treatment 2021, 17:261-268

Published Date: 29 January 2021

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval

Okayasu H, Shinozaki T, Takano Y, Sugawara N, Fujii K, Yasui-Furukori N, Ozeki Y, Shimoda K

Neuropsychiatric Disease and Treatment 2021, 17:239-249

Published Date: 27 January 2021

Reliability and Validity of the Chen ADHD Scale (C-ADHDS)

Chen YL, Chen VCH, Gossop M

Neuropsychiatric Disease and Treatment 2021, 17:229-237

Published Date: 27 January 2021

Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women

Ogawa M, Watanabe Y, Motegi T, Fukui N, Hashijiri K, Tsuboya R, Sugai T, Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya T

Neuropsychiatric Disease and Treatment 2021, 17:221-227

Published Date: 26 January 2021

Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study

Qiao S, Wu H, Liu L, Wang M, Zhang R, Han T, Liu X

Neuropsychiatric Disease and Treatment 2021, 17:203-212

Published Date: 25 January 2021

Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders

Yang T, Lam RW, Huang J, Su Y, Liu J, Yang X, Yang L, Zhu N, Zhao G, Mao R, Zhou R, Xia W, Liu H, Wang Z, Chen J, Fang Y

Neuropsychiatric Disease and Treatment 2021, 17:183-193

Published Date: 22 January 2021

Anxiety and Stress Among Undergraduate Medical Students of Haramaya University, Eastern Ethiopia

Asfaw H, Fekadu G, Tariku M, Oljira A

Neuropsychiatric Disease and Treatment 2021, 17:139-146

Published Date: 22 January 2021

A Retrospective Study of Patients with GABABR Encephalitis: Therapy, Disease Activity and Prognostic Factors

Wen X, Wang B, Wang C, Han C, Guo S

Neuropsychiatric Disease and Treatment 2021, 17:99-110

Published Date: 18 January 2021

Behavior Disorder and Social Function Impairment in Children with Basal Ganglia Germ Cell Tumors

Lv W, Feng J, Chen L, Liu S, Qiu X

Neuropsychiatric Disease and Treatment 2021, 17:91-98

Published Date: 14 January 2021

Implementing Measurement-Based Care for Depression: Practical Solutions for Psychiatrists and Primary Care Physicians

Hong RH, Murphy JK, Michalak EE, Chakrabarty T, Wang Z, Parikh SV, Culpepper L, Yatham LN, Lam RW, Chen J

Neuropsychiatric Disease and Treatment 2021, 17:79-90

Published Date: 14 January 2021

Clinical Manifestations, Fluid Changes and Neuroimaging Alterations in Patients with General Paresis of the Insane

Gao JH, Li WR, Xu DM, Zheng BW, Huang YM, Wu WQ, Zhang W

Neuropsychiatric Disease and Treatment 2021, 17:69-78

Published Date: 13 January 2021

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden [Corrigendum]

Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, Canesi M, Fabbrini G, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Gualberti G, Lopiano L

Neuropsychiatric Disease and Treatment 2021, 17:67-68

Published Date: 13 January 2021

MicroRNA-488-3p Regulates Neuronal Cell Death in Cerebral Ischemic Stroke Through Vacuolar Protein Sorting 4B (VPS4B)

Zhou L, Yang W, Yao E, Li H, Wang J, Wang K, Zhong X, Peng Z, Huang X

Neuropsychiatric Disease and Treatment 2021, 17:41-55

Published Date: 7 January 2021

Characterizations of Ischemic Stroke Complications in Cardiac Myxoma Patients at a Single Institution in Eastern China

Zhang Y, Ye Z, Fu Y, Zhang Z, Ye Q, Chen F, Cheng J

Neuropsychiatric Disease and Treatment 2021, 17:33-40

Published Date: 7 January 2021

The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study

Knez R, Stevanovic D, Nasic S, Doric A, Wentz E

Neuropsychiatric Disease and Treatment 2021, 17:19-32

Published Date: 6 January 2021

Correlations Between SIRT Genetic Polymorphisms and Postpartum Depressive Symptoms in Chinese Parturients Who Had Undergone Cesarean Section

Luo SC, Duan KM, Fang C, Li DY, Zheng SS, Yang SQ, Yang ST, Yang M, Zhang LB, Wang SY

Neuropsychiatric Disease and Treatment 2020, 16:3225-3238

Published Date: 24 December 2020

Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia

Lambert M, Sanchez P, Bergmans P, Gopal S, Mathews M, Wooller A, Pungor K

Neuropsychiatric Disease and Treatment 2020, 16:3197-3208

Published Date: 23 December 2020

Polysomnographic Correlates for the Risk of Relapse in Detoxified Opiate-Misuse Patients

Rady A, Mekky J, Moulokheya T, Elsheshai A

Neuropsychiatric Disease and Treatment 2020, 16:3187-3196

Published Date: 22 December 2020

Suspected Transverse Myelitis with Normal MRI and CSF Findings in a Patient with Lupus: What to Do? A Case Series and Systematic Review

Monahan RC, Beaart HJL, Fronczek R, Terwindt GM, Beaart-van de Voorde LJJ, de Bresser J, Kloppenburg M, van der Wee NJA, Huizinga TWJ, Steup-Beekman GM

Neuropsychiatric Disease and Treatment 2020, 16:3173-3186

Published Date: 22 December 2020

The Effect of Oral L-cysteine on Breast Milk and Plasma Cysteine Concentrations

Dowlati Y, Maheux M, Meyer JH

Neuropsychiatric Disease and Treatment 2020, 16:3163-3172

Published Date: 21 December 2020

The Relationship Between Symptoms of Anxiety and Somatic Symptoms in Health Professionals During the Coronavirus Disease 2019 Pandemic

Li H, Zhang Y, Wang H, Liang J, Zhou Y, Huang Y, Zhai T, Yang Q, Yang M, Ning Y, He H, Wu K, Chen F, Wu F, Zhang X

Neuropsychiatric Disease and Treatment 2020, 16:3153-3161

Published Date: 18 December 2020

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia

Pu C, Huang B, Zhou T, Cheng Z, Wang Y, Shi C, Yu X

Neuropsychiatric Disease and Treatment 2020, 16:3145-3152

Published Date: 17 December 2020

Predictors of Passive and Active Suicidal Ideation and Suicide Attempt Among Older People: A Study in Tertiary Care Settings in Thailand

Booniam S, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Kuntawong P, Wongpakaran N

Neuropsychiatric Disease and Treatment 2020, 16:3135-3144

Published Date: 17 December 2020

The Dual-Gate Lumen Model of Renal Monoamine Transport [Retraction]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:3133-3134

Published Date: 16 December 2020

Parkinson’s Disease Managing Reversible Neurodegeneration [Retraction]

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2020, 16:3125-3126

Published Date: 16 December 2020

APRESS: Apical Regulatory Super System, Serotonin, and Dopamine Interaction [Retraction]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:3123-3124

Published Date: 16 December 2020

Depression, Anxiety and Primiparity are Negatively Associated with Mother–Infant Bonding in Japanese Mothers

Motegi T, Watanabe Y, Fukui N, Ogawa M, Hashijiri K, Tsuboya R, Sugai T, Egawa J, Araki R, Haino K, Yamaguchi M, Nishijima K, Enomoto T, Someya T

Neuropsychiatric Disease and Treatment 2020, 16:3117-3122

Published Date: 14 December 2020

The Impact of Childhood Trauma on Developing Bipolar Disorder: Current Understanding and Ensuring Continued Progress

Quidé Y, Tozzi L, Corcoran M, Cannon DM, Dauvermann MR

Neuropsychiatric Disease and Treatment 2020, 16:3095-3115

Published Date: 14 December 2020

Impaired Cognitive Abilities in Siblings of Patients with Temporal Lobe Epilepsy

Tan L, Chen Y, Wu W, Liu C, Fu Y, He J, Zhang M, Wang G, Wang K, Long H, Xiao W, Xiao B, Long L

Neuropsychiatric Disease and Treatment 2020, 16:3071-3079

Published Date: 14 December 2020

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms

Sugawara N, Yasui-Furukori N, Tsuji T, Hayashi S, Ajisawa Y, Ochiai T, Imagawa H, Shimoda K

Neuropsychiatric Disease and Treatment 2020, 16:3063-3070

Published Date: 11 December 2020

Association Between Weight Misperception and Some Mental Health-Related Characteristics in Korean Adolescents

Lee KH, Bong SH, Kang DH, Choi TY, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:3053-3062

Published Date: 10 December 2020

Association of Orthorexic Tendencies with Obsessive-Compulsive Symptoms, Eating Attitudes and Exercise

Yılmaz H, Karakuş G, Tamam L, Demirkol ME, Namlı Z, Yeşiloğlu C

Neuropsychiatric Disease and Treatment 2020, 16:3035-3044

Published Date: 14 December 2020

The Role of Resilience and Gender in Relation to Infectious-Disease-Specific Health Literacy and Anxiety During the COVID-19 Pandemic

Xiao X, Xiao J, Yao J, Chen Y, Saligan L, Reynolds NR, Wang H

Neuropsychiatric Disease and Treatment 2020, 16:3011-3021

Published Date: 8 December 2020

Abnormal Anhedonia as a Potential Endophenotype in Obsessive–Compulsive Disorder

Xu C, Chen J, Cui Z, Wen R, Han H, Jin L, Wan G, Wei Z, Peng Z

Neuropsychiatric Disease and Treatment 2020, 16:3001-3010

Published Date: 8 December 2020

Transcranial Magnetic Stimulation (TMS) Safety with Respect to Seizures: A Literature Review

Stultz DJ, Osburn S, Burns T, Pawlowska-Wajswol S, Walton R

Neuropsychiatric Disease and Treatment 2020, 16:2989-3000

Published Date: 7 December 2020

Antiapoptotic and Anti-Inflammatory Effects of CPCGI in Rats with Traumatic Brain Injury

Niu F, Qian K, Qi H, Zhao Y, Jiang Y, Sun M

Neuropsychiatric Disease and Treatment 2020, 16:2975-2987

Published Date: 7 December 2020

Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Wang G, Han C, Liu CY, Chan S, Kato T, Tan W, Zhang L, Feng Y, Ng CH

Neuropsychiatric Disease and Treatment 2020, 16:2943-2959

Published Date: 3 December 2020

Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Han C, Wang G, Chan S, Kato T, Ng CH, Tan W, Zhang L, Feng Y, Liu CY

Neuropsychiatric Disease and Treatment 2020, 16:2929-2941

Published Date: 3 December 2020

Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients

Chee IS, Kim HJ, Lee Y, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:2921-2928

Published Date: 3 December 2020

A Nomogram Model to Predict Malignant Cerebral Edema in Ischemic Stroke Patients Treated with Endovascular Thrombectomy: An Observational Study

Du M, Huang X, Li S, Xu L, Yan B, Zhang Y, Wang H, Liu X

Neuropsychiatric Disease and Treatment 2020, 16:2913-2920

Published Date: 2 December 2020

Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden

Modugno N, Antonini A, Tessitore A, Marano P, Pontieri FE, Tambasco N, Canesi M, Fabbrini G, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Gualberti G, Lopiano L

Neuropsychiatric Disease and Treatment 2020, 16:2899-2912

Published Date: 2 December 2020

Serum C-Reactive Protein in Patients with Deficit Schizophrenia and the Relationship with Cognitive Function

Pan LH, Qian M, Qu W, Tang Q, Yan Y

Neuropsychiatric Disease and Treatment 2020, 16:2891-2897

Published Date: 1 December 2020

Knowledge of Prevention Measures and Information About Coronavirus in Romanian Male Patients with Severe Mental Illness and Severe Alcohol Use Disorder

Matei V, Pavel A, Giurgiuca A, Roșca A, Sofia A, Duțu I, Tudose C

Neuropsychiatric Disease and Treatment 2020, 16:2857-2864

Published Date: 26 November 2020

Neuropsychological Comparison Between Patients with Social Anxiety and Healthy Controls: Weak Central Coherence and Visual Scanning Deficit

Okawa S, Hamatani S, Hayashi Y, Arai H, Nihei M, Yoshida T, Takahashi J, Shimizu E, Hirano Y

Neuropsychiatric Disease and Treatment 2020, 16:2849-2855

Published Date: 25 November 2020

Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital

Yi W, She S, Zhang J, Wu H, Zheng Y, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:2827-2836

Published Date: 24 November 2020

Reversible Neuropsychiatric Disturbances Caused by Nitrous Oxide Toxicity: Clinical, Imaging and Electrophysiological Profiles of 21 Patients with 6–12 Months Follow-up

Zheng R, Wang Q, Li M, Liu F, Zhang Y, Zhao B, Sun Y, Zhang D, Yan C, Zhao Y, Li W

Neuropsychiatric Disease and Treatment 2020, 16:2817-2825

Published Date: 23 November 2020

Telepsychiatry in the Arab World: A Viewpoint Before and During COVID-19

El Hayek S, Nofal M, Abdelrahman D, Adra A, Al Harthi M, Al Shamli S, AlNuaimi N, Bensid L, Cheaito MA, Emberish AM, Larnaout A, Radwan A, Slaih M, Kobeissy F, Bizri M

Neuropsychiatric Disease and Treatment 2020, 16:2805-2815

Published Date: 19 November 2020

Randomized Clinical Trial Examining the Impact of Lactobacillus rhamnosus GG Probiotic Supplementation on Cognitive Functioning in Middle-aged and Older Adults

Sanborn V, Azcarate-Peril MA, Updegraff J, Manderino L, Gunstad J

Neuropsychiatric Disease and Treatment 2020, 16:2765-2777

Published Date: 13 November 2020

MiRNA-532-5p Regulates CUMS-Induced Depression-Like Behaviors and Modulates LPS-Induced Proinflammatory Cytokine Signaling by Targeting STAT3

Yan X, Zeng D, Zhu H, Zhang Y, Shi Y, Wu Y, Tang H, Li D

Neuropsychiatric Disease and Treatment 2020, 16:2753-2764

Published Date: 12 November 2020

Spatial Patterns of Amyloid Deposition in Patients with Chronic Focal or Diffuse Traumatic Brain Injury Using 18F-FPYBF-2 PET

Ubukata S, Oishi N, Higashi T, Kagawa S, Yamauchi H, Okuyama C, Watanabe H, Ono M, Saji H, Aso T, Murai T, Ueda K

Neuropsychiatric Disease and Treatment 2020, 16:2719-2732

Published Date: 12 November 2020

Ketamine in Bipolar Disorder: A Review

Wilkowska A, Szałach Ł, Cubała WJ

Neuropsychiatric Disease and Treatment 2020, 16:2707-2717

Published Date: 12 November 2020

Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder

Liang JQ, Liao HR, Xu CX, Li XL, Wei ZX, Xie GJ, Cheng Y

Neuropsychiatric Disease and Treatment 2020, 16:2689-2693

Published Date: 10 November 2020

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose

Yeung PY, Wong LLL, Chan CC, Yung CY, Leung LMJ, Tam YY, Tang LN, Li HS, Lau ML

Neuropsychiatric Disease and Treatment 2020, 16:2681-2687

Published Date: 6 November 2020

Virtual Reality Exposure Therapy (VRET) for Anxiety Due to Fear of COVID-19 Infection: A Case Series

Zhang W, Paudel D, Shi R, Liang J, Liu J, Zeng X, Zhou Y, Zhang B

Neuropsychiatric Disease and Treatment 2020, 16:2669-2675

Published Date: 6 November 2020

Comparisons Between Infectious and Autoimmune Encephalitis: Clinical Signs, Biochemistry, Blood Counts, and Imaging Findings

Huang CN, Tian XB, Jiang SM, Chang SH, Wang N, Liu MQ, Zhang QX, Li T, Zhang LJ, Yang L

Neuropsychiatric Disease and Treatment 2020, 16:2649-2660

Published Date: 4 November 2020

Care Needs of Community-Residing Male Patients with Vascular Cognitive Impairment

Jhang KM, Wang WF, Chang HF, Liu YH, Chang MC, Wu HH

Neuropsychiatric Disease and Treatment 2020, 16:2613-2621

Published Date: 3 November 2020

Sensory Hypersensitivity Severity and Association with Obsessive-Compulsive Symptoms in Adults with Tic Disorder

Isaacs D, Key AP, Cascio CJ, Conley AC, Walker HC, Wallace MT, Claassen DO

Neuropsychiatric Disease and Treatment 2020, 16:2591-2601

Published Date: 2 November 2020

Psychometric Properties of the Chinese Version of the Intolerance of Uncertainty Inventory in Chinese College Students

Li S, Yang F, Li P, Wang X, Dai J, Deng Y

Neuropsychiatric Disease and Treatment 2020, 16:2579-2589

Published Date: 29 October 2020

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2020, 16:2569-2577

Published Date: 29 October 2020

Validation of the Dutch Version of the Brief Negative Symptom Scale

Seelen-de Lang BL, Boumans CE, Nijman HLI

Neuropsychiatric Disease and Treatment 2020, 16:2563-2567

Published Date: 29 October 2020

Association Between Autistic Symptoms and Self-Stigma in Patients with Schizophrenia Spectrum Disorders

Komatsu H, Ono T, Maita Y, Ishida Y, Kikuchi T, Maki T, Hase S, Sakurai H, Oba A, Teshirogi O, Suzuki A, Mori Y, Shoji C, Fujita A, Takahashi S, Ebina T, Ozaki S, Honma R, Tomita H, Kakuto Y

Neuropsychiatric Disease and Treatment 2020, 16:2553-2561

Published Date: 29 October 2020

Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression

Szarmach J, Cubała WJ, Włodarczyk A, Gałuszko-Węgielnik M

Neuropsychiatric Disease and Treatment 2020, 16:2539-2551

Published Date: 29 October 2020

Individual Perceived Stress Mediates Psychological Distress in Medical Workers During COVID-19 Epidemic Outbreak in Wuhan

Zhang C, Peng D, Lv L, Zhuo K, Yu K, Shen T, Xu Y, Wang Z

Neuropsychiatric Disease and Treatment 2020, 16:2529-2537

Published Date: 28 October 2020

Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia

Tsegay EW, Demise DG, Hailu NA, Gufue ZH

Neuropsychiatric Disease and Treatment 2020, 16:2499-2509

Published Date: 28 October 2020

Biochemical Parameters in Cognitive Functions

Popiolek AK, Chyrek-Tomaszewska A, Stachowicz-Karpińska A, Bieliński MK, Borkowska A

Neuropsychiatric Disease and Treatment 2020, 16:2479-2489

Published Date: 27 October 2020

A Survey on Public Attitudes Toward Mental Illness and Mental Health Services Among Four Cities in Saudi Arabia

Alsubaie S, Almathami M, Alkhalaf H, Aboulyazid A, Abuhegazy H

Neuropsychiatric Disease and Treatment 2020, 16:2467-2477

Published Date: 27 October 2020

Incidence and Risk Factors of Depressive Symptoms in Chinese College Students

Song Y, Liu Z, Chen H, Guo Q, Huang Y

Neuropsychiatric Disease and Treatment 2020, 16:2449-2457

Published Date: 23 October 2020

Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression

Zhang W, Zhu N, Lai J, Liu J, Ng CH, Chen J, Qian C, Du Y, Hu C, Chen J, Hu J, Wang Z, Zhou H, Xu Y, Fang Y, Shi C, Hu S

Neuropsychiatric Disease and Treatment 2020, 16:2419-2428

Published Date: 21 October 2020

Dissociative Symptoms and Self-Reported Childhood and Current Trauma in Male Incarcerated People with Borderline Personality Disorder – Results from a Small Cross-Sectional Study in Iran

Golshani S, Ghanbari S, Firoozabadi A, Shakeri J, Hookari S, Rahami B, Sadeghi Bahmani D, Brand S

Neuropsychiatric Disease and Treatment 2020, 16:2407-2417

Published Date: 21 October 2020

Psychometric Analysis of the Perceived Stress Scale Among Healthy University Students

Anwer S, Manzar MD, Alghadir AH, Salahuddin M, Abdul Hameed U

Neuropsychiatric Disease and Treatment 2020, 16:2389-2396

Published Date: 19 October 2020

Validity of the Korean Version of DIVA-5: A Semi-Structured Diagnostic Interview for Adult ADHD

Hong M, Kooij JJS, Kim B, Joung YS, Yoo HK, Kim EJ, Lee SI, Bhang SY, Lee SY, Han DH, Lee YS, Bahn GH

Neuropsychiatric Disease and Treatment 2020, 16:2371-2376

Published Date: 12 October 2020

Value of Combination of the A2DS2 Score and IL-6 in Predicting Stroke-Associated Pneumonia

Yang J, Dai Y, Zhang Z, Chen Y

Neuropsychiatric Disease and Treatment 2020, 16:2353-2359

Published Date: 9 October 2020

Can Quantitative Gait Analysis Be Used to Guide Treatment of Patients with Different Subtypes of Parkinson’s Disease?

Wu Z, Zhong M, Jiang X, Shen B, Zhu J, Pan Y, Dong J, Yan J, Xu P, Zhang W, Gao Y, Zhang L

Neuropsychiatric Disease and Treatment 2020, 16:2335-2341

Published Date: 9 October 2020

Post-Traumatic Stress Disorder and Associated Factors Among Internally Displaced People in South Ethiopia: A Cross-Sectional Study

Madoro D, Kerebih H, Habtamu Y, G/tsadik M, Mokona H, Molla A, Wondie T, Yohannes K

Neuropsychiatric Disease and Treatment 2020, 16:2317-2326

Published Date: 7 October 2020

Association Between Glutathione Peroxidase-1 (GPx-1) Polymorphisms and Schizophrenia in the Chinese Han Population

Shao X, Yan C, Sun D, Fu C, Tian C, Duan L, Zhu G

Neuropsychiatric Disease and Treatment 2020, 16:2297-2305

Published Date: 6 October 2020

Comparison of Cerebral Blood Flow Patterns in Patients with Phantom Bite Syndrome with Their Corresponding Clinical Features

Umezaki Y, Watanabe M, Shinohara Y, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Miura A, Takenoshita M, Sato Y, Minami I, Oyama J, Toriihara A, Yoshikawa T, Naito T, Motomura H, Toyofuku A

Neuropsychiatric Disease and Treatment 2020, 16:2277-2284

Published Date: 6 October 2020

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study

Inada K, Yamada S, Akiyoshi H, Kojima Y, Iwashita S, Ishigooka J

Neuropsychiatric Disease and Treatment 2020, 16:2267-2275

Published Date: 6 October 2020

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan

Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Sagae T, Someya T

Neuropsychiatric Disease and Treatment 2020, 16:2229-2236

Published Date: 30 September 2020

Validity of the Shahin Mixed Depression Scale: A Self-Rated Instrument Designed to Measure the Non-DSM Mixed Features in Depression

Shahin I, Bonnin CDM, Saleh E, Helmy K, Youssef UM, Vieta E

Neuropsychiatric Disease and Treatment 2020, 16:2209-2219

Published Date: 28 September 2020

Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives

Lloyd JR, Silverman ER, Kugler JL, Cooper JJ

Neuropsychiatric Disease and Treatment 2020, 16:2191-2208

Published Date: 25 September 2020

Relationship Among Sensory Over-Responsivity, Problem Behaviors, and Anxiety in Emerging Adults with Autism Spectrum Disorder

Syu YC, Huang PC, Wang TY, Chang YC, Lin LY

Neuropsychiatric Disease and Treatment 2020, 16:2181-2190

Published Date: 24 September 2020

Mu-Opioid Receptor Polymorphism Moderates Sensitivity to Parental Behaviors During Characterization of Personality Traits

Noto K, Suzuki A, Shirata T, Matsumoto Y, Takahashi N, Goto K, Otani K

Neuropsychiatric Disease and Treatment 2020, 16:2161-2167

Published Date: 22 September 2020

Elevated Neutrophil-to-Lymphocyte Ratio Predicts Depression After Intracerebral Hemorrhage

Gong X, Lu Z, Feng X, Yu C, Xue M, Yu L, Wang T, Cheng X, Lu J, Zhang M

Neuropsychiatric Disease and Treatment 2020, 16:2153-2159

Published Date: 21 September 2020

Magnitude, Symptom Presentation and Correlates of Psychological Distress Among People with Epilepsy in Southern Ethiopia: A Cross-Sectional Study

Mekuriaw B, Mantefardo B, Molla A, Berhanu G, Mehare T, Belayneh Z

Neuropsychiatric Disease and Treatment 2020, 16:2143-2151

Published Date: 18 September 2020

Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study

Nakajima A, Kanie A, Ito M, Hirabayashi N, Imamura F, Takebayashi Y, Horikoshi M

Neuropsychiatric Disease and Treatment 2020, 16:2135-2142

Published Date: 18 September 2020

Low Concentrations of Dehydroepiandrosterone Sulfate are Associated with Depression and Fatigue in Patients with Non-Small-Cell Lung Cancer After Chemotherapy

Fang YH, Hsieh MJ, Hung MS, Lin YC, Kuo LT, Lu ML, Tzang BS, Chen VCH

Neuropsychiatric Disease and Treatment 2020, 16:2103-2109

Published Date: 17 September 2020

Eating and Mealtime Behaviors in Patients with Autism Spectrum Disorder: Current Perspectives

Margari L, Marzulli L, Gabellone A, de Giambattista C

Neuropsychiatric Disease and Treatment 2020, 16:2083-2102

Published Date: 11 September 2020

Physical Comorbidities are Independently Associated with Higher Rates of Psychiatric Readmission in a Chinese Han Population

Yang C, Zhong X, Zhou H, Wu Z, Zhang M, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:2073-2082

Published Date: 10 September 2020

Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

Gattaz WF, Saracco-Alvarez R, Daltio CS, Van de Bilt MT, Ortegón JJ, Villaseñor-Bayardo SJ, Louzã M, Elkis H, Soares B, Cabrera Jaramillo P, Lawson F, Díaz-Galvis L

Neuropsychiatric Disease and Treatment 2020, 16:2063-2072

Published Date: 10 September 2020

Metabolic Syndrome Predicts Poor Outcome in Acute Ischemic Stroke Patients After Endovascular Thrombectomy

Chen Z, Su M, Li Z, Du H, Zhang S, Pu M, Zhang Y

Neuropsychiatric Disease and Treatment 2020, 16:2045-2052

Published Date: 7 September 2020

Spotlight on Compulsive Sexual Behavior Disorder: A Systematic Review of Research on Women

Kowalewska E, Gola M, Kraus SW, Lew-Starowicz M

Neuropsychiatric Disease and Treatment 2020, 16:2025-2043

Published Date: 4 September 2020

Identification of Potential Metabolite Markers for Middle-Aged Patients with Post-Stroke Depression Using Urine Metabolomics

Xie J, Han Y, Hong Y, Li W, Pei Q, Zhou X, Zhang B, Wang Y

Neuropsychiatric Disease and Treatment 2020, 16:2017-2024

Published Date: 25 August 2020

Influence of Parenting Quality and Neuroticism on Perceived Job Stressors and Psychological and Physical Stress Response in Adult Workers from the Community

Seki T, Shimura A, Miyama H, Furuichi W, Ono K, Masuya J, Odagiri Y, Inoue S, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:2007-2015

Published Date: 24 August 2020

Association of Chronotypes and Sleep Disturbance with Perceived Job Stressors and Stress Response: A Covariance Structure Analysis

Miyama H, Shimura A, Furuichi W, Seki T, Ono K, Masuya J, Odagiri Y, Inoue S, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:1997-2005

Published Date: 21 August 2020

Functional Recovery Patterns of Hemorrhagic and Ischemic Stroke Patients Under Post-Acute Care Rehabilitation Program

Chu CL, Chen YP, Chen CCP, Chen CK, Chang HN, Chang CH, Pei YC

Neuropsychiatric Disease and Treatment 2020, 16:1975-1985

Published Date: 13 August 2020

Association Between IL-6 and Seizure Recurrence in Patients with the First Post-Ischemic Stroke Seizure

Jia Q, Jiang F, Ma D, Li J, Wang F, Wang Z

Neuropsychiatric Disease and Treatment 2020, 16:1955-1963

Published Date: 11 August 2020

Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy

El Sabaa RM, Hamdi E, Hamdy NA, Sarhan HA

Neuropsychiatric Disease and Treatment 2020, 16:1945-1953

Published Date: 11 August 2020

Cerebral Arteriovenous Malformation Treatment by Full Transcranial Neuroendoscopic Approaches

Cai Q, Ji B, Li Z, Wang W, Liu J, Chen Z

Neuropsychiatric Disease and Treatment 2020, 16:1899-1905

Published Date: 6 August 2020

Prevalence of Eating Disorders Among Medical Students in a Lebanese Medical School: A Cross-Sectional Study

Bizri M, Geagea L, Kobeissy F, Talih F

Neuropsychiatric Disease and Treatment 2020, 16:1879-1887

Published Date: 4 August 2020

Association of Pain Catastrophizing with Postnatal Depressive States in Nulliparous Parturients: A Prospective Study

Zeng Y, Tan CW, Sultana R, Chua TE, Chen HY, Sia ATH, Sng BL

Neuropsychiatric Disease and Treatment 2020, 16:1853-1862

Published Date: 30 July 2020

A Novel Diagnostic Prediction Model for Vestibular Migraine

Zhou C, Zhang L, Jiang X, Shi S, Yu Q, Chen Q, Yao D, Pan Y

Neuropsychiatric Disease and Treatment 2020, 16:1845-1852

Published Date: 29 July 2020

Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

Constantin VA, Szász JA, Orbán-Kis K, Rosca EC, Popovici M, Cornea A, Bancu LA, Ciorba M, Mihály I, Nagy E, Szatmári S, Simu M

Neuropsychiatric Disease and Treatment 2020, 16:1835-1844

Published Date: 28 July 2020

Effects of Job Stressors, Stress Response, and Sleep Disturbance on Presenteeism in Office Workers

Furuichi W, Shimura A, Miyama H, Seki T, Ono K, Masuya J, Inoue T

Neuropsychiatric Disease and Treatment 2020, 16:1827-1833

Published Date: 27 July 2020

Liraglutide Attenuates Aβ42 Generation in APPswe/SH-SY5Y Cells Through the Regulation of Autophagy

Kong J, Wan L, Wang Y, Zhang H, Zhang W

Neuropsychiatric Disease and Treatment 2020, 16:1817-1825

Published Date: 27 July 2020

Gastrointestinal Problems in Chinese Children with Autism Spectrum Disorder

Lai KYC, Leung PWL, Hung SF, Shea CKS, Mo F, Che KKI, Tse CY, Lau FLF, Ma SL, Wu JCY, So S, Dadds MR

Neuropsychiatric Disease and Treatment 2020, 16:1807-1815

Published Date: 24 July 2020

MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment

Choe YM, Lee BC, Choi IG, Suh GH, Lee DY, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:1767-1775

Published Date: 24 July 2020

The Current State of Physical Activity and Exercise Programs in German-Speaking, Swiss Psychiatric Hospitals: Results from a Brief Online Survey [Corrigendum]

Brand S, Colledge F, Beeler N, Pühse U, Kalak N, Sadeghi Bahmani D, Mikoteit T, Holsboer-Trachsler E, Gerber M

Neuropsychiatric Disease and Treatment 2020, 16:1765-1766

Published Date: 23 July 2020

Lack of Association Between PLA2G6 Genetic Variation and Parkinson’s Disease: A Systematic Review

Liu H, Yao Y, Liu H, Peng Y, Ren J, Wu X, Mao R, Zhao J, Zhu Y, Niu Z, Yang T, Sun X, Jiang P, Zhang C, Fang Y

Neuropsychiatric Disease and Treatment 2020, 16:1755-1763

Published Date: 23 July 2020

Prediction of Amyloid Positivity in Mild Cognitive Impairment Using Fully Automated Brain Segmentation Software

Kang KM, Sohn CH, Byun MS, Lee JH, Yi D, Lee Y, Lee JY, Kim YK, Sohn BK, Yoo RE, Yun TJ, Choi SH, Kim J, Lee DY

Neuropsychiatric Disease and Treatment 2020, 16:1745-1754

Published Date: 22 July 2020

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology

Huang Y, Wang J, Zhu B, Fu P

Neuropsychiatric Disease and Treatment 2020, 16:1737-1744

Published Date: 22 July 2020

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study

Hsing SC, Jin YT, Tzeng NS, Chung CH, Chen TY, Chang HA, Kao YC, Chien WC

Neuropsychiatric Disease and Treatment 2020, 16:1727-1736

Published Date: 22 July 2020

Clinical Characteristics of Pesticide Self-Harm as Associated with Suicide Attempt Repetition Status

Huang WC, Yen TH, Lin L, Lin C, Juang YY, Wang BH, Lee SH

Neuropsychiatric Disease and Treatment 2020, 16:1717-1726

Published Date: 16 July 2020

Evaluation of Fear in Idiopathic Epilepsy Using Population-Based Survey and Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ)

Gharagozli K, Lotfalinezhad E, Amini F, Saii V, Bhalla D

Neuropsychiatric Disease and Treatment 2020, 16:1685-1693

Published Date: 10 July 2020

Does Subjective Cognitive Function Mediate the Effect of Affective Temperaments on Functional Disability in Japanese Adults?

Toyoshima K, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I

Neuropsychiatric Disease and Treatment 2020, 16:1675-1684

Published Date: 8 July 2020

Analysis of Risk Factors for Postoperative Delirium After Liver Transplantation

Chen J, Wang H, He Z, Li T

Neuropsychiatric Disease and Treatment 2020, 16:1645-1652

Published Date: 3 July 2020

Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder

Markowitz JT, Oberdhan D, Ciesluk A, Rams A, Wigal SB

Neuropsychiatric Disease and Treatment 2020, 16:1619-1643

Published Date: 1 July 2020

Bridging the Gap Between Physical Health and Autism Spectrum Disorder

Sala R, Amet L, Blagojevic-Stokic N, Shattock P, Whiteley P

Neuropsychiatric Disease and Treatment 2020, 16:1605-1618

Published Date: 30 June 2020

Depression Relationship with Dietary Patterns and Dietary Inflammatory Index in Women: Result from Ravansar Cohort Study

Moludi J, Moradinazar M, Hamzeh B, Najafi F, Soleimani D, Pasdar Y

Neuropsychiatric Disease and Treatment 2020, 16:1595-1603

Published Date: 29 June 2020

Effect of Mental Health Problems on the Quality of Life in Children with Lupus Nephritis

Putera AM, Irwanto I, Maramis MM, Prasetyo RV, Soemyarso NA, Noer MS

Neuropsychiatric Disease and Treatment 2020, 16:1583-1593

Published Date: 26 June 2020

Altered Intrinsic Functional Connectivity of the Primary Visual Cortex in Patients with Corneal Ulcer: A Resting-State fMRI Study

Hu SL, Tang LY, Fang JW, Su T, Ge QM, Lin Q, Li B, Shi WQ, Li QY, Liang RB, Shao Y

Neuropsychiatric Disease and Treatment 2020, 16:1571-1581

Published Date: 23 June 2020

Aberrant Executive Control and Auditory Networks in Recent-Onset Schizophrenia

Joo SW, Yoon W, Jo YT, Kim H, Kim Y, Lee J

Neuropsychiatric Disease and Treatment 2020, 16:1561-1570

Published Date: 22 June 2020

Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy

Zheng W, Jiang ML, He HB, Li RP, Li QL, Zhang CP, Zhou SM, Yan S, Ning YP, Huang X

Neuropsychiatric Disease and Treatment 2020, 16:1555-1560

Published Date: 22 June 2020

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

Sun N, Yang C, He X, Liu Z, Liu S, Li X, Wang Y, Jin R, Zhang K

Neuropsychiatric Disease and Treatment 2020, 16:1543-1554

Published Date: 19 June 2020

Association Between Polymorphisms in the 5′ Region of the GALR1 Gene and Schizophrenia in the Northern Chinese Han Population: A Case–Control Study

Li Y, Gao M, Zeng K, Xing J, Xu F, Xuan J, Xia X, Liu Y, Yao J, Wang B

Neuropsychiatric Disease and Treatment 2020, 16:1519-1532

Published Date: 17 June 2020

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan

Chiou YE, Chien WC, Chung CH, Chang HA, Kao YC, Tsay PK, Tzeng NS

Neuropsychiatric Disease and Treatment 2020, 16:1493-1504

Published Date: 12 June 2020

Decreased Serum Retinoic Acid May Predict Poor Outcome in Ischemic Stroke Patients

Xu M, Xu L, Du H, Shan W, Feng J, Zhai G, Yang X

Neuropsychiatric Disease and Treatment 2020, 16:1483-1491

Published Date: 10 June 2020

Atrophic Corpus Callosum Associated with Altered Functional Asymmetry in Major Depressive Disorder

Ran S, Zuo Z, Li C, Yin X, Qu W, Tang Q, Wang Y, Shi Y, Li H

Neuropsychiatric Disease and Treatment 2020, 16:1473-1482

Published Date: 10 June 2020

Change in Functional Brain Activation Patterns Induced by Olfactory Stimulation in Multiple Sclerosis

OuYang Q, Wang Y, Zhang Y, Yu M, Wang X

Neuropsychiatric Disease and Treatment 2020, 16:1451-1458

Published Date: 9 June 2020

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder

Bhattacharjee S, Lee JK, Vadiei N, Patanwala AE, Malone DC, Knapp SM, Lo-Ciganic WH, Burke WJ

Neuropsychiatric Disease and Treatment 2020, 16:1433-1450

Published Date: 8 June 2020

Psychometric Properties of the Generalized Anxiety Disorder Scale Among Saudi University Male Students

Alghadir A, Manzar MD, Anwer S, Albougami A, Salahuddin M

Neuropsychiatric Disease and Treatment 2020, 16:1427-1432

Published Date: 8 June 2020

Safety and Efficacy of Centanafadine Sustained-Release in Adults With Attention-Deficit Hyperactivity Disorder: Results of Phase 2 Studies

Wigal SB, Wigal T, Hobart M, Madera JJ, Baker RA, Kohegyi E, McKinney A, Wilens TE

Neuropsychiatric Disease and Treatment 2020, 16:1411-1426

Published Date: 8 June 2020

Can Maternal Autoantibodies Play an Etiological Role in ASD Development?

Dudova I, Horackova K, Hrdlicka M, Balastik M

Neuropsychiatric Disease and Treatment 2020, 16:1391-1398

Published Date: 3 June 2020

Lupeol Alleviates Cerebral Ischemia–Reperfusion Injury in Correlation with Modulation of PI3K/Akt Pathway

Wang Z, Han Y, Tian S, Bao J, Wang Y, Jiao J

Neuropsychiatric Disease and Treatment 2020, 16:1381-1390

Published Date: 2 June 2020

Influence of COVID-19 on Cerebrovascular Disease and its Possible Mechanism

Fan H, Tang X, Song Y, Liu P, Chen Y

Neuropsychiatric Disease and Treatment 2020, 16:1359-1367

Published Date: 28 May 2020

Hemodynamic and Morphological Analysis of Mirror Aneurysms Prior to Rupture

Yuan J, Huang C, Lai N, Li Z, Jiang X, Wang X, Zhao X, Wu D, Liu J, Xia D, Fang X

Neuropsychiatric Disease and Treatment 2020, 16:1339-1347

Published Date: 27 May 2020

The Long-Term Effects of Adolescent Social Defeat Stress on Oligodendrocyte Lineage Cells and Neuroinflammatory Mediators in Mice

Xu Y, Fang Z, Wu C, Xu H, Kong J, Huang Q, Zhang H

Neuropsychiatric Disease and Treatment 2020, 16:1321-1330

Published Date: 22 May 2020

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan

Lee H, Chen VCH, Yang YH, Kuo TY, Lin TC, Wu SI, Kao KL, Weng JC, Kelsen BA, Liang SHY

Neuropsychiatric Disease and Treatment 2020, 16:1309-1319

Published Date: 21 May 2020

Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation

Zhou X, Chen J, Tao H, Cai Y, Huang L, Zhou H, Chen Y, Cui L, Zhong W, Li K

Neuropsychiatric Disease and Treatment 2020, 16:1295-1307

Published Date: 20 May 2020

HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals

Han Y, Yang L, Liu X, Feng Y, Pang Z, Lin Y

Neuropsychiatric Disease and Treatment 2020, 16:1285-1293

Published Date: 19 May 2020

Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke

Sabetghadam M, Mazdeh M, Abolfathi P, Mohammadi Y, Mehrpooya M

Neuropsychiatric Disease and Treatment 2020, 16:1265-1278

Published Date: 18 May 2020

Association Between Attention Deficit Hyperactivity Disorder and Risk of Burn Injury: A Propensity-Matched Cohort Study

Yeh JY, Hou TY, Tseng WT, Chen VCH, Yang YH, Kuo TY, Weng JC, Lee CTC, Chen YL, Lee MJ

Neuropsychiatric Disease and Treatment 2020, 16:1249-1255

Published Date: 13 May 2020

Expression Profiles of Long Noncoding RNAs in Mice with High-Altitude Hypoxia-Induced Brain Injury Treated with Gymnadenia conopsea (L.) R. Br.

Zhang Y, Liu L, Liang C, Zhou L, Tan L, Zong Y, Wu L, Liu T

Neuropsychiatric Disease and Treatment 2020, 16:1239-1248

Published Date: 12 May 2020

CACNA1C Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder

Rodríguez-Ramírez AM, Meza-Urzúa F, Cedillo-Ríos V, Becerra-Palars C, Jiménez-Pavón J, Morales-Cedillo IP, Sanabrais-Jiménez MA, Hernández-Muñoz S, Camarena-Medellín B

Neuropsychiatric Disease and Treatment 2020, 16:1199-1206

Published Date: 12 May 2020

Risk Factors and a Nomogram for Predicting Intracranial Hemorrhage in Stroke Patients Undergoing Thrombolysis

Zhou Z, Yin X, Niu Q, Liang S, Mu C, Zhang Y

Neuropsychiatric Disease and Treatment 2020, 16:1189-1197

Published Date: 11 May 2020

Vagal Nerve Stimulation in Epilepsy: Experiences of Participants with Cognitive Deficits

Pipan E, Apostolou A, Bograkou M, Brooks P, Vigren P, Gauffin H

Neuropsychiatric Disease and Treatment 2020, 16:1181-1188

Published Date: 8 May 2020

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study

Lunghi C, Antonazzo IC, Burato S, Raschi E, Zoffoli V, Forcesi E, Sangiorgi E, Menchetti M, Roberge P, Poluzzi E

Neuropsychiatric Disease and Treatment 2020, 16:1157-1170

Published Date: 7 May 2020

Gene–Environment Interactions in Major Mental Disorders in the Czech Republic

Latalova K, Sery O, Hosakova K, Hosak L

Neuropsychiatric Disease and Treatment 2020, 16:1147-1156

Published Date: 6 May 2020

The Effect of Perceptual-Motor Training on Executive Functions in Children with Non-Verbal Learning Disorder

Soltani Kouhbanani S, Arabi SM, Zarenezhad S, Khosrorad R

Neuropsychiatric Disease and Treatment 2020, 16:1129-1137

Published Date: 5 May 2020

Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients

Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M

Neuropsychiatric Disease and Treatment 2020, 16:1121-1128

Published Date: 4 May 2020

Validation of the Chinese Version of the 16-Item Negative Symptom Assessment

Huang B, Wang Y, Miao Q, Yu X, Pu C, Shi C

Neuropsychiatric Disease and Treatment 2020, 16:1113-1120

Published Date: 4 May 2020

Effect of Depression and Antidepressants on Sexual Dysfunction in Men with Diabetes: A National Population-Based Cohort Study

Chung PL, Huang CW, Lee MJ, Yang YH, Chen KJ, Lu ML, Weng JC, Chen VCH

Neuropsychiatric Disease and Treatment 2020, 16:1105-1112

Published Date: 30 April 2020

Similar and Different Regional Homogeneity Changes Between Bipolar Disorder and Unipolar Depression: A Resting-State fMRI Study

Liu P, Li Q, Zhang A, Liu Z, Sun N, Yang C, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2020, 16:1087-1093

Published Date: 28 April 2020

The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1085-1086

Published Date: 23 April 2020

APRESS: Apical Regulatory Super System, Serotonin and Dopamine Interaction [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1071-1072

Published Date: 23 April 2020

Parkinson’s Disease-Associated Melanin Steal [Expression of Concern]

Hinz M, Stein A, Cole T

Neuropsychiatric Disease and Treatment 2020, 16:1063-1064

Published Date: 23 April 2020

Parkinson’s Disease Managing Reversible Neurodegeneration [Expression of Concern]

Hinz M, Stein A, Cole T, McDougall B, Westaway M

Neuropsychiatric Disease and Treatment 2020, 16:1061-1062

Published Date: 23 April 2020

5-HTP Efficacy and Contraindications [Expression of Concern]

Hinz M, Stein A, Uncini T

Neuropsychiatric Disease and Treatment 2020, 16:1059-1060

Published Date: 23 April 2020

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia

Boiko AS, Mednova IA, Kornetova EG, Bokhan NA, Semke AV, Loonen AJM, Ivanova SA

Neuropsychiatric Disease and Treatment 2020, 16:1051-1058

Published Date: 22 April 2020

What Types of Internet Services Make Adolescents Addicted? Correlates of Problematic Internet Use

Kim KM, Kim H, Choi JW, Kim SY, Kim JW

Neuropsychiatric Disease and Treatment 2020, 16:1031-1041

Published Date: 20 April 2020

Characterization of Endothelial Cells Associated with Cerebral Arteriovenous Malformation

Jia YC, Fu JY, Huang P, Zhang ZP, Chao B, Bai J

Neuropsychiatric Disease and Treatment 2020, 16:1015-1022

Published Date: 20 April 2020

Investigating the Role of Glutamate in Obsessive-Compulsive Disorder: Current Perspectives

Karthik S, Sharma LP, Narayanaswamy JC

Neuropsychiatric Disease and Treatment 2020, 16:1003-1013

Published Date: 17 April 2020

Association Analysis Between SNPs in the Promoter Region of RGS4 and Schizophrenia in the Northern Chinese Han Population

Xu F, Yao J, Wu X, Xia X, Xing J, Xuan J, Liu Y, Wang B

Neuropsychiatric Disease and Treatment 2020, 16:985-992

Published Date: 16 April 2020

Clinical, Electrophysiological and Radiological Features of Nitrous Oxide-Induced Neurological Disorders

Bao L, Li Q, Li Q, Chen H, Zhang R, Shi H, Cui G

Neuropsychiatric Disease and Treatment 2020, 16:977-984

Published Date: 15 April 2020

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease [Retraction]

Zhao XM, Zhuang P, Li Y, Zhang Y, Li J, Wang Y, Li J

Neuropsychiatric Disease and Treatment 2020, 16:975-976

Published Date: 16 April 2020

miR-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus

Li C, Wang F, Miao P, Yan L, Liu S, Wang X, Jin Z, Gu Z

Neuropsychiatric Disease and Treatment 2020, 16:949-957

Published Date: 9 April 2020

Prediction of Risk Factors for the Evolution of Traumatic Subdural Effusion into Chronic Subdural Hematoma

Chen S, Peng H, Shao X, Yao L, Liu J, Tian J, Sun L, Dai Y, Jiang X, Cheng L

Neuropsychiatric Disease and Treatment 2020, 16:943-948

Published Date: 9 April 2020

APOE ϵ4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease

Wang L, Zhang M, Wang Q, Jiang X, Li K, Liu J

Neuropsychiatric Disease and Treatment 2020, 16:923-931

Published Date: 8 April 2020

The Prevalence of Sarcopenia in Bipolar Disorder

Bulbul F, Koca I, Tamam L, Demirkol ME, Cakmak S, Ersahinoglu E

Neuropsychiatric Disease and Treatment 2020, 16:915-921

Published Date: 8 April 2020

The Clinical Effect of Electroconvulsive Therapy and Its Relationship with Serum Levels of MMP-9 and CXCL12 in Patients with Mania

Kashefi B, Mohammadi M, Rezaei F, Ghadami N, Jalili K, Jalili A

Neuropsychiatric Disease and Treatment 2020, 16:909-914

Published Date: 5 April 2020

BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study

Huang XB, Huang X, He HB, Mei F, Sun B, Zhou SM, Yan S, Zheng W, Ning Y

Neuropsychiatric Disease and Treatment 2020, 16:901-908

Published Date: 5 April 2020

Intracerebral Hemorrhage Induced Brain Injury Is Mediated by the Interleukin-12 Receptor in Rats

Yue X, Liu L, Yan H, Gui Y, Zhao J, Zhang P

Neuropsychiatric Disease and Treatment 2020, 16:891-900

Published Date: 1 April 2020

Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)

Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K

Neuropsychiatric Disease and Treatment 2020, 16:881-890

Published Date: 31 March 2020

Deltonin Ameliorates Cerebral Ischemia/Reperfusion Injury in Correlation with Modulation of Autophagy and Inflammation

Zhang Y, Tian Z, Wan H, Liu W, Kong F, Ma G

Neuropsychiatric Disease and Treatment 2020, 16:871-879

Published Date: 31 March 2020

Gut Microbiota Regulates Depression-Like Behavior in Rats Through the Neuroendocrine-Immune-Mitochondrial Pathway

Liu S, Guo R, Liu F, Yuan Q, Yu Y, Ren F

Neuropsychiatric Disease and Treatment 2020, 16:859-869

Published Date: 31 March 2020

Influence of Self-Esteem and Psychiatric Diagnosis on Health-Related Quality of Life in Children and Adolescents with School Refusal Behavior

Matsuura H, Iwasaka H, Nezu S, Ota T, Okazaki K, Yamamuro K, Nakanishi Y, Kishimoto N, Iida J, Kishimoto T

Neuropsychiatric Disease and Treatment 2020, 16:847-858

Published Date: 31 March 2020

Performance of the Arabic Population on the Adolescent-Adult Sensory Profile: An Observational Study [Corrigendum]

Al-Momani F, Alghadir AH, Al-Momani MO, Alharethy S, Al-Sharman A, Al-Dibii R, Anwer S

Neuropsychiatric Disease and Treatment 2020, 16:837-838

Published Date: 30 March 2020

Medication Profile and Treatment Cost Estimation Among Outpatients with Schizophrenia, Bipolar Disorder, Depression, and Anxiety Disorders in Indonesia

Puspitasari IM, Sinuraya RK, Rahayu C, Witriani W, Zannah U, Hafifah A, Ningtyas AR, Vildayanti H

Neuropsychiatric Disease and Treatment 2020, 16:815-828

Published Date: 26 March 2020

The Occurrence and Longitudinal Changes of Cognitive Impairment After Acute Ischemic Stroke

Liao X, Zuo L, Zhang N, Yang Y, Pan Y, Xiang X, Chen L, Meng X, Li H, Zhao X, Wang Y, Wang C, Shi J, Wang Y

Neuropsychiatric Disease and Treatment 2020, 16:807-814

Published Date: 26 March 2020

Cerebral Salt Wasting in Traumatic Brain Injury Is Associated with Increased Morbidity and Mortality

Chendrasekhar A, Chow PT, Cohen D, Akella K, Vadali V, Bapatla A, Patwari J, Rubinshteyn V, Harris L

Neuropsychiatric Disease and Treatment 2020, 16:801-806

Published Date: 25 March 2020

The Expression of GLAST and GLT1 in a Transient Cerebral Ischemia Mongolian Gerbil Model

Shen Y, Lu H, Xu R, Tian H, Xia X, Zhou FH, Wang L, Dong J, Sun L

Neuropsychiatric Disease and Treatment 2020, 16:789-800

Published Date: 23 March 2020

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey

Nagai N, Tani H, Yoshida K, Gerretsen P, Suzuki T, Ikai-Tani S, Mimura M, Uchida H

Neuropsychiatric Disease and Treatment 2020, 16:781-787

Published Date: 23 March 2020

Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia

Chang JP, Huang KH, Lin CH, Lane HY

Neuropsychiatric Disease and Treatment 2020, 16:771-780

Published Date: 20 March 2020

Commensal Microbiota Regulation of Metabolic Networks During Olfactory Dysfunction in Mice

Wang H, Liu L, Rao X, Chai T, Zeng B, Zhang X, Yu Y, Zhou C, Pu J, Zhou W, Li W, Zhang H, Wei H, Xie P

Neuropsychiatric Disease and Treatment 2020, 16:761-769

Published Date: 19 March 2020

Factors Associated with the Development of Postnatal Depression After Cesarean Delivery: A Prospective Study

Chan CLJ, Tan CW, Chan JJI, Sultana R, Chua TE, Chen HY, Sia ATH, Sng BL

Neuropsychiatric Disease and Treatment 2020, 16:715-727

Published Date: 12 March 2020

Number of Electroconvulsive Therapy Sessions required for Thai Psychiatric Patients: a Retrospective Study

Ittasakul P, Vora-arporn S, Waleeprakhon P, Tor PC

Neuropsychiatric Disease and Treatment 2020, 16:673-679

Published Date: 4 March 2020

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease

Hu S, Hu M, Liu J, Zhang B, Zhang Z, Zhou FH, Wang L, Dong J

Neuropsychiatric Disease and Treatment 2020, 16:651-663

Published Date: 4 March 2020

A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression

Chen C, Dong Y, Liu F, Gao C, Ji C, Dang Y, Ma X, Liu Y

Neuropsychiatric Disease and Treatment 2020, 16:637-649

Published Date: 4 March 2020

Effectiveness of Family Stress-Relief Interventions for Patients with Dementia: A Systematic Evaluation of Literature

Stoia DCM, Ștefănuț A, Moldovan R, Hogea L, Giurgi-Oncu C, Bredicean C

Neuropsychiatric Disease and Treatment 2020, 16:629-635

Published Date: 4 March 2020

Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease

Saito Y, Sakata M, Kobayakawa M, Kawachi H, Kawaguchi K, Hiki Y, Kato M, Mori M, Hasegawa M, Ohashi N, Yuzawa Y, Kitaguchi N

Neuropsychiatric Disease and Treatment 2020, 16:607-627

Published Date: 3 March 2020

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study

Castellano S, Torrent C, Petralia MC, Godos J, Cantarella RA, Ventimiglia A, De Vivo S, Platania S, Guarnera M, Pirrone C, Drago F, Vieta E, Di Nuovo S, Popovic D, Caraci F

Neuropsychiatric Disease and Treatment 2020, 16:589-595

Published Date: 28 February 2020

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients

Takeshima M, Ishikawa H, Umeta Y, Kudoh M, Umakoshi A, Yoshizawa K, Ito Y, Hosoya T, Tsutsui K, Ohta H, Mishima K

Neuropsychiatric Disease and Treatment 2020, 16:579-587

Published Date: 26 February 2020

Chronic Stress in a Rat Model of Depression Disturbs the Glutamine–Glutamate–GABA Cycle in the Striatum, Hippocampus, and Cerebellum

Xu S, Liu Y, Pu J, Gui S, Zhong X, Tian L, Song X, Qi X, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2020, 16:557-570

Published Date: 24 February 2020

The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia

Radu G, Luca C, Petrescu L, Bordejevic DA, Tomescu MC, Andor M, Cîtu I, Mavrea A, Buda V, Tomescu C, Borcan F, Dehelean L

Neuropsychiatric Disease and Treatment 2020, 16:545-555

Published Date: 24 February 2020

Affective Symptoms and Health-Related Quality of Life Among Women with Stress Urinary Incontinence: Cross-Sectional Study

Steibliene V, Aniuliene R, Aniulis P, Raskauskiene N, Adomaitiene V

Neuropsychiatric Disease and Treatment 2020, 16:535-544

Published Date: 24 February 2020

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)

Lin CH, Yang HT, Chen PK, Wang SH, Lane HY

Neuropsychiatric Disease and Treatment 2020, 16:509-518

Published Date: 20 February 2020

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

Wang F, Yu S, Zhou R, Mao R, Zhao G, Guo X, Xu Q, Chen J, Zhang C, Fang Y

Neuropsychiatric Disease and Treatment 2020, 16:501-507

Published Date: 20 February 2020

Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients

Ghavidel N, Khodagholi F, Ahmadiani A, Khosrowabadi R, Asadi S, Shams J

Neuropsychiatric Disease and Treatment 2020, 16:489-499

Published Date: 19 February 2020

Association Between Glutathione S-Transferase (GST) Polymorphisms and Schizophrenia in a Chinese Han Population

Yan C, Duan L, Fu C, Tian C, Zhang B, Shao X, Zhu G

Neuropsychiatric Disease and Treatment 2020, 16:479-487

Published Date: 18 February 2020

Indexing Executive Functions with Test Scores, Parent Ratings and ERPs: How Do the Measures Relate in Children versus Adolescents with ADHD?

Häger LA, Øgrim G, Danielsen M, Billstedt E, Gillberg C, Åsberg Johnels J

Neuropsychiatric Disease and Treatment 2020, 16:465-477

Published Date: 17 February 2020

Comparing Expert and Non-Expert Assessment of Patients Presenting with Neurological Symptoms to the Emergency Department: A Retrospective Observational Study

Hoyer C, Stein P, Ebert A, Rausch HW, Nagel S, Eisele P, Alonso A, Platten M, Szabo K

Neuropsychiatric Disease and Treatment 2020, 16:447-456

Published Date: 13 February 2020

ABCA7 Gene Expression and Genetic Association Study in Schizophrenia

Yamazaki K, Yoshino Y, Kawabe K, Ibuki T, Ochi S, Mori Y, Ozaki Y, Numata S, Iga J, Ohmori T, Ueno S

Neuropsychiatric Disease and Treatment 2020, 16:441-446

Published Date: 13 February 2020

Treatment-Seeking Behavior Towards Epilepsy Among Rural Residents in Ethiopia: A Cross-Sectional Study

Molla A, Mekuriaw B, Habtamu E, Mareg M

Neuropsychiatric Disease and Treatment 2020, 16:433-439

Published Date: 13 February 2020

The CYP2C19*2 and CYP2C19*17 Polymorphisms Influence Responses to Clozapine for the Treatment of Schizophrenia

Rodrigues-Silva C, Semedo AT, Neri HFS, Vianello RP, Galaviz-Hernández C, Sosa-Macías M, de Brito RB, Ghedini PC

Neuropsychiatric Disease and Treatment 2020, 16:427-432

Published Date: 11 February 2020

Comorbid Premenstrual Dysphoric Disorder in Women with Bipolar Disorder: Management Challenges

Sepede G, Brunetti M, Di Giannantonio M

Neuropsychiatric Disease and Treatment 2020, 16:415-426

Published Date: 10 February 2020

Impulsivity, Unplanned Pregnancies, and Contraception Among Women with Bipolar Disorder

Zengin Eroglu M, Lus MG

Neuropsychiatric Disease and Treatment 2020, 16:407-414

Published Date: 7 February 2020

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects

Morano A, Fanella M, Albini M, Cifelli P, Palma E, Giallonardo AT, Di Bonaventura C

Neuropsychiatric Disease and Treatment 2020, 16:381-396

Published Date: 7 February 2020

Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review

Balagura G, Riva A, Marchese F, Verrotti A, Striano P

Neuropsychiatric Disease and Treatment 2020, 16:369-379

Published Date: 5 February 2020

Family-Based Analysis Combined with Case–Controls Study Implicate Roles of PCNT in Tourette Syndrome

Liu W, Guo Y, Liu X, Zhang R, Dong J, Deng H, He F, Che F, Liu S, Yi M

Neuropsychiatric Disease and Treatment 2020, 16:349-354

Published Date: 31 January 2020

microRNA-182 Negatively Influences the Neuroprotective Effect of Apelin Against Neuronal Injury in Epilepsy

Dong H, Dong B, Zhang N, Liu S, Zhao H

Neuropsychiatric Disease and Treatment 2020, 16:327-338

Published Date: 30 January 2020

Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity [Corrigendum]

Saleem TH, Shehata GA, Toghan R, Sakhr HM, Bakri AH, Desoky T, Hamdan FRA, Mohamed NF, Hassan MH

Neuropsychiatric Disease and Treatment 2020, 16:325-326

Published Date: 30 January 2020

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease

Zhao XM, Zhuang P, Li Y, Zhang Y, Li J, Wang Y, Li J

Neuropsychiatric Disease and Treatment 2020, 16:313-323

Published Date: 28 January 2020

Personal Construct Therapy vs Cognitive Behavioral Therapy in the Treatment of Depression in Women with Fibromyalgia: Study Protocol for a Multicenter Randomized Controlled Trial

Paz C, Aguilera M, Salla M, Compañ V, Medina JC, Bados A, García-Grau E, Castel A, Cañete Crespillo J, Montesano A, Medeiros-Ferreira L, Feixas G

Neuropsychiatric Disease and Treatment 2020, 16:301-311

Published Date: 24 January 2020

Effects of Remote Ischemic Conditioning on Cerebral Hemodynamics in Ischemic Stroke

Qin C, Yan X, Jin H, Zhang R, He Y, Sun X, Zhang Y, Guo ZN, Yang Y

Neuropsychiatric Disease and Treatment 2020, 16:283-299

Published Date: 23 January 2020

Aberrant Thalamic-Centered Functional Connectivity in Patients with Persistent Somatoform Pain Disorder

Sun X, Pan X, Ni K, Ji C, Wu J, Yan C, Luo Y

Neuropsychiatric Disease and Treatment 2020, 16:273-281

Published Date: 23 January 2020

Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease

Tang Y, Han L, Bai X, Liang X, Zhao J, Huang F, Wang J

Neuropsychiatric Disease and Treatment 2020, 16:249-262

Published Date: 23 January 2020

Autonomic Nervous System Is Related to Inhibitory and Control Function Through Functional Inter-Region Connectivities of OFC in Major Depression

Zhou H, Hua L, Jiang H, Dai Z, Han Y, Lin P, Wang H, Lu Q, Yao Z

Neuropsychiatric Disease and Treatment 2020, 16:235-247

Published Date: 21 January 2020

Management of Treatment-Resistant Depression: Challenges and Strategies

Voineskos D, Daskalakis ZJ, Blumberger DM

Neuropsychiatric Disease and Treatment 2020, 16:221-234

Published Date: 21 January 2020

Development and Validation of a Japanese Version of the Emotion Regulation Questionnaire for Children and Adolescents

Namatame H, Fujisato H, Ito M, Sawamiya Y

Neuropsychiatric Disease and Treatment 2020, 16:209-219

Published Date: 21 January 2020

Post-Stroke Depression and Estimated Glomerular Filtration Rate: A Prospective Stroke Cohort

Lin S, Luan X, He W, Ruan Y, Yuan C, Fan A, Chen X, He J

Neuropsychiatric Disease and Treatment 2020, 16:201-208

Published Date: 21 January 2020

The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia

He X, Ma Q, Fan Y, Zhao B, Wang W, Zhu F, Ma X, Zhou L

Neuropsychiatric Disease and Treatment 2020, 16:191-199

Published Date: 21 January 2020

Left Ventricular End-Diastolic Diameter and Cardiac Mortality in Duchenne Muscular Dystrophy

Segawa K, Sugawara N, Maruo K, Kimura K, Komaki H, Takahashi Y, Sasaki M

Neuropsychiatric Disease and Treatment 2020, 16:171-178

Published Date: 16 January 2020

Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives

Stein DJ, Fernandes Medeiros L, Caumo W, Torres ILS

Neuropsychiatric Disease and Treatment 2020, 16:161-169

Published Date: 14 January 2020

Exosomal Long Non-Coding RNA Expression from Serum of Patients with Acute Minor Stroke

Xu X, Zhuang C, Chen L

Neuropsychiatric Disease and Treatment 2020, 16:153-160

Published Date: 13 January 2020

Unilateral Spatial Neglect After Stroke: Current Insights

Gammeri R, Iacono C, Ricci R, Salatino A

Neuropsychiatric Disease and Treatment 2020, 16:131-152

Published Date: 10 January 2020

Effects of AQP4 and KCNJ10 Gene Polymorphisms on Drug Resistance and Seizure Susceptibility in Chinese Han Patients with Focal Epilepsy

Zhu H, Zhang M, Fu Y, Long H, Xiao W, Feng L, Xiao B, Zhou L

Neuropsychiatric Disease and Treatment 2020, 16:119-129

Published Date: 9 January 2020

Effects of GSTA1 and GPX3 Polymorphisms on the Risk of Schizophrenia in Chinese Han Population

Liu C, Song S, Zhang J, Li X, Gao H

Neuropsychiatric Disease and Treatment 2020, 16:113-118

Published Date: 9 January 2020

Nonsuicidal Self-Injury: Diagnostic Challenges And Current Perspectives

Hooley JM, Fox KR, Boccagno C

Neuropsychiatric Disease and Treatment 2020, 16:101-112

Published Date: 10 January 2020

Alcohol and Dementia – What is the Link? A Systematic Review

Wiegmann C, Mick I, Brandl EJ, Heinz A, Gutwinski S

Neuropsychiatric Disease and Treatment 2020, 16:87-99

Published Date: 9 January 2020

Abnormal Baseline Brain Activity in Neuromyelitis Optica Patients Without Brain Lesion Detected by Resting-State Functional Magnetic Resonance Imaging

Liu Y, Xiong H, Li X, Zhang D, Yang C, Yu J, Liao R, Zhou B, Huang X, Tang Z

Neuropsychiatric Disease and Treatment 2020, 16:71-79

Published Date: 8 January 2020

Predictors of Current DSM-5 PTSD Diagnosis and Symptom Severity Among Deployed Veterans: Significance of Predisposition, Stress Exposure, and Genetics

Hu Y, Chu X, Urosevich TG, Hoffman SN, Kirchner HL, Adams RE, Dugan RJ, Boscarino JJ, Shi W, Withey CA, Figley CR, Boscarino JA

Neuropsychiatric Disease and Treatment 2020, 16:43-54

Published Date: 8 January 2020

Performance of the Arabic Population on the Adolescent-Adult Sensory Profile: An Observational Study

Al-Momani F, Alghadir AH, Al-Momani MO, Alharethy S, Al-Sharman A, Al-Dibii R, Anwer S

Neuropsychiatric Disease and Treatment 2020, 16:35-42

Published Date: 7 January 2020

Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity

Saleem TH, Shehata GA, Toghan R, Sakhr HM, Bakri AH, Desoky T, Hamdan FRA, Mohamed NF, Hassan MH

Neuropsychiatric Disease and Treatment 2020, 16:11-24

Published Date: 6 January 2020

Influence of Childhood Maltreatment, Adulthood Stressful Life Events, and Affective Temperaments on Premenstrual Mental Symptoms of Nonclinical Adult Volunteers

Wakatsuki Y, Inoue T, Hashimoto N, Fujimura Y, Masuya J, Ichiki M, Tanabe H, Kusumi I

Neuropsychiatric Disease and Treatment 2020, 16:1-10

Published Date: 6 January 2020

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA

Tu L, Wu ZY, Yang XL, Zhang Q, Gu R, Wang Q, Tian T, Yao H, Qu X, Tian JY

Neuropsychiatric Disease and Treatment 2019, 15:3615-3625

Published Date: 3 January 2020

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia

Urban-Kowalczyk M, Kotlicka-Antczak M, Strzelecki D, Rudecka E, Śmigielski J

Neuropsychiatric Disease and Treatment 2019, 15:3609-3614

Published Date: 3 January 2020

Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome

Suga T, Takenoshita M, Watanabe T, Tu TTH, Mikuzuki L, Hong C, Miura K, Yoshikawa T, Nagamine T, Toyofuku A

Neuropsychiatric Disease and Treatment 2019, 15:3599-3607

Published Date: 30 December 2019

Managing Functional Neurological Disorders: Protocol of a Cohort Study on Psychogenic Non-Epileptic Seizures Study

Altalib HH, Galluzzo D, Argraves S, Goulet J, Bornovski Y, Cheung KH, Jackson-Shaheed E, Tolchin B, Fenton BT, Pugh MJ

Neuropsychiatric Disease and Treatment 2019, 15:3557-3568

Published Date: 27 December 2019

Widely Impaired White Matter Integrity and Altered Structural Brain Networks in Psychogenic Non-Epileptic Seizures

Sone D, Sato N, Ota M, Kimura Y, Matsuda H

Neuropsychiatric Disease and Treatment 2019, 15:3549-3555

Published Date: 24 December 2019

Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)

Wu G, Gan R, Li Z, Xu L, Tang X, Wei Y, Hu Y, Cui H, Li H, Tang Y, Hui L, Liu X, Li C, Wang J, Zhang T

Neuropsychiatric Disease and Treatment 2019, 15:3541-3548

Published Date: 24 December 2019

Psychache and Suicidal History in Patients with Obsessive-Compulsive Disorder

Demirkol ME, Namlı Z, Eriş Davul Ö, Karaytuğ MO, Tamam L, Yılmaz H

Neuropsychiatric Disease and Treatment 2019, 15:3531-3539

Published Date: 24 December 2019

Type C Personality and Depression Among Newly Diagnosed Breast Cancer Patients: The Mediating Role of Sense of Coherence

Wei M, Guo L, Zhu Y, Guo Y, Yv S, Namassevayam G, Xue W, Li J, Li L, Shen Z, Yv J, Zhu Z, Wang W, Liu Y, Zhao J, Chen F

Neuropsychiatric Disease and Treatment 2019, 15:3519-3529

Published Date: 24 December 2019

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)

Hashimoto N, Toyomaki A, Oka M, Takanobu K, Okubo R, Narita H, Kitagawa K, Udo N, Maeda T, Watanabe S, Oyanagi Y, Miyazaki A, Ito K, Kusumi I

Neuropsychiatric Disease and Treatment 2019, 15:3511-3518

Published Date: 23 December 2019

Posttraumatic Stress Disorder and Associated Factors Among Drivers Surviving Road Traffic Crashes in Southwest Ethiopia

Alenko A, Berhanu H, Tareke AA, Reta W, Bariso M, Mulat E, Kenenisa C, Debebe W, Tolesa K, Girma S

Neuropsychiatric Disease and Treatment 2019, 15:3501-3509

Published Date: 24 December 2019

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography

Ortner M, Hauser C, Schmaderer C, Muggenthaler C, Hapfelmeier A, Sorg C, Diehl-Schmid J, Kurz A, Förstl H, Ikenberg B, Kotliar K, Poppert H, Grimmer T

Neuropsychiatric Disease and Treatment 2019, 15:3487-3499

Published Date: 20 December 2019

Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia

Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM

Neuropsychiatric Disease and Treatment 2019, 15:3475-3486

Published Date: 20 December 2019

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

Correll CU, Brevig T, Brain C

Neuropsychiatric Disease and Treatment 2019, 15:3461-3473

Published Date: 19 December 2019

Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients

Milano G, Vergani HM, Cattedra S, Carrozzino R, Mattioli F, Robbiano L, Martelli A

Neuropsychiatric Disease and Treatment 2019, 15:3453-3459

Published Date: 18 December 2019

Thromboelastography with Platelet Mapping Detects Platelet Dysfunction in Patients with Aneurysmal Subarachnoid Hemorrhage with Rebleeding

He Q, Zhou Y, Liu C, Zhang X, Huang N, Wang F, Liu G, Cheng Y, Xie Z

Neuropsychiatric Disease and Treatment 2019, 15:3443-3451

Published Date: 16 December 2019

Electroacupuncture Promoting Axonal Regeneration in Spinal Cord Injury Rats via Suppression of Nogo/NgR and Rho/ROCK Signaling Pathway

Xiao WP, Ding LLQ, Min YJ, Yang HY, Yao HH, Sun J, Zhou X, Zeng XB, Yu W

Neuropsychiatric Disease and Treatment 2019, 15:3429-3442

Published Date: 13 December 2019

The Effect of Counseling on Stigma in Psychiatric Patients Receiving Electroconvulsive Therapy: A Clinical Trial Study

Sadeghian E, Rostami P, Shamsaei F, Tapak L

Neuropsychiatric Disease and Treatment 2019, 15:3419-3427

Published Date: 6 December 2019

Experiences Of Immigrant Parents In Sweden Participating In A Community Assessment And Intervention Program For Preschool Children With Autism

Nilses Å, Jingrot M, Linnsand P, Gillberg C, Nygren G

Neuropsychiatric Disease and Treatment 2019, 15:3397-3410

Published Date: 6 December 2019

Validity and Reliability Study of the Chinese Traditional Version of the Devereux Early Childhood Assessment for Toddlers DECA T

Liang SHY, Chou JY, Wu YY, Lee CP, Kelsen BA, Lee YC

Neuropsychiatric Disease and Treatment 2019, 15:3375-3385

Published Date: 5 December 2019

Clinical Characteristics of Women with ADHD in Japan

Hayashi W, Suzuki H, Saga N, Arai G, Igarashi R, Tokumasu T, Ota H, Yamada H, Takashio O, Iwanami A

Neuropsychiatric Disease and Treatment 2019, 15:3367-3374

Published Date: 4 December 2019

Resting-State Functional MRI Study: Connection Strength of Brain Networks in DR Patients

Li L, Dai H, Ke J, Shi C, Jiang N, Yang CM

Neuropsychiatric Disease and Treatment 2019, 15:3359-3366

Published Date: 5 December 2019

Effect of Benzo[a]pyrene-DNA Adduct in Cord Blood on the Neurodevelopment of 12-Month-Old Infants in Qingdao City

Zhang Y, Yang Y, Zhang Q, Cui J, Rahaman A, Huang XR, Su Y, Gao R, Wang B, Baloch Z

Neuropsychiatric Disease and Treatment 2019, 15:3351-3357

Published Date: 2 December 2019

Employment-Related Factors of Forensic Psychiatric Outpatients with Psychotic Disorders

Takeda K, Sugawara N, Yamada Y, Nagata T, Kashiwagi H, Kono T, Hirabayashi N, Okada T

Neuropsychiatric Disease and Treatment 2019, 15:3341-3350

Published Date: 2 December 2019

Adaptive Affect: The Nature of Anxiety and Depression

Morris DW

Neuropsychiatric Disease and Treatment 2019, 15:3323-3326

Published Date: 2 December 2019

Reversible Affective Symptoms and Attention Executive Control Network Impairment Following Thyroid Function Normalization in Hyperthyroidism

Yuan L, Zhang Y, Luan D, Xu X, Yang Q, Zhao S, Zhou Z

Neuropsychiatric Disease and Treatment 2019, 15:3305-3312

Published Date: 26 November 2019

Empathy In Neurodegenerative Diseases: A Systematic Review

Pick E, Kleinbub JR, Mannarini S, Palmieri A

Neuropsychiatric Disease and Treatment 2019, 15:3287-3304

Published Date: 22 November 2019

Alterations Of Glycerophospholipid And Fatty Acyl Metabolism In Multiple Brain Regions Of Schizophrenia Microbiota Recipient Mice

Liang W, Huang Y, Tan X, Wu J, Duan J, Zhang H, Yin B, Li Y, Zheng P, Wei H, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:3219-3229

Published Date: 19 November 2019

Psychometric Properties Of The Persian Version Of The Memory Impact Questionnaire In Older Adults

Ebadi A, Ebtekar F, Parizad N, Afkhamzadeh A, Dalvand S, Ghanei Gheshlagh R

Neuropsychiatric Disease and Treatment 2019, 15:3197-3204

Published Date: 14 November 2019

Profile Of Patients With Advanced Parkinson’s disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients

Szász JA, Constantin VA, Orbán-Kis K, Rácz A, Bancu LA, Georgescu D, Szederjesi J, Mihály I, Fárr AM, Kelemen K, Vajda T, Szatmári S

Neuropsychiatric Disease and Treatment 2019, 15:3187-3195

Published Date: 13 November 2019

Traditional Chinese Medicine Shenmayizhi Decoction Ameliorates Memory And Cognitive Impairment Induced By Scopolamine Via Preventing Hippocampal Cholinergic Dysfunction In Rats

Wu Q, Cao Y, Liu M, Liu F, Brantner AH, Yang Y, Wei Y, Zhou Y, Wang Z, Ma L, Wang F, Pei H, Li H

Neuropsychiatric Disease and Treatment 2019, 15:3167-3176

Published Date: 12 November 2019

No Association Between Human Immunodeficiency Virus Infections And Dementia: A Nationwide Cohort Study In Taiwan

Yang CC, Chien WC, Chung CH, Liu YP, Yeh CB, Chen KH, Yang SN, Chang HA, Kao YC, Lu WC, Tzeng NS

Neuropsychiatric Disease and Treatment 2019, 15:3155-3166

Published Date: 12 November 2019

Mindfulness-Based Intervention For Nurses In AIDS Care In China: A Pilot Study

Pan C, Wang H, Chen M, Cai Y, Xiao C, Tang Q, Koniak-Griffin D

Neuropsychiatric Disease and Treatment 2019, 15:3131-3141

Published Date: 8 November 2019

The Efficacy, Feasibility And Acceptability Of A Remotely Accessible Use Of CIRCuiTS, A Computerized Cognitive Remediation Therapy Program For Schizophrenia: A Pilot Study

Palumbo D, Mucci A, Giordano GM, Piegari G, Aiello C, Pietrafesa D, Annarumma N, Chieffi M, Cella M, Galderisi S

Neuropsychiatric Disease and Treatment 2019, 15:3103-3113

Published Date: 8 November 2019

Is visuomotor training an effective intervention for children with autism spectrum disorders?

Arabi M, Saberi Kakhki A, Sohrabi M, Soltani Kouhbanani S, Jabbari Nooghabi M

Neuropsychiatric Disease and Treatment 2019, 15:3089-3102

Published Date: 8 November 2019

Improvement Of Frontal Lobe Dysfunction And White Matter Integrity By rTMS In Treatment-Resistant Depression

Tateishi H, Nishihara M, Kawaguchi A, Matsushima J, Murakawa T, Haraguchi Y, Kunitake Y, Maekawa T, Kato TA, Asami T, Mizoguchi Y, Monji A

Neuropsychiatric Disease and Treatment 2019, 15:3079-3087

Published Date: 6 November 2019

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation

Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:3069-3078

Published Date: 6 November 2019

Differential Diagnosis Of Multiple-System Atrophy With Parkinson’s Disease By External Anal- And Urethral-Sphincter Electromyography

Qiu F, Wang K, Li T, Song D, Wang Z, Zhang H, Liu J, Ren M, Qi X

Neuropsychiatric Disease and Treatment 2019, 15:3061-3067

Published Date: 5 November 2019

Correlations And Correlates Of Post-Traumatic Growth And Post-Traumatic Stress Symptoms In Patients With Breast Cancer

Chen HM, Chen VCH, Hsiao HP, Weng YP, Hsu YT, Weng JC, Su JA, Chen YL

Neuropsychiatric Disease and Treatment 2019, 15:3051-3060

Published Date: 1 November 2019

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?

Chung JY, Yoon HJ, Kim H, Choi KY, Lee JJ, Lee KH, Seo EH

Neuropsychiatric Disease and Treatment 2019, 15:3021-3032

Published Date: 25 October 2019

Association study of genetic variants of the ANGPTL3 gene and susceptibility to ischemic stroke

Gong Q, Ye L, Gui H, Liu J, Li H, Sun Q

Neuropsychiatric Disease and Treatment 2019, 15:3015-3020

Published Date: 24 October 2019

Evaluation Of Subjective Cognitive Function Using The Cognitive Complaints In Bipolar Disorder Rating Assessment (COBRA) In Japanese Adults

Toyoshima K, Inoue T, Masuya J, Ichiki M, Fujimura Y, Kusumi I

Neuropsychiatric Disease and Treatment 2019, 15:2981-2990

Published Date: 18 October 2019

Efficacy Of Dual-Task Training With Two Different Priorities Instructional Sets On Gait Parameters In Patients With Chronic Stroke

Sengar S, Raghav D, Verma M, Alghadir AH, Iqbal A

Neuropsychiatric Disease and Treatment 2019, 15:2959-2969

Published Date: 17 October 2019

Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature

Gogos A, Skokou M, Ferentinou E, Gourzis P

Neuropsychiatric Disease and Treatment 2019, 15:2943-2958

Published Date: 16 October 2019

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients

Lin Y, Yang X, Lv J, Liu X, Wang S

Neuropsychiatric Disease and Treatment 2019, 15:2909-2915

Published Date: 11 October 2019

Clozapine As Transformative Treatment In Bipolar Patients

Wilkowska A, Cubała WJ

Neuropsychiatric Disease and Treatment 2019, 15:2901-2905

Published Date: 9 October 2019

Changes In Plasma NPY, IL-1β And Hypocretin In People Who Died By Suicide

Lu J, Li S, Li H, Mou T, Zhou L, Huang B, Huang M, Xu Y

Neuropsychiatric Disease and Treatment 2019, 15:2893-2900

Published Date: 10 October 2019

Is Autism Inborn And Lifelong For Everyone?

Whiteley P, Carr K, Shattock P

Neuropsychiatric Disease and Treatment 2019, 15:2885-2891

Published Date: 7 October 2019

Associations Of Personality Traits With The Capacity-Performance Discrepancy Of Functional Outcome In Patients With Schizophrenia

Uchino T, Nemoto T, Yamaguchi T, Katagiri N, Tsujino N, Murakami Y, Tanaka K, Mizuno M

Neuropsychiatric Disease and Treatment 2019, 15:2869-2877

Published Date: 3 October 2019

Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia

Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:2853-2867

Published Date: 2 October 2019

Diffusion Tensor Imaging And Tractography In Autistic, Dysphasic, And Healthy Control Children

Hrdlicka M, Sanda J, Urbanek T, Kudr M, Dudova I, Kickova S, Pospisilova L, Mohaplova M, Maulisova A, Krsek P, Kyncl M, Blatny M, Komarek V

Neuropsychiatric Disease and Treatment 2019, 15:2843-2852

Published Date: 3 October 2019

Victimization In Childhood Affects Depression In Adulthood Via Neuroticism: A Path Analysis Study

Tachi S, Asamizu M, Uchida Y, Katayama S, Naruse M, Masuya J, Ichiki M, Inoue T

Neuropsychiatric Disease and Treatment 2019, 15:2835-2841

Published Date: 3 October 2019

Public Awareness, Beliefs, And Attitudes Toward Bipolar Disorder In Saudi Arabia

Alosaimi FD, AlAteeq DA, Bin Hussain SI, Alhenaki RS, Bin Salamah AA, AlModihesh NA

Neuropsychiatric Disease and Treatment 2019, 15:2809-2818

Published Date: 27 September 2019

Association Of Cigarette Smoking With Anxiety, Depression, And Suicidal Ideation Among Brazilian Adolescents

Slomp FM, Bara TS, Picharski GL, Cordeiro ML

Neuropsychiatric Disease and Treatment 2019, 15:2799-2808

Published Date: 25 September 2019

The Risk Of Seizure-Related Hospitalization Among Older Adults On Levetiracetam Monotherapy: A Retrospective Comparative Cohort Study

Alzahrani H, Almalag HM, AlRuthia Y, Al-hussain F, Balkhi B, Almutairi L, Algasem R, De Vol EB, Almarzouqi MR, Alsemari A

Neuropsychiatric Disease and Treatment 2019, 15:2781-2788

Published Date: 24 September 2019

Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives

Coppola G, Operto FF, Matricardi S, Verrotti A

Neuropsychiatric Disease and Treatment 2019, 15:2773-2780

Published Date: 24 September 2019

Subthreshold Depression Needs A Prime Time In Old Age Psychiatry? A Narrative Review Of Current Evidence

Biella MM, Borges MK, Strauss J, Mauer S, Martinelli JE, Aprahamian I

Neuropsychiatric Disease and Treatment 2019, 15:2763-2772

Published Date: 23 September 2019

Transcranial magnetic stimulation for the treatment of anxiety disorder

Rodrigues PA, Zaninotto AL, Neville IS, Hayashi CY, Brunoni AR, Teixeira MJ, Paiva WS

Neuropsychiatric Disease and Treatment 2019, 15:2743-2761

Published Date: 23 September 2019

Catatonia in Down syndrome: systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients

Miles JH, Takahashi N, Muckerman J, Nowell KP, Ithman M

Neuropsychiatric Disease and Treatment 2019, 15:2723-2741

Published Date: 20 September 2019

Differentiation Between Dementia With Lewy Bodies And Alzheimer’s Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study

Matsuda H, Yokoyama K, Sato N, Ito K, Nemoto K, Oba H, Hanyu H, Kanetaka H, Mizumura S, Kitamura S, Shinotoh H, Shimada H, Suhara T, Terada H, Nakatsuka T, Kawakatsu S, Hayashi H, Asada T, Ono T, Goto T, Shigemori K

Neuropsychiatric Disease and Treatment 2019, 15:2715-2722

Published Date: 19 September 2019

Analysis of correlation between cerebral perfusion and KIM score of white matter lesions in patients with Alzheimer’s disease

Li RR, He YS, Liu M, Nie ZY, Huang LH, Lu Z, Jin LJ, Li YX

Neuropsychiatric Disease and Treatment 2019, 15:2705-2714

Published Date: 18 September 2019

Transcranial direct current stimulation for Obsessive-Compulsive Disorder: patient selection and perspectives

da Silva RMF, Brunoni AR, Miguel EC, Shavitt RG

Neuropsychiatric Disease and Treatment 2019, 15:2663-2669

Published Date: 16 September 2019

Comparative diagnostic accuracy of ACE-III and MoCA for detecting mild cognitive impairment

Wang BR, Zheng HF, Xu C, Sun Y, Zhang YD, Shi JQ

Neuropsychiatric Disease and Treatment 2019, 15:2647-2653

Published Date: 13 September 2019

Disrupted Brain Entropy And Functional Connectivity Patterns Of Thalamic Subregions In Major Depressive Disorder

Xue SW, Wang D, Tan Z, Wang Y, Lian Z, Sun Y, Hu X, Wang X, Zhou X

Neuropsychiatric Disease and Treatment 2019, 15:2629-2638

Published Date: 11 September 2019

C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia

Chang CH, Lane HY, Liu CY, Cheng PC, Chen SJ, Lin CH

Neuropsychiatric Disease and Treatment 2019, 15:2621-2627

Published Date: 10 September 2019

Borderline personality disorder, trauma, and the hypothalamus–pituitary–adrenal axis

Thomas N, Gurvich C, Kulkarni J

Neuropsychiatric Disease and Treatment 2019, 15:2601-2612

Published Date: 9 September 2019

Repetitive transcranial magnetic stimulation significantly influences the eating behavior in depressive patients

Jaššová K, Albrecht J, Čerešňáková S, Papežová H, Anders M

Neuropsychiatric Disease and Treatment 2019, 15:2579-2586

Published Date: 6 September 2019

Evaluating optic nerve diameter as a possible biomarker for disability in patients with multiple sclerosis

Koraysha NA, Kishk N, Hassan A, Samy El Gendy NM, Shehata HS, Al-Azayem SA, Kamal YS

Neuropsychiatric Disease and Treatment 2019, 15:2571-2578

Published Date: 6 September 2019

A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ

Neuropsychiatric Disease and Treatment 2019, 15:2559-2569

Published Date: 5 September 2019

Efficacy of ginkgo biloba extract as augmentation of venlafaxine in treating post-stroke depression

Liang ZH, Jia YB, Wang ML, Li ZR, Li M, Yun YL, Zhu RX

Neuropsychiatric Disease and Treatment 2019, 15:2551-2557

Published Date: 3 September 2019

Affective theory of mind in Parkinson’s disease: the effect of cognitive performance

Romosan AM, Dehelean L, Romosan RS, Andor M, Bredicean AC, Simu MA

Neuropsychiatric Disease and Treatment 2019, 15:2521-2535

Published Date: 30 August 2019

Risk taking behaviors in relation to Attention Deficit and Hyperactivity Disorder in Iranian male workers: a latent class analysis

Abbasi-Ghahramanloo A, Janani L, Malakouti SK, Rabetian M, Rimaz S

Neuropsychiatric Disease and Treatment 2019, 15:2513-2520

Published Date: 28 August 2019

Dementia care in the Danube Region. A multi-national expert survey

Mehrabian S, Schwarzkopf L, Auer S, Holmerova I, Kramberger MG, Boban M, Stefanova E, Tudose C, Bachinskaya N, Kovács T, Koranda P, Kunchev T, Traykov L, Diehl-Schmid J, Milecka K, Kurz A

Neuropsychiatric Disease and Treatment 2019, 15:2503-2511

Published Date: 29 August 2019

Disrupted topological organization of human brain connectome in diabetic retinopathy patients

Huang X, Tong Y, Qi CX, Xu YT, Dan HD, Shen Y

Neuropsychiatric Disease and Treatment 2019, 15:2487-2502

Published Date: 27 August 2019

Complex effects of childhood abuse, affective temperament, and subjective social status on depressive symptoms of adult volunteers from the community

Higashiyama M, Hayashida T, Sakuta K, Fujimura Y, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2019, 15:2477-2485

Published Date: 27 August 2019

The association between cortisol:C-reactive protein ratio and depressive fatigue is a function of CRP rather than cortisol

Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL

Neuropsychiatric Disease and Treatment 2019, 15:2467-2475

Published Date: 27 August 2019

Association between ADORA2A gene polymorphisms and schizophrenia in the North Chinese Han population

Miao J, Liu L, Yan C, Zhu X, Fan M, Yu P, Ji K, Huang Y, Wang Y, Zhu G

Neuropsychiatric Disease and Treatment 2019, 15:2451-2458

Published Date: 28 August 2019

Clinical improvement following vitamin D3 supplementation in children with chronic tic disorders

Li HH, Xu ZD, Wang B, Feng JY, Dong HY, Jia FY

Neuropsychiatric Disease and Treatment 2019, 15:2443-2450

Published Date: 26 August 2019

A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder

Katsuki A, Kakeda S, Watanabe K, Igata R, Otsuka Y, Kishi T, Nguyen L, Ueda I, Iwata N, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2019, 15:2425-2432

Published Date: 23 August 2019

Functional capacity as a predictor of postoperative delirium in transurethral resection of prostate patients in Northeast Brazil

Braga ILS, Castelo-Filho J, Pinheiro RSB, de Azevedo RB, Ponte AT, da Silveira RA, Braga-Neto P, Campos AR

Neuropsychiatric Disease and Treatment 2019, 15:2395-2401

Published Date: 22 August 2019

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study

Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T

Neuropsychiatric Disease and Treatment 2019, 15:2353-2363

Published Date: 19 August 2019

Psychological status of nursing survivors in China and its associated factors: 6 years after the 2008 Sichuan earthquake

Liao J, Ma X, Gao B, Zhang M, Zhang Y, Liu M, Li X

Neuropsychiatric Disease and Treatment 2019, 15:2301-2311

Published Date: 14 August 2019

Macrocytosis among patients with heroin use disorder

Ng MH, Chen VCH, Ting H, Lin TY, Chang SH, Gossop M

Neuropsychiatric Disease and Treatment 2019, 15:2293-2298

Published Date: 12 August 2019

Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study [Erratum]

Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X

Neuropsychiatric Disease and Treatment 2019, 15:2291-2292

Published Date: 12 August 2019

The burden of suicidal ideation across Europe: a cross-sectional survey in five countries

Jaffe DH, Rive B, Denee TR

Neuropsychiatric Disease and Treatment 2019, 15:2257-2271

Published Date: 7 August 2019

Insula H-coil deep transcranial magnetic stimulation in severe and enduring anorexia nervosa (SE-AN): a pilot study

Knyahnytska YO, Blumberger DM, Daskalakis ZJ, Zomorrodi R, Kaplan AS

Neuropsychiatric Disease and Treatment 2019, 15:2247-2256

Published Date: 6 August 2019

Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice

Du HX, Chen XG, Zhang L, Liu Y, Zhan CS, Chen J, Zhang Y, Yu ZQ, Zhang J, Yang HY, Zhong K, Liang CZ

Neuropsychiatric Disease and Treatment 2019, 15:2231-2245

Published Date: 6 August 2019

Reduced plasma orexin-A levels in patients with bipolar disorder

Tsuchimine S, Hattori K, Ota M, Hidese S, Teraishi T, Sasayama D, Hori H, Noda T, Yoshida S, Yoshida F, Kunugi H

Neuropsychiatric Disease and Treatment 2019, 15:2221-2230

Published Date: 6 August 2019

Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey

Hermanowicz N, Jones SA, Hauser RA

Neuropsychiatric Disease and Treatment 2019, 15:2205-2212

Published Date: 5 August 2019

Orthostatic hypotension and dementia incidence: links and implications

Robertson AD, Udow SJ, Espay AJ, Merola A, Camicioli R, Lang AE, Masellis M

Neuropsychiatric Disease and Treatment 2019, 15:2181-2194

Published Date: 2 August 2019

Social communication deficits and restricted repetitive behavior symptoms in Tourette syndrome

Eapen V, McPherson S, Karlov L, Nicholls L, Črnčec R, Mulligan A

Neuropsychiatric Disease and Treatment 2019, 15:2151-2160

Published Date: 26 July 2019

Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis

Zhang H, Wang L, Fan Y, Yang L, Wen X, Liu Y, Liu Z

Neuropsychiatric Disease and Treatment 2019, 15:2137-2149

Published Date: 29 July 2019

Alterations of amplitude of low-frequency fluctuation in treatment-resistant versus non-treatment-resistant depression patients

Zhang A, Li G, Yang C, Liu P, Wang Y, Kang L, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2019, 15:2119-2128

Published Date: 25 July 2019

Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia

Gupta AK, Pokhriyal R, Das U, Khan MI, Ratna Kumar D, Gupta R, Chadda RK, Ramachandran R, Goyal V, Tripathi M, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:2073-2085

Published Date: 19 July 2019

An intervention targeting social, communication and daily activity skills in children and adolescents with Down syndrome and autism: a pilot study

Wester Oxelgren U, Westerlund J, Myrelid Å, Annerén G, Johansson L, Åberg M, Gustafsson J, Fernell E

Neuropsychiatric Disease and Treatment 2019, 15:2049-2056

Published Date: 18 July 2019

Relationships between sleep patterns and metabolic profile in patients maintained on antipsychotics: a cross-sectional comparative study

Kiwan N, Mahfoud Z, Ghuloum S, Yehya A, Hammoudeh S, Hani Y, Chamali R, Amro I, Mook-Kanamori D, Al-Amin H

Neuropsychiatric Disease and Treatment 2019, 15:2035-2047

Published Date: 19 July 2019

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization

Mar J, Arrospide A, Soto-Gordoa M, Iruin Á, Tainta M, Gabilondo A, Mar-Barrutia L, Calvo M, Mateos M, Ibarrondo O

Neuropsychiatric Disease and Treatment 2019, 15:2027-2034

Published Date: 17 July 2019

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation

Bagyinszky E, Kang MJ, Pyun J, Giau VV, An SSA, Kim S

Neuropsychiatric Disease and Treatment 2019, 15:2003-2013

Published Date: 16 July 2019

Simvastatin pretreatment ameliorates t-PA–induced hemorrhage transformation and MMP-9/TIMP-1 imbalance in thromboembolic cerebral ischemic rats

Yin B, Li DD, Xu SY, Huang H, Lin J, Sheng HS, Fang JH, Song JN, Zhang M

Neuropsychiatric Disease and Treatment 2019, 15:1993-2002

Published Date: 16 July 2019

Development of the 12-item questionnaire for quantitative assessment of depressive mixed state (DMX-12)

Shinzato H, Koda M, Nakamura A, Kondo T

Neuropsychiatric Disease and Treatment 2019, 15:1983-1991

Published Date: 15 July 2019

Psychological factors associated with smoking and quitting: addiction map of Turkey study

Ünübol H, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2019, 15:1971-1982

Published Date: 11 July 2019

Heart rate variability and incidence of depression during the first six months following first myocardial infarction

Wilkowska A, Rynkiewicz A, Wdowczyk J, Landowski J, Cubała WJ

Neuropsychiatric Disease and Treatment 2019, 15:1951-1956

Published Date: 10 July 2019

Factors related to lithium blood concentrations in Chinese Han patients with bipolar disorder

Xu YY, Xia QH, Liang J, Cao Y, Shan F, Liu Y, Yan CY, Xia QR

Neuropsychiatric Disease and Treatment 2019, 15:1929-1937

Published Date: 10 July 2019

Apolipoprotein E e4 allele is associated with extrapyramidal symptoms in Alzheimer’s disease

Chang YP, Chou MC, Lai CL, Chien I, Yang YH

Neuropsychiatric Disease and Treatment 2019, 15:1915-1919

Published Date: 9 July 2019

Febrile infection-related epilepsy syndrome (FIRES): prevalence, impact and management strategies

Serino D, Santarone ME, Caputo D, Fusco L

Neuropsychiatric Disease and Treatment 2019, 15:1897-1903

Published Date: 9 July 2019

Developmental coordination disorder and dysgraphia: signs and symptoms, diagnosis, and rehabilitation

Biotteau M, Danna J, Baudou É, Puyjarinet F, Velay JL, Albaret JM, Chaix Y

Neuropsychiatric Disease and Treatment 2019, 15:1873-1885

Published Date: 8 July 2019

Antipsychotics and risk of natural death in patients with schizophrenia

Chen Y, Yang X, Qin X, Yang Q, Fan H, Li J, Song X, Xu S, Guo W, Deng W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1863-1871

Published Date: 5 July 2019

Validation of the Chinese version of the Health Cognitions Questionnaire in Chinese college students

Dai L, Xu Z, Yin M, Wang X, Deng Y

Neuropsychiatric Disease and Treatment 2019, 15:1845-1854

Published Date: 5 July 2019

Resting-state functional magnetic resonance imaging (fMRI) and functional connectivity density mapping in patients with corneal ulcer

Zhu F, Tang L, Zhu P, Lin Q, Yuan Q, Shi W, Li B, Ye L, Min Y, Su T, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:1833-1844

Published Date: 5 July 2019

QT and P-wave dispersion during the manic phase of bipolar disorder

Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M

Neuropsychiatric Disease and Treatment 2019, 15:1805-1811

Published Date: 3 July 2019

Patients’ experiences of long-acting injectable antipsychotics: a qualitative study

Chiu LL, Liu CH, Chu CL, Lin HL, Lii SC

Neuropsychiatric Disease and Treatment 2019, 15:1797-1804

Published Date: 3 July 2019

Impact of serotonin transporter gene on rTMS augmentation of SSRIs for obsessive compulsive disorder

Zhang K, Fan X, Yuan J, Yin J, Su H, Hashimoto K, Wang G

Neuropsychiatric Disease and Treatment 2019, 15:1771-1779

Published Date: 2 July 2019

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L

Neuropsychiatric Disease and Treatment 2019, 15:1723-1736

Published Date: 1 July 2019

Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population

García-de la Cruz DD, Juárez-Rojop IE, Tovilla-Zárate CA, Martínez-Magaña JJ, Genis-Mendoza AD, Nicolini H, González-Castro TB, Guzmán-Priego CG, López-Martínez NA, Hernández-Cisneros JA, Caballero-Prado F

Neuropsychiatric Disease and Treatment 2019, 15:1717-1722

Published Date: 28 June 2019

The level of IL-6 was associated with sleep disturbances in patients with major depressive disorder

Wang M, Wei J, Yang X, Ni P, Wang Y, Zhao L, Deng W, Guo W, Wang Q, Li T, Ma X

Neuropsychiatric Disease and Treatment 2019, 15:1695-1700

Published Date: 27 June 2019

Long-term efficacy and safety of paliperidone palmitate once-monthly in Chinese patients with recent-onset schizophrenia

Si T, Zhuo J, Feng Y, Lu H, Hong D, Zhang L

Neuropsychiatric Disease and Treatment 2019, 15:1685-1694

Published Date: 27 June 2019

Reduction in apathy following epilepsy surgery

Mah L, Swearer J, Phillips CA, Benjamin S

Neuropsychiatric Disease and Treatment 2019, 15:1679-1684

Published Date: 28 June 2019

The role of long noncoding RNA in traumatic brain injury

Li Z, Han K, Zhang D, Chen J, Xu Z, Hou L

Neuropsychiatric Disease and Treatment 2019, 15:1671-1677

Published Date: 28 June 2019

The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies

Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ

Neuropsychiatric Disease and Treatment 2019, 15:1659-1669

Published Date: 24 June 2019

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder

Bo Q, Tian L, Li F, Mao Z, Wang Z, Ma X, Wang C

Neuropsychiatric Disease and Treatment 2019, 15:1649-1657

Published Date: 24 June 2019

The efficacy of a “cocktail therapy” on Parkinson’s disease with dementia

Zhang C, Zang Y, Song Q, Li H, Hu L, Zhao W, Feng S, Gu F, Zhao F, Zhang C

Neuropsychiatric Disease and Treatment 2019, 15:1639-1647

Published Date: 24 June 2019

Correlation between precontemplation and alpha activity in gambling disorder

Lee J, Choi SW, Kim KM, Lee YS, Kim JW

Neuropsychiatric Disease and Treatment 2019, 15:1629-1637

Published Date: 21 June 2019

Machine learning techniques in a structural and functional MRI diagnostic approach in schizophrenia: a systematic review

de Filippis R, Carbone EA, Gaetano R, Bruni A, Pugliese V, Segura-Garcia C, De Fazio P

Neuropsychiatric Disease and Treatment 2019, 15:1605-1627

Published Date: 19 June 2019

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies

Madera JJ, Such P, Zhao C, Baker RA

Neuropsychiatric Disease and Treatment 2019, 15:1593-1604

Published Date: 18 June 2019

Status epilepticus in patients with genetic (idiopathic) generalized epilepsy

Bosak M, Pawełczak D, Słowik A

Neuropsychiatric Disease and Treatment 2019, 15:1585-1592

Published Date: 20 June 2019

Serum lipid profiles and post-stroke depression in acute ischemic stroke patients

Shen H, Tu X, Luan X, Zeng Y, He J, Tang W

Neuropsychiatric Disease and Treatment 2019, 15:1573-1583

Published Date: 17 June 2019

COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder

Otsuka Y, Kakeda S, Sugimoto K, Katsuki A, Nguyen LH, Igata R, Watanabe K, Ueda I, Kishi T, Iwata N, Korogi Y, Yoshimura R

Neuropsychiatric Disease and Treatment 2019, 15:1537-1545

Published Date: 6 June 2019

GABAB receptor activation ameliorates spatial memory impairments in stress-exposed rats

Sahraei H, Askaripour M, Esmaeilpour K, Shahsavari F, Rajabi S, Moradi-Kor N

Neuropsychiatric Disease and Treatment 2019, 15:1497-1506

Published Date: 30 May 2019

Patient and physician perceptions of disease management in Parkinson’s disease: results from a US-based multicenter survey

Hermanowicz N, Castillo-Shell M, McMean A, Fishman J, D’Souza J

Neuropsychiatric Disease and Treatment 2019, 15:1487-1495

Published Date: 30 May 2019

Cross-sectional study of psychiatric comorbidities in patients with atopic dermatitis and nonatopic eczema, urticaria, and psoriasis

Ahn HJ, Shin MK, Seo JK, Jeong SJ, Cho AR, Choi SH, Lew BL

Neuropsychiatric Disease and Treatment 2019, 15:1469-1478

Published Date: 28 May 2019

HO-1 protects the nerves of rats with cerebral hemorrhage by regulating the PI3K/AKT signaling pathway

Zhao Q, Qu R, Teng L, Yin C, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:1459-1468

Published Date: 28 May 2019

Clinical association of vitamin D and serotonin levels among patients with fibromyalgia syndrome

Amin OA, Abouzeid SM, Ali SA, Amin BA, Alswat KA

Neuropsychiatric Disease and Treatment 2019, 15:1421-1426

Published Date: 27 May 2019

The relationship between serum cobalamin, folic acid, and homocysteine and the risk of post-cardiac surgery delirium

Vahdat Shariatpanahi M, Velayati A, Jamalian SA, Babevaynejad M, Vahdat Shariatpanahi Z

Neuropsychiatric Disease and Treatment 2019, 15:1413-1419

Published Date: 23 May 2019

Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments

Parfenov VA, Ostroumova OD, Ostroumova TM, Kochetkov AI, Fateeva VV, Khacheva KK, Khakimova GR, Epstein OI

Neuropsychiatric Disease and Treatment 2019, 15:1381-1402

Published Date: 21 May 2019

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU

Neuropsychiatric Disease and Treatment 2019, 15:1365-1379

Published Date: 21 May 2019

Structural changes in white matter lesion patients and their correlation with cognitive impairment

Wang J, Liang Y, Chen H, Wang W, Wang Y, Liang Y, Zhang Y

Neuropsychiatric Disease and Treatment 2019, 15:1355-1363

Published Date: 21 May 2019

What are the links between hypoxia and Alzheimer’s disease?

Lall R, Mohammed R, Ojha U

Neuropsychiatric Disease and Treatment 2019, 15:1343-1354

Published Date: 21 May 2019

Cognitive impairment in eating disorder patients of short and long-term duration: a case–control study

Grau A, Magallón-Neri E, Faus G, Feixas G

Neuropsychiatric Disease and Treatment 2019, 15:1329-1341

Published Date: 21 May 2019

Risk factors for delirium: are therapeutic interventions part of it?

Xing J, Yuan Z, Jie Y, Liu Y, Wang M, Sun Y

Neuropsychiatric Disease and Treatment 2019, 15:1321-1327

Published Date: 17 May 2019

A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder

Nikolakaros G, Kurki T, Myllymäki A, Ilonen T

Neuropsychiatric Disease and Treatment 2019, 15:1311-1320

Published Date: 22 May 2019

Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy

Pinter A, Szatmari Jr S, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T

Neuropsychiatric Disease and Treatment 2019, 15:1287-1310

Published Date: 17 May 2019

Deep brain stimulation in the treatment of obsessive-compulsive disorder: current perspectives

Tastevin M, Spatola G, Régis J, Lançon C, Richieri R

Neuropsychiatric Disease and Treatment 2019, 15:1259-1272

Published Date: 15 May 2019

Cognitive impairment in depression: recent advances and novel treatments

Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A

Neuropsychiatric Disease and Treatment 2019, 15:1249-1258

Published Date: 10 May 2019

Quality and utilization of the Finnish clinical practice guideline in schizophrenia: evaluation using AGREE II and the vignette approach

Vähäniemi A, Välimäki M, Pekurinen V, Anttila M, Lantta T

Neuropsychiatric Disease and Treatment 2019, 15:1239-1248

Published Date: 9 May 2019

Rumination, posttraumatic stress disorder, and mood symptoms in borderline personality disorder

Dell’Osso L, Cremone IM, Carpita B, Dell’Oste V, Muti D, Massimetti G, Barlati S, Vita A, Fagiolini A, Carmassi C, Gesi C

Neuropsychiatric Disease and Treatment 2019, 15:1231-1238

Published Date: 13 May 2019

Chronic stress increases susceptibility to food addiction by increasing the levels of DR2 and MOR in the nucleus accumbens

Wei NL, Quan ZF, Zhao T, Yu XD, Xie Q, Zeng J, Ma FK, Wang F, Tang QS, Wu H, Zhu JH

Neuropsychiatric Disease and Treatment 2019, 15:1211-1229

Published Date: 8 May 2019

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Rodríguez C, García T, Areces D, Fernández E, García-Noriega M, Domingo JC

Neuropsychiatric Disease and Treatment 2019, 15:1193-1209

Published Date: 8 May 2019

The prognosis and changes of regional brain gray matter volume in MDD with gastrointestinal symptoms

Liu P, Li G, Zhang A, Sun N, Kang L, Yang C, Wang Y, Zhang K

Neuropsychiatric Disease and Treatment 2019, 15:1181-1191

Published Date: 9 May 2019

The relationships between video game experience and cognitive abilities in adolescents

Özçetin M, Gümüştaş F, Çağ Y, Gökbay İZ, Özmel A

Neuropsychiatric Disease and Treatment 2019, 15:1171-1180

Published Date: 8 May 2019

Health, functionality, and social support in families with a child with a neurodevelopmental disorder – a pilot study

Cavonius-Rintahaka D, Aho AL, Voutilainen A, Billstedt E, Gillberg C

Neuropsychiatric Disease and Treatment 2019, 15:1151-1161

Published Date: 8 May 2019

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial

Zhuo K, Tang Y, Song Z, Wang Y, Wang J, Qian Z, Li H, Xiang Q, Chen T, Yang Z, Xu Y, Fan X, Wang J, Liu D

Neuropsychiatric Disease and Treatment 2019, 15:1141-1150

Published Date: 8 May 2019

Personality associated with depressive status in individuals with type 2 diabetes mellitus

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N

Neuropsychiatric Disease and Treatment 2019, 15:1133-1139

Published Date: 3 May 2019

Effects of transection of cervical sympathetic trunk on cognitive function of traumatic brain injury rats

Long J, He CJ, Dai H, Kang XG, Zou JF, Ye SL, Yu Q

Neuropsychiatric Disease and Treatment 2019, 15:1121-1131

Published Date: 3 May 2019

Detection of cognitive impairment using a machine-learning algorithm [Corrigendum]

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2019, 15:1119-1120

Published Date: 1 May 2019

Metabonomics reveals peripheral and central short-chain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques

Deng F, Pan J, Zheng P, Xia J, Yin B, Liang W, Li Y, Wu J, Xu F, Wu Q, Qu C, Li W, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:1077-1088

Published Date: 1 May 2019

Deep brain stimulation in Tourette’s syndrome: evidence to date

Casagrande SCB, Cury RG, Alho EJL, Fonoff ET

Neuropsychiatric Disease and Treatment 2019, 15:1061-1075

Published Date: 29 April 2019

The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia

Pietrini F, Albert U, Ballerini A, Calò P, Maina G, Pinna F, Vaggi M, Boggian I, Fontana M, Moro C, Carpiniello B

Neuropsychiatric Disease and Treatment 2019, 15:1045-1060

Published Date: 30 April 2019

2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad G

Neuropsychiatric Disease and Treatment 2019, 15:1031-1044

Published Date: 24 April 2019

Aldehyde dehydrogenase 2 rs671G>A polymorphism and ischemic stroke risk in Chinese population: a meta-analysis

Xu YL, Hu YY, Li JW, Zhou L, Li L, Niu YM

Neuropsychiatric Disease and Treatment 2019, 15:1015-1029

Published Date: 23 April 2019

The influence of non-breathing-related sleep fragmentation on cognitive function in patients with cerebral small vessel disease

Wang J, Chen X, Liao J, Zhou L, Liao S, Shan Y, Lu Z, Tao J

Neuropsychiatric Disease and Treatment 2019, 15:1009-1014

Published Date: 18 April 2019

Abnormal resting-state functional connectivity of amygdala subregions in patients with obstructive sleep apnea

Yu H, Chen L, Li H, Xin H, Zhang J, Wei Z, Peng D

Neuropsychiatric Disease and Treatment 2019, 15:977-987

Published Date: 17 April 2019

Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study

Yuan H, Zhu X, Luo Q, Halim A, Halim M, Yao H, Cai Y, Shi S

Neuropsychiatric Disease and Treatment 2019, 15:957-966

Published Date: 16 April 2019

Cortical thinning and flattening in schizophrenia and their unaffected parents

Yan J, Cui Y, Li Q, Tian L, Liu B, Jiang T, Zhang D, Yan H

Neuropsychiatric Disease and Treatment 2019, 15:935-946

Published Date: 12 April 2019

Minimally invasive evacuation of spontaneous supratentorial intracerebral hemorrhage by transcranial neuroendoscopic approach

Cai Q, Guo Q, Li Z, Wang W, Zhang W, Ji B, Chen Z, Liu J

Neuropsychiatric Disease and Treatment 2019, 15:919-925

Published Date: 11 April 2019

Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Shams J, Asadi S, Ahmadiani A

Neuropsychiatric Disease and Treatment 2019, 15:895-904

Published Date: 10 April 2019

Objective diagnosis of post-stroke depression using NMR-based plasma metabonomics

Hu Z, Fan S, Liu M, Zhong J, Cao D, Zheng P, Wang Y, Wei Y, Fang L, Xie P

Neuropsychiatric Disease and Treatment 2019, 15:867-881

Published Date: 10 April 2019

Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients

Sun H, Yang Y, Zhang J, Liu T, Wang H, Garg S, Zhang B

Neuropsychiatric Disease and Treatment 2019, 15:857-865

Published Date: 8 April 2019

Lifetime predictors of stroke in subjects without a diagnosis of hypertension: the aerobics center longitudinal study

Cavero-Redondo I, Sui X, Blair SN, Lavie CJ, Álvarez-Bueno C, Martínez-Vizcaíno V

Neuropsychiatric Disease and Treatment 2019, 15:849-856

Published Date: 8 April 2019

Proton magnetic resonance spectroscopy changes in a longitudinal schizophrenia study: a pilot study in eleven patients

Galińska-Skok B, Szulc A, Małus A, Konarzewska B, Cwalina U, Tarasów E, Waszkiewicz N

Neuropsychiatric Disease and Treatment 2019, 15:839-847

Published Date: 8 April 2019

Therapeutic strategies in the early stages of Parkinson’s disease: a cross-sectional evaluation of 15 years’ experience with a large cohort of Romanian patients

Szász JA, Orbán-Kis K, Constantin VA, Péter C, Bíró I, Mihály I, Szegedi K, Balla A, Szatmári S

Neuropsychiatric Disease and Treatment 2019, 15:831-838

Published Date: 5 April 2019

Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment

Jarzemski P, Brzoszczyk B, Popiołek A, Stachowicz-Karpińska A, Gołota S, Bieliński M, Borkowska A

Neuropsychiatric Disease and Treatment 2019, 15:819-829

Published Date: 5 April 2019

Genetic polymorphisms in Sox17 associated with intracranial aneurysm in Chinese Han people: a genotype-phenotype study

Li M, Wang W, Zhang L, Xin W, Zhao Y, Huan L, Yu J, Zhang H, Zhang J, Yang S, Liang D, Yang W, Yang X

Neuropsychiatric Disease and Treatment 2019, 15:779-783

Published Date: 2 April 2019

Relationships between Internet addiction and clinicodemographic and behavioral factors

ElSalhy M, Miyazaki T, Noda Y, Nakajima S, Nakayama H, Mihara S, Kitayuguchi T, Higuchi S, Muramatsu T, Mimura M

Neuropsychiatric Disease and Treatment 2019, 15:739-752

Published Date: 26 March 2019

Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation

Nash AI, Turkoz I, Savitz AJ, Mathews M, Kim E

Neuropsychiatric Disease and Treatment 2019, 15:731-737

Published Date: 22 March 2019

Impaired comprehension of metaphorical expressions in very mild Alzheimer’s disease

Fujimoto N, Nakamura H, Tsuda T, Wakutani Y, Takao T

Neuropsychiatric Disease and Treatment 2019, 15:713-720

Published Date: 20 March 2019

Repetitive transcranial magnetic stimulation in trauma-related conditions

Namgung E, Kim M, Yoon S

Neuropsychiatric Disease and Treatment 2019, 15:701-712

Published Date: 19 March 2019

Identification of key genes, pathways and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis

Ma K, Zhang HX, Wei GH, Dong ZF, Zhao HJ, Han XC, Song XB, Zhang HL, Zong X, Baloch Z, Wang SJ

Neuropsychiatric Disease and Treatment 2019, 15:685-700

Published Date: 14 March 2019

The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis

Zhao L, Li X, Liu G, Han B, Wang J, Jiang X

Neuropsychiatric Disease and Treatment 2019, 15:675-684

Published Date: 12 March 2019

Effects of prenatal exposure to temephos on behavior and social interaction

Martins Laurentino AO, Durante de Medeiros F, de Oliveira J, da Rosa N, Mateus Gomes T, de Medeiros Peretti E, Somariva Prophiro J, Fortunato JJ

Neuropsychiatric Disease and Treatment 2019, 15:669-673

Published Date: 11 March 2019

Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment

Masi G, Fantozzi P, Villafranca A, Tacchi A, Ricci F, Ruglioni L, Inguaggiato E, Pfanner C, Cortese S

Neuropsychiatric Disease and Treatment 2019, 15:663-667

Published Date: 7 March 2019

GSK-3β and BDNF genes may not be associated with venlafaxine treatment response in Chinese of Han ethnicity

Sun Q, Yuan F, Ren D, Ma G, Yang F, Wu X, He L, He G

Neuropsychiatric Disease and Treatment 2019, 15:657-661

Published Date: 7 March 2019

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations [Corrigendum]

Mayerova M, Ustohal L, Jarkovsky J, Pivnicka J, Kasparek T, Ceskova E

Neuropsychiatric Disease and Treatment 2019, 15:655-656

Published Date: 5 March 2019

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis

Urban-Kowalczyk M, Strzelecki D, Śmigielski J, Kotlicka-Antczak M

Neuropsychiatric Disease and Treatment 2019, 15:647-654

Published Date: 5 March 2019

Vascular risk modulates the relationship between cerebral amyloid deposition and subjective memory complaints

Kim JW, Byun MS, Yi D, Lee JH, Ko K, Jung G, Lee DY

Neuropsychiatric Disease and Treatment 2019, 15:637-645

Published Date: 4 March 2019

Prevalence and outcomes of Guillain-Barré syndrome among pediatrics in Saudi Arabia: a 10-year retrospective study

Asiri S, Altwaijri WA, Ba-Armah D, Al Rumayyan A, Alrifai MT, Salam M, Almutairi AF

Neuropsychiatric Disease and Treatment 2019, 15:627-635

Published Date: 1 March 2019

Social cognitive training for adults with Noonan syndrome: a feasibility study

Roelofs RL, Wingbermühle E, Kessels RPC, Egger JIM

Neuropsychiatric Disease and Treatment 2019, 15:611-626

Published Date: 26 February 2019

Racial and ethnic differences in depression: current perspectives

Bailey RK, Mokonogho J, Kumar A

Neuropsychiatric Disease and Treatment 2019, 15:603-609

Published Date: 22 February 2019

Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats

Alachkar A, Khan N, Łażewska D, Kieć-Kononowicz K, Sadek B

Neuropsychiatric Disease and Treatment 2019, 15:531-542

Published Date: 20 February 2019

The interactive effects of stress and coping style on cognitive function in patients with schizophrenia

Zhu X, Xu X, Xu C, Zhang J, Zhang X, Ma L, Liu J, Wang K

Neuropsychiatric Disease and Treatment 2019, 15:523-530

Published Date: 21 February 2019

Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study

Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I

Neuropsychiatric Disease and Treatment 2019, 15:511-521

Published Date: 20 February 2019

Aberrant attentive and inattentive brain activity to auditory negative words, and its relation to persecutory delusion in patients with schizophrenia

Iwashiro N, Takano Y, Natsubori T, Aoki Y, Yahata N, Gonoi W, Kunimatsu A, Abe O, Kasai K, Yamasue H

Neuropsychiatric Disease and Treatment 2019, 15:491-502

Published Date: 14 February 2019

Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia

She S, Zhang B, Mi L, Li H, Kuang Q, Bi T, Zheng Y

Neuropsychiatric Disease and Treatment 2019, 15:481-489

Published Date: 18 February 2019

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress

Rinaldi A, Rinaldi C, Coelho Pereira JA, Lotti Margotti M, Bittencourt MN, Barcessat ARP, Fontani V, Rinaldi S

Neuropsychiatric Disease and Treatment 2019, 15:469-480

Published Date: 13 February 2019

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression

Kumar A, Bunker MT, Aaronson ST, Conway CR, Rothschild AJ, Mordenti G, Rush AJ

Neuropsychiatric Disease and Treatment 2019, 15:457-468

Published Date: 13 February 2019

The effect of night shift on sleep quality and depressive symptoms among Chinese nurses

Dai C, Qiu H, Huang Q, Hu P, Hong X, Tu J, Xie Q, Li H, Ren W, Ni S, Chen F

Neuropsychiatric Disease and Treatment 2019, 15:435-440

Published Date: 7 February 2019

Stimulus intensity determined by dose-titration versus age-based methods in electroconvulsive therapy in Thai patients

Ittasakul P, Likitnukul A, Pitidhammabhorn U, Waleeprakhon P, Goldman MB

Neuropsychiatric Disease and Treatment 2019, 15:429-434

Published Date: 7 February 2019

Analysis of motor performance in individuals with cerebral palsy using a non-immersive virtual reality task – a pilot study

Martins FPA, Massetti T, Crocetta TB, Bianchi Lopes P, da Silva AA, Figueiredo EF, de Abreu LC, da Silva TD, Monteiro CBM

Neuropsychiatric Disease and Treatment 2019, 15:417-428

Published Date: 4 February 2019

HDAC4 gene silencing alleviates epilepsy by inhibition of GABA in a rat model

Zhang YN, Dong HT, Duan L, Niu L, Yuan GQ, Dai JQ, Hou BR, Pan YW

Neuropsychiatric Disease and Treatment 2019, 15:405-416

Published Date: 4 February 2019

Psychiatric comorbidities in patients with intentional methanol intoxication

Yang WS, Yen TH, Juang YY, Lee SH, Wang BH, Lee CP

Neuropsychiatric Disease and Treatment 2019, 15:397-402

Published Date: 31 January 2019

Clinical factors influencing resilience in patients with anorexia nervosa

Kane C, Tomotake M, Hamatani S, Chiba S, Kameoka N, Watanabe S, Nakataki M, Numata S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:391-395

Published Date: 30 January 2019

Evacuation of chronic and subacute subdural hematoma via transcranial neuroendoscopic approach

Cai Q, Guo Q, Zhang F, Sun D, Zhang W, Ji B, Chen Z, Mao S

Neuropsychiatric Disease and Treatment 2019, 15:385-390

Published Date: 30 January 2019

Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms

Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y

Neuropsychiatric Disease and Treatment 2019, 15:375-383

Published Date: 29 January 2019

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication

Andor M, Dehelean L, Romosan AM, Buda V, Radu G, Caruntu F, Bordejevic A, Manea MM, Papava I, Bredicean CA, Romosan RS, Tomescu M

Neuropsychiatric Disease and Treatment 2019, 15:349-355

Published Date: 25 January 2019

The association between HTR1B gene rs13212041 polymorphism and onset of alcohol abuse

Svob Strac D, Nedic Erjavec G, Nikolac Perkovic M, Nenadic-Sviglin K, Konjevod M, Grubor M, Pivac N

Neuropsychiatric Disease and Treatment 2019, 15:339-347

Published Date: 24 January 2019

Effects of early administration of insulin-like growth factor-1 on cognitive function in septic encephalopathy

Yang Y, Liang S, Li Y, Gao F, Cao Y, Zhao X, Gao G, Li L

Neuropsychiatric Disease and Treatment 2019, 15:323-337

Published Date: 23 January 2019

Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation

Dowlati Y, de Jesus DR, Selby P, Fan I, Meyer JH

Neuropsychiatric Disease and Treatment 2019, 15:311-321

Published Date: 23 January 2019

Cytokines and chemokines expression in serum of patients with neuromyelitis optica

Ai NP, Liu HJ, Zhou HF, Lin DH, Wang JQ, Yang M, Song HG, Sun MM, Xu QG, Wei SH

Neuropsychiatric Disease and Treatment 2019, 15:303-310

Published Date: 21 January 2019

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia

Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T

Neuropsychiatric Disease and Treatment 2019, 15:293-301

Published Date: 21 January 2019

Altered intrinsic brain activity in patients with toothaches using the amplitude of low-frequency fluctuations: a resting-state fMRI study

Yang J, Li B, Yu QY, Ye L, Zhu PW, Shi WQ, Yuan Q, Min YL, He YL, Shao Y

Neuropsychiatric Disease and Treatment 2019, 15:283-291

Published Date: 18 January 2019

Frequency-dependent neural activity in primary angle-closure glaucoma

Jiang F, Yu C, Zuo MJ, Zhang C, Wang Y, Zhou FQ, Zeng XJ

Neuropsychiatric Disease and Treatment 2019, 15:271-282

Published Date: 18 January 2019

Association between anxious distress in a major depressive episode and bipolarity

Sugawara H, Tsutsumi T, Inada K, Ishigooka J, Hashimoto M, Takebayashi M, Nishimura K

Neuropsychiatric Disease and Treatment 2019, 15:267-270

Published Date: 15 January 2019

Serum BICC1 levels are significantly different in various mood disorders

Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y

Neuropsychiatric Disease and Treatment 2019, 15:259-265

Published Date: 15 January 2019

Disturbances of mitochondrial parameters to distinguish patients with depressive episode of bipolar disorder and major depressive disorder

Zvěřová M, Hroudová J, Fišar Z, Hansíková H, Kališová L, Kitzlerová E, Lambertová A, Raboch J

Neuropsychiatric Disease and Treatment 2019, 15:233-240

Published Date: 14 January 2019

Lower vitamin D levels are associated with depression in patients with gout

Zhou Q, Shao Y, Gan Z, Fang L

Neuropsychiatric Disease and Treatment 2019, 15:227-231

Published Date: 14 January 2019

Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1

Endo M, Odaira K, Ono R, Kurauchi G, Koseki A, Goto M, Sato Y, Kon S, Watanabe N, Sugawara N, Takada H, Kimura E

Neuropsychiatric Disease and Treatment 2019, 15:219-226

Published Date: 14 January 2019

Association analysis of polymorphisms in STARD6 and near ECHDC3 in Alzheimer’s disease patients carrying the APOE ε4 Allele

Yin J, Feng W, Yuan H, Yuan J, Wu Y, Liu X, Jin C, Cheng Z

Neuropsychiatric Disease and Treatment 2019, 15:213-218

Published Date: 11 January 2019

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan

Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:205-211

Published Date: 9 January 2019

Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings

Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S

Neuropsychiatric Disease and Treatment 2019, 15:199-204

Published Date: 7 January 2019

The impact of short and long sleep duration on instrumental activities of daily living among stroke survivors

Seixas AA, Chung DP, Richards SL, Madhavaram S, Raghavan P, Gago J, Casimir G, Jean-Louis G

Neuropsychiatric Disease and Treatment 2019, 15:177-182

Published Date: 4 January 2019

Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment

Albai O, Frandes M, Timar R, Roman D, Timar B

Neuropsychiatric Disease and Treatment 2019, 15:167-175

Published Date: 3 January 2019

Risk factors for the difficulties in general activities across the day in Chinese children and adolescents with attention-deficit/hyperactivity disorder

Ke X, Du Y, Zheng Y, Su L, Chen Y, Zhang YL, Chen K, Cheng Y, Chen W

Neuropsychiatric Disease and Treatment 2019, 15:157-166

Published Date: 31 December 2018

Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis

Xu F, Wang B, Yao J

Neuropsychiatric Disease and Treatment 2019, 15:143-155

Published Date: 28 December 2018

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff

Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N

Neuropsychiatric Disease and Treatment 2019, 15:137-142

Published Date: 27 December 2018

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis

Ghaffarpasand F, Torabi S, Rasti A, Niakan MH, Aghabaklou S, Pakzad F, Beheshtian MS, Tabrizi R

Neuropsychiatric Disease and Treatment 2019, 15:127-135

Published Date: 27 December 2018

Frequent attenders in general medical practice in Italy: a preliminary report on clinical variables related to low functioning

Carmassi C, Dell’Oste V, Ceresoli D, Moscardini S, Bianchi E, Landi R, Massimetti G, Nisita C, Dell’Osso L

Neuropsychiatric Disease and Treatment 2019, 15:115-125

Published Date: 24 December 2018

Poststroke epilepsy: current perspectives on diagnosis and treatment

Sarecka-Hujar B, Kopyta I

Neuropsychiatric Disease and Treatment 2019, 15:95-103

Published Date: 24 December 2018

Associations of BRAP polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test

Kim JW, Choe YM, Shin JG, Park BL, Shin HD, Choi IG, Lee BC

Neuropsychiatric Disease and Treatment 2019, 15:83-94

Published Date: 24 December 2018

Intrinsic thalamocortical connectivity varies in the age of onset subtypes in major depressive disorder

Brown EC, Clark DL, Hassel S, MacQueen G, Ramasubbu R

Neuropsychiatric Disease and Treatment 2019, 15:75-82

Published Date: 21 December 2018

The factor structure, reliability and validity of the Chinese version of the Van Dream Anxiety Scale

Wang X, Dai L, Yin M, Deng YL

Neuropsychiatric Disease and Treatment 2019, 15:57-67

Published Date: 21 December 2018

Botulinum toxin relieves anxiety and depression in patients with hemifacial spasm and blepharospasm

Dong H, Fan S, Luo Y, Peng B

Neuropsychiatric Disease and Treatment 2019, 15:33-36

Published Date: 19 December 2018

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles

Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD

Neuropsychiatric Disease and Treatment 2019, 15:1-19

Published Date: 17 December 2018

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia

Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W

Neuropsychiatric Disease and Treatment 2018, 14:3373-3379

Published Date: 13 December 2018

Sensory function in cluster headache: an observational study comparing the symptomatic and asymptomatic sides

Malo-Urriés M, Hidalgo-García C, Estébanez-de-Miguel E, Tricás-Moreno JM, Santos-Lasaosa S, Jahanshahi M

Neuropsychiatric Disease and Treatment 2018, 14:3363-3371

Published Date: 10 December 2018

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder

Huang YC, Shi X, Li ZY, Shen Y, Shi XX, Wang LY, Li GF, Yuan Y, Wang JX, Zhang YC, Zhao L, Zhang M, Kang Y, Liang Y

Neuropsychiatric Disease and Treatment 2018, 14:3329-3337

Published Date: 3 December 2018

Altered functional connectivity of primary visual cortex in late blindness

Wen Z, Zhou FQ, Huang X, Dan HD, Xie BJ, Shen Y

Neuropsychiatric Disease and Treatment 2018, 14:3317-3327

Published Date: 3 December 2018

Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics

Zheng W, Luo XN, Li HY, Ke XY, Dai Q, Zhang CJ, Zhang XY, Ning YP

Neuropsychiatric Disease and Treatment 2018, 14:3307-3315

Published Date: 30 November 2018

Effects of personality on the association between paroxetine plasma concentration and response

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K

Neuropsychiatric Disease and Treatment 2018, 14:3299-3306

Published Date: 29 November 2018

Developmental lead (Pb)-induced deficits in hippocampal protein translation at the synapses are ameliorated by ascorbate supplementation

Ahmad F, Salahuddin M, Alsamman K, AlMulla AA, Salama KF

Neuropsychiatric Disease and Treatment 2018, 14:3289-3298

Published Date: 29 November 2018

Influence of trait anxiety, child maltreatment, and adulthood life events on depressive symptoms

Uchida Y, Takahashi T, Katayama S, Masuya J, Ichiki M, Tanabe H, Kusumi I, Inoue T

Neuropsychiatric Disease and Treatment 2018, 14:3279-3287

Published Date: 27 November 2018

Children screening positive for language delay at 2.5 years: language disorder and developmental profiles

Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C

Neuropsychiatric Disease and Treatment 2018, 14:3267-3277

Published Date: 28 November 2018

Association of HLA alleles with autism

Sayad A, Akbari MT, Noroozi R, Omrani MD, Inoko H, Taheri M, Ghafouri-Fard S

Neuropsychiatric Disease and Treatment 2018, 14:3259-3265

Published Date: 27 November 2018

Dissociative states in borderline personality disorder and their relationships to psychotropic medication

Pec O, Bob P, Simek J, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3253-3257

Published Date: 23 November 2018

The association between depression, anxiety and substance use among Canadian post-secondary students

Esmaeelzadeh S, Moraros J, Thorpe L, Bird Y

Neuropsychiatric Disease and Treatment 2018, 14:3241-3251

Published Date: 23 November 2018

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder

Cao P, Xing J, Cao Y, Cheng Q, Sun X, Kang Q, Dai L, Zhou X, Song Z

Neuropsychiatric Disease and Treatment 2018, 14:3231-3240

Published Date: 26 November 2018

Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease

Zhou Y, Gu C, Li J, Zhu L, Huang G, Dai J, Huang H

Neuropsychiatric Disease and Treatment 2018, 14:3219-3229

Published Date: 22 November 2018

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Zuilhof Z, Norris S, Blondeau C, Tessier P, Blier P

Neuropsychiatric Disease and Treatment 2018, 14:3209-3218

Published Date: 22 November 2018

Brain structural networks and connectomes: the brain–obesity interface and its impact on mental health

Chen VCH, Liu YC, Chao SH, McIntyre RS, Cha DS, Lee Y, Weng JC

Neuropsychiatric Disease and Treatment 2018, 14:3199-3208

Published Date: 26 November 2018

The hospital anxiety and depression scale, in patients with multiple sclerosis

Pais-Ribeiro JL, Martins da Silva A, Vilhena E, Moreira I, Santos E, Mendonça D

Neuropsychiatric Disease and Treatment 2018, 14:3193-3197

Published Date: 22 November 2018

The subjective perception of past, present, and future time in patients with Alzheimer's disease: a qualitative study

Shiromaru-Sugimoto A, Murakami H, Futamura A, Honma M, Kuroda T, Kawamura M, Ono K

Neuropsychiatric Disease and Treatment 2018, 14:3185-3192

Published Date: 22 November 2018

Gabapentin enacarbil for antipsychotic induced akathisia in schizophrenia patients: a pilot open-labeled study

Takeshima M, Ishikawa H, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2018, 14:3179-3184

Published Date: 22 November 2018

Elevated circulating magnesium levels in patients with Parkinson’s disease: a meta-analysis

Jin X, Liu MY, Zhang DF, Gao H, Wei MJ

Neuropsychiatric Disease and Treatment 2018, 14:3159-3168

Published Date: 19 November 2018

Aberrant prefrontal–parietal–cerebellar circuits in alcohol dependence

Liu R, Liu BX, Ma M, Kong D, Li G, Yang J, Wu X, Zheng J, Dong Y

Neuropsychiatric Disease and Treatment 2018, 14:3143-3150

Published Date: 16 November 2018

Activation of ERK/CREB/BDNF pathway involved in abnormal behavior of neonatally Borna virus-infected rats

Li C, Xu X, Zhang X, Cheng K, Guo Y, Jie J, Guo H, He Y, Zhou C, Gui S, Zhong X, Wang H, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:3121-3132

Published Date: 15 November 2018

RIP1 and RIP3 mediate hemin-induced cell death in HT22 hippocampal neuronal cells

Su X, Wang H, Lin Y, Chen F

Neuropsychiatric Disease and Treatment 2018, 14:3111-3119

Published Date: 15 November 2018

Efficacy of light therapy on nonseasonal depression among elderly adults: a systematic review and meta-analysis

Chang CH, Liu CY, Chen SJ, Tsai HC

Neuropsychiatric Disease and Treatment 2018, 14:3091-3102

Published Date: 14 November 2018

Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis

Dalvand S, Ghanei Gheshlagh R, Kurdi A

Neuropsychiatric Disease and Treatment 2018, 14:3073-3080

Published Date: 13 November 2018

Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis

Maneeton N, Maneeton B, Putthisri S, Suttajit S, Likhitsathian S, Srisurapanont M

Neuropsychiatric Disease and Treatment 2018, 14:3063-3072

Published Date: 12 November 2018

Economic analysis of acupuncture for migraine prophylaxis

Pokladnikova J, Maresova P, Dolejs J, Park AL, Wang B, Guan X, Musil F

Neuropsychiatric Disease and Treatment 2018, 14:3053-3061

Published Date: 12 November 2018

The Chinese herbal formula Fuzheng Quxie Decoction attenuates cognitive impairment and protects cerebrovascular function in SAMP8 mice

Wang F, Feng J, Yang Y, Liu J, Liu M, Wang Z, Pei H, Wei Y, Li H

Neuropsychiatric Disease and Treatment 2018, 14:3037-3051

Published Date: 9 November 2018

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report

Kulaksizoğlu B, Kara H, Bodur B, Kuloğlu M

Neuropsychiatric Disease and Treatment 2018, 14:3033-3035

Published Date: 9 November 2018

Cognitive functioning in patients treated with electroconvulsive therapy

Kalisova L, Kubinova M, Michalec J, Albrecht J, Madlova K, Raboch J

Neuropsychiatric Disease and Treatment 2018, 14:3025-3031

Published Date: 8 November 2018

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease

Giau VV, Senanarong V, Bagyinszky E, Limwongse C, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:3015-3023

Published Date: 8 November 2018

A prescription for “nature” – the potential of using virtual nature in therapeutics

White MP, Yeo NL, Vassiljev P, Lundstedt R, Wallergård M, Albin M, Lõhmus M

Neuropsychiatric Disease and Treatment 2018, 14:3001-3013

Published Date: 8 November 2018

Biomarkers in traumatic brain injury (TBI): a review

Dadas A, Washington J, Diaz-Arrastia R, Janigro D

Neuropsychiatric Disease and Treatment 2018, 14:2989-3000

Published Date: 8 November 2018

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia

Escamilla R, Camarena B, Saracco-Alvarez R, Fresán A, Hernández S, Aguilar-García A

Neuropsychiatric Disease and Treatment 2018, 14:2981-2987

Published Date: 5 November 2018

Parents’ impaired emotion recognition abilities are related to children’s autistic symptoms in autism spectrum disorder

Hu X, Yin L, Situ M, Guo K, Yang P, Zhang M, Huang Y

Neuropsychiatric Disease and Treatment 2018, 14:2973-2980

Published Date: 5 November 2018

Low levels of serum magnesium are associated with poststroke cognitive impairment in ischemic stroke patients

Tu X, Qiu H, Lin S, He W, Huang G, Zhang X, Wu Y, He J

Neuropsychiatric Disease and Treatment 2018, 14:2947-2954

Published Date: 2 November 2018

Detection of cognitive impairment using a machine-learning algorithm

Youn YC, Choi SH, Shin HW, Kim KW, Jang JW, Jung JJ, Hsiung GY, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2939-2945

Published Date: 1 November 2018

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: a case report

Kitaguchi N, Kato T, Matsunaga S, Hirano K, Iwata K, Kawaguchi K, Fujita K, Takechi H, Hasegawa M, Yuzawa Y, Ito K

Neuropsychiatric Disease and Treatment 2018, 14:2931-2937

Published Date: 1 November 2018

Structural and functional brain abnormalities in drug-naive, first-episode, and chronic patients with schizophrenia: a multimodal MRI study

Wu F, Zhang Y, Yang Y, Lu X, Fang Z, Huang J, Kong L, Chen J, Ning Y, Li X, Wu K

Neuropsychiatric Disease and Treatment 2018, 14:2889-2904

Published Date: 30 October 2018

Short duration of focal onset awareness and impaired awareness seizure are characteristic features of epilepsy in elderly patients

Fujimoto A, Okanishi T, Masuda Y, Sato K, Nishimura M, Baba S, Itamura S, Homma Y, Enoki H

Neuropsychiatric Disease and Treatment 2018, 14:2879-2887

Published Date: 30 October 2018

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D

Neuropsychiatric Disease and Treatment 2018, 14:2861-2877

Published Date: 29 October 2018

Sexual dysfunction in cervical dystonia and blepharospasm

Marek M, Grobe-Einsler M, Bedarf JR, Wabbels B, Paus S

Neuropsychiatric Disease and Treatment 2018, 14:2847-2852

Published Date: 26 October 2018

Neuroprogression: the hidden mechanism of depression

Labra Ruiz NA, Santamaría del Ángel D, Juárez Olguín H, Lindoro Silva M

Neuropsychiatric Disease and Treatment 2018, 14:2837-2845

Published Date: 30 October 2018

Neuromodulation in eating disorders and obesity: a promising way of treatment?

Jáuregui-Lobera I, Martínez-Quiñones JV

Neuropsychiatric Disease and Treatment 2018, 14:2817-2835

Published Date: 26 October 2018

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors

Černý M, Hodgins S, Kučíková R, Kážmér L, Lambertová A, Nawka A, Nawková L, Parzelka A, Raboch J, Bob P, Vevera J

Neuropsychiatric Disease and Treatment 2018, 14:2793-2805

Published Date: 23 October 2018

Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder

Chou WJ, Wang LJ, Lin CH, Liang SY, Chen VCH, Hou YM, Huang RR, Chou MC, Shang CY, Ho CP, Lai MC

Neuropsychiatric Disease and Treatment 2018, 14:2783-2791

Published Date: 23 October 2018

microRNA-451 protects neurons against ischemia/reperfusion injury-induced cell death by targeting CELF2

Liu Q, Hu Y, Zhang M, Yan Y, Yu H, Ge L

Neuropsychiatric Disease and Treatment 2018, 14:2773-2782

Published Date: 23 October 2018

Abnormal intrinsic brain activities in stable patients with COPD: a resting-state functional MRI study

Wang W, Li H, Peng D, Luo J, Xin H, Yu H, Yu J

Neuropsychiatric Disease and Treatment 2018, 14:2763-2772

Published Date: 17 October 2018

Depression, anxiety, and stress and their association with khat use: a cross-sectional study among Jazan University students, Saudi Arabia

Al Bahhawi T, Albasheer OB, Makeen AM, Arishi AM, Hakami OM, Maashi SM, Al-Khairat HK, Alganmy OM, Sahal YA, Sharif AA, Mahfouz MS

Neuropsychiatric Disease and Treatment 2018, 14:2755-2761

Published Date: 17 October 2018

Lithium treatment in bipolar adolescents: a follow-up naturalistic study

Masi G, Milone A, Scrinzi G, Mucci M, Viglione V, Bruni G, Berloffa S, Pisano S

Neuropsychiatric Disease and Treatment 2018, 14:2749-2753

Published Date: 17 October 2018

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Duncan Jr WC, Slonena EE, Hejazi NS, Brutsche N, Park LT, Henter ID, Ballard ED, Zarate Jr CA

Neuropsychiatric Disease and Treatment 2018, 14:2739-2748

Published Date: 16 October 2018

Neuronal connectivity in major depressive disorder: a systematic review

Helm K, Viol K, Weiger TM, Tass PA, Grefkes C, del Monte D, Schiepek G

Neuropsychiatric Disease and Treatment 2018, 14:2715-2737

Published Date: 17 October 2018

Minocycline as adjunct therapy for a male patient with deficit schizophrenia

Chen X, Xiong Z, Li Z, Yang Y, Zheng Z, Li Y, Xie Y, Li Z

Neuropsychiatric Disease and Treatment 2018, 14:2697-2701

Published Date: 12 October 2018

Effects of cognitive behavioral therapy for depression on improving insomnia and quality of life in Chinese women with breast cancer: results of a randomized, controlled, multicenter trial

Qiu H, Ren W, Yang Y, Zhu X, Mao G, Mao S, Lin Y, Shen S, Li C, Shi H, Jiang S, He J, Zhao K, Fu Y, Hu X, Gu Y, Wang K, Guo X, He J

Neuropsychiatric Disease and Treatment 2018, 14:2665-2673

Published Date: 10 October 2018

Menstrual disorders and their determinants among women with epilepsy

Bosak M, Słowik A, Turaj W

Neuropsychiatric Disease and Treatment 2018, 14:2657-2664

Published Date: 10 October 2018

Neuropsychiatric disturbances in atypical parkinsonian disorders

Belvisi D, Berardelli I, Suppa A, Fabbrini A, Pasquini M, Pompili M, Fabbrini G

Neuropsychiatric Disease and Treatment 2018, 14:2643-2656

Published Date: 9 October 2018

Enduring effects of a five-week behavioral activation program for subthreshold depression among late adolescents: an exploratory randomized controlled trial

Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2633-2641

Published Date: 9 October 2018

Inefficient understanding of non-factive mental verbs with social aspect in adults: comparison to cognitive factive verb processing

Nazlidou E, Moraitou D, Natsopoulos D, Papaliagkas V, Masoura E, Papantoniou G

Neuropsychiatric Disease and Treatment 2018, 14:2617-2631

Published Date: 10 October 2018

Characteristics of brain functional and structural connectivity in alexithymic students

Fang Y, Li M, Mei M, Sun X, Han D

Neuropsychiatric Disease and Treatment 2018, 14:2609-2615

Published Date: 9 October 2018

Internalized stigma and its correlates among patients with severe mental illness

Szcześniak D, Kobyłko A, Wojciechowska I, Kłapciński M, Rymaszewska J

Neuropsychiatric Disease and Treatment 2018, 14:2599-2608

Published Date: 8 October 2018

Postseizure aphasia in Wernicke's encephalopathy: a case report and review of literature

Devaraj S, Muralles SA, Gill CE, Meresh E

Neuropsychiatric Disease and Treatment 2018, 14:2593-2598

Published Date: 8 October 2018

Upregulation of vitamin D-related genes in schizophrenic patients

Asadzadeh Manjili F, Kalantar SM, Arsang-Jang S, Ghafouri-Fard S, Taheri M, Sayad A

Neuropsychiatric Disease and Treatment 2018, 14:2583-2591

Published Date: 9 October 2018

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N

Neuropsychiatric Disease and Treatment 2018, 14:2519-2530

Published Date: 1 October 2018

Association between reduced quality of life and depression in patients with type 2 diabetes mellitus: a cohort study in a Mexican population

Juárez-Rojop IE, Fortuny-Falconi CM, González-Castro TB, Tovilla-Zárate CA, Villar-Soto M, Rodríguez Sanchez E, Hernández-Díaz Y, López-Narvaez ML, Ble-Castillo JL, Pérez-Hernández N, Rodríguez-Pérez JM

Neuropsychiatric Disease and Treatment 2018, 14:2511-2518

Published Date: 4 October 2018

Construct validity and reliability of the Tachikawa Resilience Scale in the Japan Ground Self-Defense Force personnel

Saito T, Nagamine M, Shigemura J, Tanichi M, Toda H, Shimizu K, Yoshino A

Neuropsychiatric Disease and Treatment 2018, 14:2505-2510

Published Date: 2 October 2018

HPA-axis genes as potential risk variants for neurocognitive decline in trauma-exposed, HIV-positive females

Jacobs S, Moxley K, Womersley JS, Spies G, Hemmings SMJ, Seedat S

Neuropsychiatric Disease and Treatment 2018, 14:2497-2504

Published Date: 28 September 2018

The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis

González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Ramirez-Bello J, Pérez-Hernández N, Genis-Mendoza AD, Fresan A, Guzmán-Priego CG

Neuropsychiatric Disease and Treatment 2018, 14:2485-2496

Published Date: 28 September 2018

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline

Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Neuropsychiatric Disease and Treatment 2018, 14:2473-2484

Published Date: 26 September 2018

Modulatory interactions of resting-state brain functional connectivity in major depressive disorder

Tu Z, Jia YY, Wang T, Qu H, Pan JX, Jie J, Xu XY, Wang HY, Xie P

Neuropsychiatric Disease and Treatment 2018, 14:2461-2472

Published Date: 28 September 2018

Subjective memory complaint as a useful tool for the early detection of Alzheimer’s disease

Choe YM, Byun MS, Lee JH, Sohn BK, Lee DY, Kim JW

Neuropsychiatric Disease and Treatment 2018, 14:2451-2460

Published Date: 24 September 2018

Automatic epilepsy detection using fractal dimensions segmentation and GP–SVM classification

Jirka J, Prauzek M, Krejcar O, Kuca K

Neuropsychiatric Disease and Treatment 2018, 14:2439-2449

Published Date: 21 September 2018

The microglial activation profile and associated factors after experimental spinal cord injury in rats

Zhou Y, Li N, Zhu L, Lin Y, Cheng H

Neuropsychiatric Disease and Treatment 2018, 14:2401-2413

Published Date: 20 September 2018

Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life

Chen CY, Wu CC, Huang YC, Hung CF, Wang LJ

Neuropsychiatric Disease and Treatment 2018, 14:2389-2399

Published Date: 19 September 2018

Low hedonic tone and attention-deficit hyperactivity disorder: risk factors for treatment resistance in depressed adults

Sternat T, Fotinos K, Fine A, Epstein I, Katzman MA

Neuropsychiatric Disease and Treatment 2018, 14:2379-2387

Published Date: 17 September 2018

PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress

Toft H, Bramness JG, Lien L, Abebe DS, Wampold BE, Tilden T, Hestad KA, Neupane SP

Neuropsychiatric Disease and Treatment 2018, 14:2367-2378

Published Date: 17 September 2018

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

Suda A, Hattori S, Kishida I, Miyauchi M, Shiraishi Y, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Moritani T, Hirayasu Y

Neuropsychiatric Disease and Treatment 2018, 14:2361-2366

Published Date: 17 September 2018

Altered spontaneous brain activity patterns in strabismus with amblyopia patients using amplitude of low-frequency fluctuation: a resting-state fMRI study

Min YL, Su T, Shu YQ, Liu WF, Chen LL, Shi WQ, Jiang N, Zhu PW, Yuan Q, Xu XW, Ye L, Shao Y

Neuropsychiatric Disease and Treatment 2018, 14:2351-2359

Published Date: 17 September 2018

A randomized controlled trial of mindfulness-based Tai Chi Chuan for subthreshold depression adolescents

Zhang JY, Qin SD, Zhou YQ, Meng LN, Su H, Zhao S

Neuropsychiatric Disease and Treatment 2018, 14:2313-2321

Published Date: 10 September 2018

Increased serum levels of sortilin-derived propeptide after electroconvulsive therapy in treatment-resistant depressed patients

Roulot M, Minelli A, Bortolomasi M, Maffioletti E, Gennarelli M, Borsotto M, Heurteaux C, Mazella J

Neuropsychiatric Disease and Treatment 2018, 14:2307-2312

Published Date: 6 September 2018

Children with autism spectrum disorders and selective mutism [Corrigendum]

Steffenburg H, Steffenburg S, Gillberg C, Billstedt E

Neuropsychiatric Disease and Treatment 2018, 14:2305-2306

Published Date: 6 September 2018

Prescreening clinical trial volunteers using an online personality questionnaire

Patrick F, Young AH, Williams SCR, Perkins AM

Neuropsychiatric Disease and Treatment 2018, 14:2297-2303

Published Date: 5 September 2018

Trajectories of callous–unemotional traits from childhood to adolescence in referred youth with a disruptive behavior disorder who received intensive multimodal therapy in childhood

Masi G, Pisano S, Brovedani P, Maccaferri G, Manfredi A, Milone A, Nocentini A, Polidori L, Ruglioni L, Muratori P

Neuropsychiatric Disease and Treatment 2018, 14:2287-2296

Published Date: 5 September 2018

Do eyes with and without optic neuritis in multiple sclerosis age equally?

Lizrova Preiningerova J, Grishko A, Sobisek L, Andelova M, Benova B, Kucerova K, Havrdova EK

Neuropsychiatric Disease and Treatment 2018, 14:2281-2285

Published Date: 5 September 2018

Victimization and posttraumatic stress disorder in homeless women with mental illness are associated with depression, suicide, and quality of life

Tinland A, Boyer L, Loubière S, Greacen T, Girard V, Boucekine M, Fond G, Auquier P

Neuropsychiatric Disease and Treatment 2018, 14:2269-2279

Published Date: 4 September 2018

Vulnerability or resilience of motopsin knockout mice to maternal separation stress depending on adulthood behaviors

Hidaka C, Kashio T, Uchigaki D, Mitsui S

Neuropsychiatric Disease and Treatment 2018, 14:2255-2268

Published Date: 4 September 2018

Association between platelet distribution width and poor outcome of acute ischemic stroke after intravenous thrombolysis

Gao F, Chen C, Lyu J, Zheng J, Ma XC, Yuan XY, Huo K, Han JF

Neuropsychiatric Disease and Treatment 2018, 14:2233-2239

Published Date: 3 September 2018

Platelet membrane receptor P2Y12 H1/H2 polymorphisms is highly associated with cerebral infarction: a case-control study

Lu SJ, Zhou XS, Zheng Q, Chen HL, Geng YL

Neuropsychiatric Disease and Treatment 2018, 14:2225-2231

Published Date: 30 August 2018

Relationship between social and cognitive functions in people with schizophrenia

Tominaga T, Tomotake M, Takeda T, Ueoka Y, Tanaka T, Watanabe SY, Kameoka N, Nakataki M, Numata S, Izaki Y, Sumitani S, Kubo H, Kaneda Y, Ohmori T

Neuropsychiatric Disease and Treatment 2018, 14:2215-2224

Published Date: 30 August 2018

Investigation of alexithymia and levels of anxiety and depression among patients with restless legs syndrome

Yılmaz O, Şengül Y, Şengül HS, Parlakkaya FB, Öztürk A

Neuropsychiatric Disease and Treatment 2018, 14:2207-2214

Published Date: 29 August 2018

Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway

Xiao Y, Zhou L, Tu Y, Li Y, Liang Y, Zhang X, Lv J, Zhong Y, Xie Y

Neuropsychiatric Disease and Treatment 2018, 14:2191-2206

Published Date: 28 August 2018

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Zhi P, Wang Y, Quan W, Su Y, Zhang H

Neuropsychiatric Disease and Treatment 2018, 14:2175-2179

Published Date: 27 August 2018

EEG correlates of induced anxiety in obsessive–compulsive patients: comparison of autobiographical and general anxiety scenarios

Kamaradova D, Brunovsky M, Prasko J, Horacek J, Hajda M, Grambal A, Latalova K

Neuropsychiatric Disease and Treatment 2018, 14:2165-2174

Published Date: 27 August 2018

Effects of behavioral activation program without psychotropic medication treatment for depression in late adolescence: case report

Takagaki K, Okamoto Y, Jinnin R, Yokoyama S, Yoshino A, Kagawa F, Okamoto Y, Miyake Y, Yamawaki S

Neuropsychiatric Disease and Treatment 2018, 14:2159-2164

Published Date: 27 August 2018

ESSENCE-Q: Slavic language versions for developmental screening in young children

Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, Petrov P, Hadžagić Ćatibušić F, Deljković A, Brkic Cvetkovic S, Vrljičak Davidovic N, Kuzmanić Šamija R, Đorić A, Gillberg C

Neuropsychiatric Disease and Treatment 2018, 14:2141-2148

Published Date: 23 August 2018

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease

Huang L, Chen KL, Lin BY, Tang L, Zhao QH, Lv YR, Guo QH

Neuropsychiatric Disease and Treatment 2018, 14:2133-2140

Published Date: 21 August 2018

Construction of an Arabic computerized battery for cognitive rehabilitation of children with specific learning disabilities

Farghaly WMA, Ahmed MA, El-Tallawy HN, Elmestikawy TAH, Badry R, Farghaly MS, Omar MS, Hussein ASR, Salamah M, Mohammed AT

Neuropsychiatric Disease and Treatment 2018, 14:2123-2131

Published Date: 21 August 2018

Investigation of chromosome Y loss in men with schizophrenia

Hirata T, Hishimoto A, Otsuka I, Okazaki S, Boku S, Kimura A, Horai T, Sora I

Neuropsychiatric Disease and Treatment 2018, 14:2115-2122

Published Date: 20 August 2018

The interactive effects of ketamine and ethanol on dopamine expression in the ventral tegmental area of rats

Zhang ZB, Xu TY, You DY, Yi S, Liu Q, Li HJ, Gu JY

Neuropsychiatric Disease and Treatment 2018, 14:2105-2114

Published Date: 20 August 2018

Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series

Yamaguchi Y, Kimoto S, Nagahama T, Kishimoto T

Neuropsychiatric Disease and Treatment 2018, 14:2099-2104

Published Date: 17 August 2018

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C

Neuropsychiatric Disease and Treatment 2018, 14:2087-2097

Published Date: 14 August 2018

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases

Bagyinszky E, Giau VV, Youn YC, An SSA, Kim SY

Neuropsychiatric Disease and Treatment 2018, 14:2067-2085

Published Date: 14 August 2018

Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years

Umezaki Y, Miura A, Shinohara Y, Mikuzuki L, Sugawara S, Kawasaki K, Tu TTH, Watanabe T, Suga T, Watanabe M, Takenoshita M, Yoshikawa T, Uezato A, Nishikawa T, Hoshiko K, Naito T, Motomura H, Toyofuku A

Neuropsychiatric Disease and Treatment 2018, 14:2057-2065

Published Date: 13 August 2018

Schizophrenia and risk of dementia: a meta-analysis study

Cai LS, Huang JW

Neuropsychiatric Disease and Treatment 2018, 14:2047-2055

Published Date: 13 August 2018

Social communication disorder: a narrative review on current insights

Topal Z, Demir Samurcu N, Taskiran S, Tufan AE, Semerci B

Neuropsychiatric Disease and Treatment 2018, 14:2039-2046

Published Date: 13 August 2018

Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive–compulsive disorder

Hasanpour H, Ghavamizadeh Meibodi R, Navi K, Asadi S

Neuropsychiatric Disease and Treatment 2018, 14:2027-2038

Published Date: 10 August 2018

Associations between stress and depression symptom profiles vary according to serotonin transporter polymorphism in rural Australians

Sharpley CF, Bitsika V, McMillan ME, Jesulola E, Agnew LL

Neuropsychiatric Disease and Treatment 2018, 14:2007-2016

Published Date: 10 August 2018